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ABSTRACT OF DISSERTATION
COMPARATIVE CHONDROGENESIS OF INTERZONE AND ANLAGEN CELLS
IN EQUINE SKELETAL DEVELOPMENT
At the presumptive sites of future synovial joints during mammalian skeletogenesis, articular
cartilage develops from interzone located between the cartilaginous anlagen of bones. Thus,
two types of cartilaginous tissues differentiate in close proximity. While anlagen cartilage is
transient, progressing through endochondral ossification to form bones, articular cartilage is
stable and functions throughout life to facilitate both low friction movement and load
distribution. Despite important life-long functional properties, articular cartilage has a very
limited intrinsic ability to repair structural defects. On the other hand, structural lesions in
bones generally heal well by forming a cartilaginous callus and recapitulating endochondral
ossification to repair fractures and other defects. Therefore, understanding the comparative
aspects of interzone and anlagen cell differentiation may provide novel insights into emergent
cell-based therapies to support articular cartilage regeneration. The objective of this
dissertation research was to compare patterns of gene expression between equine interzone
and anlagen cells across multiple post-induction time points to test the hypothesis that
chondrogenic differentiation of these two cell lines is directed to articular and hypertrophic
developmental pathways, respectively. The first part of the study was conducted using
microfluidic RT-qPCR to analyze a selected panel of 93 genes. The data provided evidence that
genes involved in transcriptional regulation and signaling transduction are differentially
expressed as early as 1.5 hours after the start of chondrogenic induction, followed at later
time points by effector genes such as those encoding cartilage matrix proteins. Then, RNA
sequencing was used to expand the analyses at selected time points to a whole transcriptome
level. A pilot single cell RNA sequencing experiment further described the two chondrogenic
pathways characterizing subpopulations of these skeletal cell lines. Taken together, the results
demonstrated that interzone and analgen cells respond very quickly but in different ways to
the same inductive signals. Important regulatory mechanisms are likely activated almost
immediately, within a few hours, after chondrogenic induction. These differential regulatory
responses progress to cell type-specific profiles of effector genes that result in the two
different cartilaginous tissues.
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Chapter 1. Introduction

Articular cartilage and joint health
Articular cartilage is a hyaline tissue lining the ends of bones on opposing surfaces in
diarthrodial joints. Unlike other hyaline cartilage in the body, such as cartilage in the nose,
larynx, trachea, or ribcage, articular cartilage is not covered by perichondrium; instead, it is
encapsulated by a synovial membrane and surrounded by synovial fluid, from which nutrients
are delivered to the tissue. The fibrous synovial joint capsule connects the perimeter articular
surfaces on adjoining bone surfaces, anatomically delineating the total diarthrodial joint
structure.

On a broad component level, articular cartilage consists of 65 – 80% water, 10 – 25%
extracellular matrix (ECM), and 10% cells—articular chondrocytes, which produce the ECM
(Fisher et al., 2019). The composition of the ECM in dry matter is 50% collagens (primarily
type II and type IX), and the other 50% is non-collagenous proteins such as proteoglycans (e.g.,
aggrecan) and glycosaminoglycans (e.g., cartilage oligomeric matrix protein and hyaluronan;
Lane and Weiss, 1975). The cells and ECM in articular cartilage are organized in a zonal
structure: 1) superficial tangential zone, 2) middle zone, and 3) deep zone in order from the
surface towards the subchondral bone. The border between articular cartilage and the
subchondral bone is demarcated by the “tidemark,” a calcified cartilaginous junction.
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In the superficial zone, articular chondrocytes are flattened, somewhat smaller in size,
and relatively densely arranged. Cells become round in shape and are sparsely distributed in
the middle zone. Towards the deep zone, chondrocytes are stacked together, making short
columns, and arranged perpendicular to the surface. Approaching the subchondral bone,
chondrocytes become hypertrophic and calcify the ECM (Figure 1.1).

a)

b)

Figure 1.1. Structure of articular cartilage. a) Collagen fiber architecture; b) Cellular
organization across the zones of articular cartilage (Copyright, Ondrésik et al., 2017,
reproduced with permission)

The ECM is also arranged differently across the zones. Collagen fibrils, which make up a
major part of the ECM content, are oriented parallel to the surface in the superficial zone and
become isometrically distributed in the middle zone. Parallel to chondrocyte columns,
collagen fibrils orient to a more vertical arrangement in the deep zone (Figure 1.1). At the
same time, proteoglycan content becomes greater in the middle zone and the deep zone
2

compared to the superficial zone. Aggrecan is the major proteoglycan in articular cartilage
and is highly sulfated and heavily glycosylated, which gives it a net negative electrostatic
charge. This protein binds to hyaluronan and captures water, creating osmotic swelling
pressure, and its interaction with collagens endows colloidal properties. Altogether, the
characteristics of the ECM provide tensile strength and compressive stiffness of articular
cartilage. This smooth, tough tissue facilitates low friction movement, shock absorption, and
weight load distribution. Articular cartilage is a stable tissue, which maintains its structure
and functions throughout life.

Despite its important biomechanical functions, traumatic injuries in articular cartilage
often manifest as chronic arthritis and are the most prevalent joint diseases in various animals
including humans, livestock animals, companion animals, and horses. Among the US equine
population, chronic joint problems are the most common reason for lameness (20.9% of lame
resident horses; USDA, 2017). Although the occurrence of articular cartilage degenerative
diseases generally increases with age (USDA, 2017), these joint injuries are even more
problematic in younger horses because their “product” usually centers on athletic
performance. Horses, the primary patient population of interest in our laboratory, have
several advantages as a model animal for these studies. In addition to the fact that the
thickness of articular cartilage is comparable between horses and human (Sophia et al., 2009),
several logistical challenges involving technical issues that would be present with small rodent
models can be avoided with horses. The fetal limb buds are only a couple of millimeters in
length even in horses, and isolating interzone and analgen cells from this small tissue is
extremely difficult with smaller animal models and typically requires laser dissection
3

techniques and very limited cell yields. Also, horses are athletic individuals and therefore
aspects of the data obtained from equine samples will be more relevant to the further
translational experiments that address specific biomedical questions related to sport
medicine.

While articular cartilage degeneration is frequently seen in synovial joints, the tissue’s
intrinsic ability to restore structural defects is very limited in mature mammals (Alford and
Cole, 2005). Located in a hypoxic environment, this tissue is aneural, avascular, and
alymphatic; these are the reasons why its degeneration is more troublesome. Because the
tissue does not have any nerves, even though it is injured, the afflicted individual does not
perceive pain directly from the articular cartilage. Nociceptive neurons would be located in
the surrounding tissues such as the subchondral bone area or joint capsule. Furthermore,
because this tissue does not have blood and lymph vessels, materials and factors needed for
the tissue regeneration need to diffuse across large distances, which hinders the intrinsic
tissue repair. Therefore, clinical interventions are challenged and efforts to support articular
cartilage restoration met with limited success.

For this purpose, emergent cell-based therapies in articular cartilage regenerative
medicine are being commonly applied; mesenchymal stem cells with multipotent
differentiation potential are treated with chondrogenic induction factors and transplanted
into articular cartilage lesions. Clinical outcomes to date, however, continue to have
frustratingly limited success. The repaired tissue is often fibrous (fibrocartilage), and
chondrocytes in repaired cartilage may undergo hypertrophy, followed by calcification of the
4

ECM (Beris et al., 2005, Caldwell and Wang, 2015). Thus, repaired cartilage has inferior
biomechanical function and durability compared to normal articular cartilage, and therefore,
the performance of the animal would be deteriorated. Further research is still required to
improve clinical approaches for supporting articular cartilage regeneration.

Fetal limb skeletal development
To advance current articular cartilage regenerative medicine, consideration of the normal
developmental processes that generate limb skeletal elements may provide novel insights. In
early embryonic stages, mesenchymal cells derived from the paraxial/lateral mesoderm
aggregate together at a presumptive site of a limb. This mesenchymal condensation then
undergoes chondrogenic differentiation forming a continuous, uninterrupted cartilaginous
limb bud. Then, this cartilaginous tissue becomes properly segmented, resulting in several
cartilaginous anlagen, which serve as templates for limb bones (Pitsillides and Ashhurst, 2008,
Decker et al., 2014).

Between those cartilaginous tissues, “interzone” tissue develops, and cells in this region
change their morphology, becoming flattened and densely packed. This tissue is characterized
by paused chondrogenesis. At early stages in fetal development, multiple synovial joint
elements—ligament, joint capsule, synovial membrane as well as articular cartilage—develop
from this layer of interzone cells. As synovial joint formation proceeds in mammals, the space
between adjoining bone surfaces becomes cavitated. During these processes, a portion of
interzone cells resume chondrogenic differentiation for articular cartilage formation (Figure
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1.2). Once articular chondrocytes are differentiated, these cells are stable, maintaining
articular cartilage on the joint surface location for life.

Figure 1.2. Synovial joint formation
(Copyright: Moskalewski et al., 2013,
reproduced with permission)

At the same time, cartilaginous anlagen undergo terminal hypertrophic differentiation.
Starting from the center of each anlage, chondrocytes rapidly proliferate, maturate, and start
expressing hypertrophic ECM such as collagen type X. Then, the tissue becomes calcified,
preventing the chondrocytes from approaching nutrients and in turn, resulting in apoptosis
(Ham, 1952, Cameron, 1963). The cell death generates vacancy in the anlagen and allows
blood vessels to invade the hypertrophic regions. The blood brings osteogenic factors and cells
into the anlagen, establishing the primary ossification centers. Finally, the medullary cavity
becomes enlarged, and hypertrophic cartilage is replaced by bone tissue in the normal process
of bone formation, which is termed endochondral ossification (Figure 1.3). Thus, anlagen
chondrocytes are transient.

6

Mesenchymal stem cells

a)

Chondrocytes
Hypertrophic chondrocytes

b)

Terminally hypertrophic
chondrocytes
c)

d)

Figure 1.3. Endochondral ossification. a) Mesenchymal condensation; b) Chondrocyte
differentiation; from the center of the mesenchymal condensation, cells differentiate into
chondrocytes; c) Chondrocyte maturation; chondrocytes at the center of the cartilaginous
anlage undergo hypertrophy until terminal stages; d) Cartilage vascularization; blood vessels
(red lines) invade the center of the hypertrophic zone, and vascular invasion leads to
resorption of cartilaginous matrix and deposition of bone (black) within the medullary cavity
(Copyright: Long and Ornitz, 2013, reproduced with permission).
These two different developmental chondrogenic processes—one directed towards
articular cartilage development and the other directed towards hypertrophic differentiation
leading to bone formation—occur simultaneously and in close proximity. As a result of
recapitulating developmental processes, fractured bones actually repair quite well, provided
that the fracture is reduced, stabilized, and not compromised by infection or loss of blood
supply. In stark contrast mammalian articular cartilage has limited potential for tissue
regeneration.
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Interestingly, as demonstrated roughly a decade ago in our laboratory, some vertebrate
species such as mature axolotl salamanders retain interzone-like tissue in their distal limb
joints which provides this amphibia with the ability to restore even large articular cartilage
defects (Cosden et al., 2011). Furthermore, this axolotl interzone-like tissue has the potential
to generate an entirely new diarthrodial joint de novo within a skeletal microenvironment
(Cosden-Decker et al., 2012). These axolotl studies demonstrated the potential of interzone
cells, which do not undergo hypertrophic differentiation, to regenerate articular cartilage
tissue. Taken together, this developmental biology and previous literature suggest that
understanding developmental processes of limb skeletal elements and the comparative
aspect of interzone and anlagen cells may well provide important information to advance
therapeutic approaches for mammalian articular cartilage regeneration.

Molecular mechanisms involved in limb skeletal development
The homeobox (HOX) gene family of transcription factors is well-conserved across the
species. These genes are widely involved in embryonic developmental processes and
participate in axial patterning. Mammalian HOX paralogs (HOXA-D) are located on four
separate chromosomes and their functional annotations are more similar to their own
paralogs on the other chromosomes compared to their neighboring HOX genes on the same
chromosome. The relative location within a chromosome defines their groups: anterior
(HOX1-5), central (HOX6-8), and posterior (HOX9-13) clusters from the 3’ end to the 5’ end.
While the HOX genes generally establish the anterior-posterior axis in the body, the posterior
HOX genes (HOX9-13) are also involved in limb fields specification and appendicular skeletal
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(limb) patterning (Mohanty-Hejmadi et al., 1992, Nelson et al., 1996, Pineault and Wellik,
2014). Along a limb bud, from proximal to distal, the posterior HOX genes are collinearly
expressed as their relative location on chromosomes; HOX9 and 10 patterns the stylopod,
HOX11 patterns the zeugopod, and HOX13 patterns the autopod. In the earlier developmental
stages, their expression gradually overlaps while it is collinear. However, the expression
patterns become restricted in the specific regions within the limb as development progresses.

At the presumptive sites of limbs, mesenchymal cells derived from the mesoderm come
together in an aggregate structure to form limb buds, a process induced by FGF10 (Sekine et
al., 1999). In an in vitro study, transforming growth factor beta 1 (TGF-1) treatment resulted
in chondrogenic differentiation in limb mesenchymal cells preceding the condensation,
suggesting TGF-1 may stimulate chondrogenesis during cartilage pattern formation (Leonard
et al., 1991). The mesenchymal condensation and initial chondrogenesis are regulated by
SOX9 expression and result in the production of a cartilaginous ECM, such as collagen type II
and aggrecan core protein (Bi et al., 1999, Akiyama et al., 2002). This undisturbed cartilaginous
tissue becomes subdivided into several anlagen, and each segment is strongly correlated with
the spatially discrete domains of HOX9-13 expression (Nelson et al., 1996). Between these
cartilaginous anlagen—at the future joint sites, cells begin expressing interzone marker genes
(GDF5, WNT9A, and ENPP2) and stop expressing cartilaginous genes (Karsenty and Wagner,
2002, Pacifici et al., 2005). A portion of these interzone cells resume chondrogenesis and
differentiate into articular chondrocyte, however, the molecular and cellular mechanisms
have not been fully understood.
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Some of the major cytokines that promote both chondrogenesis and hypertrophy in
various cell lines are members of the transforming growth factor beta (TGF-β) family
(Goldsmith et al., 2006, Dobaczewski et al., 2011, Wang et al., 2014). While multiple TGF-β
ligands can bind to multiple TGF-β receptors, the downstream events are mediated by various
combinations of receptors including, TGF-β receptor type I (ALK1, and ALK5), type II (TGFBR2),
and type III (TGFBR3; Figure 1.4). Also, these downstream signals can have different effects on
limb skeletal development (Wang et al., 2014). The two canonical SMAD-dependent pathways
are transduced by TGFBR2 and ALK5 and by TGFBR2 and ALK1. On the other hand, the
noncanonical SMAD-independent pathway is transduced by TGFBR3 and ALK5 (Iwata et al.,
2012). TGFBR3 not only transduces the noncanonical TGF-β pathway, but also facilitates the
TGFBR2 and ALK5 mediated canonical TGF-β pathway by providing stable ligands (Shi and
Massagué, 2003). The canonical TGF-β pathway mediated by ALK5 activates SMAD2 and
SMAD3, which are transcription factors promoting production of collagen type II and aggrecan
core protein. Articular cartilage phenotypes are induced and maintained by SMAD2/3
signaling, which represses RUNX2-inducible MMP13 expression (Chen et al., 2012). Also, the
noncanonical TGF-β pathway has been reported to interact with SMAD2/3 signaling
(Watanabe et al., 2001). Yet, the canonical pathway mediated by ALK1 induces hypertrophic
differentiation by activating Smad1/5/8 (Nishida et al., 2013). However, the roles of the
noncanonical TGF-β pathway in chondrocyte hypertrophy are still unclear (Wang et al., 2014).
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Figure 1.4. TGF-β signaling pathways in cartilage formation and maintenance (Copyright:
Wang et al., 2014, reproduced with permission).

In summary, various genes and signaling pathways are involved in molecular and cellular
mechanisms that regulate the process and sequence of limb skeletal development. Thus,
investigating kinetics or interactions of gene expression during these processes should help to
elucidate the molecular mechanisms of the binary decision that is made by chondrocytes
within a fetal limb bud, in which one population of cells take a non-hypertrophic program to
stable articular cartilage, while others progress through terminal hypertrophic differentiation
leading to osteogenesis. An important knowledge gap is whether interzone and anlagen cells
are intrinsically determined to become articular cartilage and hypertrophic cartilage,
respectively. If so, critical questions arise regarding the identity of the molecular regulators
and the plasticity in their commitment to these two developmental pathways.
11

Advances in technologies for gene expression evaluation
As the intricacy of biology have become more revealed, molecular approaches
investigating the expression of a greater number of genes with a larger sample numbers have
been developed. Today, “high throughput” capabilities have become a priority for studying
gene expression leading to a diverse set of powerful technologies.

While conventional reverse transcription-quantitative polymerase chain reaction (RTqPCR) has enabled sensitive and reproducible measurements in gene expression, this method
is quite labor-intensive and expensive, requiring a greater volume of samples and reagents.
Overcoming the disadvantages of conventional RT-qPCR systems, microfluidic RT-qPCR
technology has allowed gene expression measurements from a number of targeted gene loci
with a smaller amount of starting materials (both reagents and samples). By channeling
reagents and cDNA samples within a microfluidic chip, thousands of gene expression reactions
are simultaneously measured, and the reaction volume is scaled down to a nanoliter scale
compared to traditional systems requiring microliters of reaction volumes. The microfluidic
RT-qPCR systems work well for experiments investigating a defined set of target transcripts of
interest.

On the other hand, gene expression can be assessed at the whole transcriptome level
using next generation sequencing platforms. By profiling transcriptomic signatures, RNAsequencing (RNA-seq) evaluates expression of not only genes that have been conventionally
considered biomarkers or biologically relevant to the research subjects, but also genes that
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have not been identified in their roles or have received less scientific attention. While
traditional, bulk RNA-seq systems measure overall gene expression from all cells existing in a
sample, single cell RNA-seq can separately profile the transcriptome from individual cells
within a sample. Since single cell RNA-seq is still emerging and is a relatively novel technology,
the high expense can be a barrier to broad use. However, single cell methods are rapidly
bringing to consideration new and novel opportunities in transcriptome research.

Overview of the dissertation
In this dissertation, chondrogenic divergence between equine fetal interzone and anlagen
cell cultures was studied using various, advanced technologies for evaluating gene expression.
The overall hypothesis tested in the present research project was that chondrogenic
differentiation of interzone and anlagen cells is directed to articular and hypertrophic
developmental pathways, respectively. In Chapter 2, using microfluidic RT-qPCR, the
expression kinetics of 93 selected genes was evaluated at ten different time points during the
336-hour in vitro chondrogenesis. The hypothesis tested in this first study was that
chondrogenic divergence between the two fetal skeletal cell lines will become evident within
an earlier time frame—within the first 24 hours—after initiating the chondrogenic induction.
Then, five time points prioritized based on the data from Chapter 2, and the different
chondrogenic pathways between interzone and anlagen cells were further investigated in
Chapter 3 using traditional, bulk RNA-seq. This study tested the hypothesis that regulatory
genes will differentially respond to the chondrogenic stimulation between the two skeletal
cell cultures within the first 1.5 hours, and more distinctive transcriptomic characteristics will

13

accumulate as time passes during the 96-hour experimental period. In addition, a pilot single
cell RNA-seq study is reported in Chapter 4. The hypotheses of this pilot study were that
interzone and analgen cell pellet cultures will develop different levels of heterogeneity in cell
subpopulations at 24h and 48h after inducing chondrogenesis, and these fetal cell lines will
present cell type-unique traits as well as common chondrogenic characteristics. In closing,
Chapter 5 summarizes the studies conducted for this dissertation project and indicates future
research directions. Altogether, the new kinetics information on gene expression in interzone
and anlagen cell cultures will not only enhance our understanding of these two
developmental cell types, but also lay a foundation for future studies investigating novel
therapeutic approaches to enhance articular cartilage repair.
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Chapter 2. Kinetics of gene expression changes in equine fetal interzone and anlagen cells
during 14 days of in vitro chondrogenesis

Introduction
During the early stages of limb formation, articular cartilage develops from interzone
located at the presumptive sites of future synovial joints within the cartilaginous anlagen of
bones. Therefore, two different types of cartilage differentiate in close proximity. While
anlagen cartilage is transient, progressing through endochondral ossification to form bones,
articular cartilage remains stable and functions throughout life to facilitate biomechanical
load distribution and low friction movement between adjoining bone surfaces. Despite the
important functional properties of articular cartilage, its intrinsic ability to restore structural
defects is limited in mature mammals (Alford and Cole, 2005). Almost the polar opposite is
true regarding the potential for bone tissue regeneration. Fractured bones repair quite well
by recapitulating endochondral ossification; provided the fracture ends are brought together,
stabilized, and not compromised by infection or loss of blood supply. Thus, research on the
comparative cell biology between interzone and anlagen cells, as well as their developmental
chondrogenic pathways may provide novel information relevant to improving mammalian
articular cartilage regenerative treatments.

In an effort to understand the biology of fetal interzone and anlagen cells, their
chondrogenic potential was measured and compared after 21 days in three dimensional pellet
culture and continuous stimulation with a chondrogenic induction medium containing
transforming growth factor beta 1 (TGF-β1; Adam et al., 2019). The results demonstrated that
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interzone and anlagen cultures respond differently to chondrogenic stimulation based on
expression of cartilaginous marker genes, such as aggrecan core protein (ACAN) and collagen
type II alpha 1 chain (COL2A1). Also, the cell pellets showed distinguishing histological
characteristics, including proteoglycan amount and distribution, as well as cellular
morphology and arrangement. In other research studies, the protocol for in vitro
chondrogenic differentiation has also been reported after 21 days, with the expression of
extracellular matrix (ECM) genes measured at the mRNA or protein level used as targeted
functional outcomes (McCarthy et al., 2012, Rakic et al., 2018). However, gene expression
changes induced by TGF-β, a well-established chondrogenic factor, start as early as 30 minutes
to 1 hour after treating TGF-β in culture (Franco et al., 2010, Aomatsu et al., 2011). Molecular
details of these early responses are not fully understood, so an important gap of knowledge
is whether there are qualitative or quantitative differences of gene expression kinetics over
time in these two chondrogenic cell cultures.

By comparing a timed sequence of the cellular response to TGF-β1 induced
chondrogenesis between interzone and anlagen cell cultures, the present study was designed
to answer the following questions: 1) how do gene expression patterns change over time and
2) when do the differential pathways of the two cell types start to diverge in this in vitro
chondrogenesis model? The hypothesis tested in this study is that divergent chondrogenic
differentiation pathways in interzone and anlagen cultures will be evident within the first 24
hours after in vitro chondrogenic induction.
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Materials and Methods
Cell culture and sample collection
Equine fetal interzone cells, anlagen cells, and dermal fibroblasts (a negative control) were
previously harvested from seven 45-days-old fetuses (Adam et al., 2019), and the cells were
frozen and stored at passage 2 (P2). Using standard protocols, frozen cells were thawed and
cultured in T-75 polystyrene flasks with high glucose Dulbecco's modified Eagles medium
(DMEM; cat No. 10569044; Gibco) supplemented by 10% (v/v) fetal bovine serum (heat
inactivated; cat No. S11150H; Atlanta Biologicals) and 1% (v/v) penicillin/streptomycin (P/S;
cat No. 15070063; Gibco) and termed ‘complete medium’ in this study. When the cell
monolayers reached approximately 80% confluence, the adherent cells were lifted by 0.25%
Trypsin-EDTA solution (cat No. 25200056; Gibco) and split into new flasks (seeding density of
10,000 cells/cm2). Cell viability in the suspension of >95% was confirmed by trypan blue dye
exclusion test.

When P4 monolayers reached >80% confluence, a portion of the cells were used to collect
total RNA. The cells were harvested in a guanidinium thiocyanate solution (1ml/T-75 flask;
QIAzol Lysis Reagent; cat No. 79306; Qiagen), immediately snap-frozen, and stored at –80°C
until total RNA isolation. The rest of P4 monolayers were lifted by trypsin digestion, and
chondrogenic cell pellets were established at P5 as previously described (Adam et al., 2019).
Each cell pellet was comprised of 500,000 viable cells and maintained in chondrogenic
induction medium (high glucose DMEM + 1% P/S + bovine serum albumin, 12.5 mg/ml +
ascorbic-2-phosphate, 50 µg/ml + TGF-β1 (Transforming Growth Factor-β1 human; cat No.
T7039-50UG; Sigma-Aldrich), 10 ng/ml + 1% insulin-transferrin-selenium-sodium pyruvate +
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Dexamethasone, 100 nM + 1% nonessential amino acid) for the full culture period.

Aliquots of pellet cultures were collected at ten different time points: baseline (0h), 1.5,
3, 6, 12, 24, 48, 96, 168, and 336 hours after the initiation of the chondrogenic induction.
These time points were selected based on a literature review (Ranganathan et al., 2007, Rudini
et al., 2008, Franco et al., 2010, Aomatsu et al., 2011, Koyama et al., 2013, Nejadnik et al.,
2015, Yokota et al., 2014, Yamazaki et al., 2015) to assess the kinetics of gene expression over
time after the TGF-β1 treatment in the cell pellet cultures. At each time point, the collected
pellets were washed with phosphate-buffered saline (PBS), snap-frozen (3 pellets/vial), and
stored at –80°C until total RNA isolation.

Total RNA isolation
Thawed cell monolayers and pellets (3 pellets per 1 ml of the guanidinium thiocyanate
solution) were homogenized using a PowerGen homogenizer (Model 125; Fisher Scientific).
Total RNA was then extracted and purified using a spin-column based RNeasy Mini kit (cat No.
74106; Qiagen) followed by ethanol precipitation. The quantity of RNA was determined using
a Qubit™ RNA Broad Range Assay Kit (cat No. Q10211; Life Technologies) with a Qubit® 3.0
Fluorometer (cat No. Q33216; Life Technologies), and the 260/280 and 260/230 ratios were
measured by a Nano Drop ND 1000 spectrophotometer (Thermo Fisher Scientific). Finally,
RNA integrity numbers (RIN) were determined using a Bioanalyzer 2100 (Agilent Technologies)
with an Agilent RNA 6000 Pico kit (cat No. 5067-1513; Agilent Technologies) to assess the
quality of the RNA samples. The monolayer RNA samples resulted in 260/280 ratios of 2.0 –
2.1, 260/230 ratios of 2.3 – 2.7, and RINs of 8.7 – 10, except for one sample that showed a RIN
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of 6.8. A substantial majority of cell pellet RNA samples had 260/280 ratios of 1.8 – 2.1,
260/230 ratios of 1.8 – 2.7, and RINs of 6.4 – 10. Out of 210 cell pellet RNA samples, ten
samples had 260/230 ratios outside of this range, but gene expression patterns were
consistent with experimental group averages so the data were retained. Any potential
genomic DNA contamination was removed with dsDNase (cat No. K1672; Thermo Fisher
Scientific) during reverse-transcription protocol using the Maxima First Strand cDNA Synthesis
Kit for RT-qPCR (cat No. K1672; Thermo Fisher Scientific). The cDNA samples were then stored
at –20°C pending qPCR analysis.

Quantitative polymerase chain reaction (qPCR)
1) Targeted gene loci
Three prospective endogenous control genes, B2M, GUSB, and RPLP0 (Mienaltowski et
al., 2008) were evaluated in a preliminary RT-qPCR analysis conducted on a subset (n=2) of
the entire sample set. Ninety-three genes (Table 2.1) of interest were selected for analysis
based on equine cartilaginous tissue RNA-seq data generated in the MacLeod lab (Adam et
al., in preparation) and a literature review. The earlier data or published reports from these
genes were either 1) differentially expressed between interzone and anlagen tissue samples
at three developmental ages (day-45 fetuses, day-60 fetuses and neonatal foals), 2)
functionally annotated to include fetal developmental processes, 3) known to be involved in
chondrogenic differentiation or 4) established components or regulators of TGF-β signaling
pathways.
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These 96 gene loci were studied with commercially available (59 assays) and customized
(37 assays) equine-specific TaqMan® primer-probe sets (Thermo Fisher Scientific; Table 2.1).
Where possible, the primer-probe sets were designed to span two exons (88 assays), with
eight assays designed within a single exon.

20

Table 2.1. The panel of 96 equine specific TaqMan® primer-probe sets used in the RT-qPCR
analysis
Gene
symbol

Gene name

ThermoFisher
cat IDa

Predicted
amplicon
length, nt

Spanning
exon design

EquCab 3.0
amplicon
coordinates

ABCC9

ATP Binding Cassette
Subfamily C Member 9

ARZTE9G

89

Spanning 2
exons

6:4922410149222665

ABI3BP

ABI Family Member 3
Binding Protein

Ec06625599_m1

57

Spanning 2
exons

19:57461128
-57461991

ADAMTS5

ADAM
Metallopeptidase with
Thrombospondin Type
1 Motif 5

Ec03470666_m1

73

Spanning 2
exons

26:25148986
-25137605

ADGRG1

Adhesion G ProteinCoupled Receptor G1

ARPRK7Z

75

Spanning 2
exons

3:1054164710542471

ADGRG2

Adhesion G ProteinCoupled Receptor G2

ARU63XT

93

Spanning 2
exons

X:1485881314858548

ALPK3

Alpha Kinase 3

Ec07042890_g1

60

Spanning 2
exons

1:9321101193210198

ALPL

Alkaline Phosphatase,
Biomineralization
Associated

ARYMKNG

120

Spanning 2
exons

2:3312104633118823

ANGPTL4

Angiopoietin Like 4

Ec06997549_m1

62

Spanning 2
exons

APLNR

Apelin Receptor

Ec07019415_s1

82

Single exon

7:60656576066055
12:20444024
-20443928

AQP1

Aquaporin 1 (Colton
Blood Group)

AR2W9UC

82

Spanning 2
exons

4:6160135561601398

ARHGEF15

Rho Guanine
Nucleotide Exchange
Factor 15

Ec07058476_g1

68

Spanning 2
exons

11:51540160
-51540207

ASS1

Arginosuccinate
Synthase 1

Ec06982992_g1

66

Spanning 2
exons

25:33865022
-33867929

B2Mb

Beta-2-Microglobulin

Ec03468699_m1

70

Spanning 2
exons

1:145964634
-145961332

BMP2

Bone Morphogenetic
Protein 2

ARRWFTX

55

Spanning 2
exons

22:16917593
-16910100

BMPR1A

Bone Morphogenetic
Protein Receptor Type
1A

ARWCXHP

88

Spanning 2
exons

1:8443110884427100

BOC

Boc Cell Adhesion
Associated, Oncogene
Regulated

ARZTE9E

120

Spanning 2
exons

19:47322846
-47322396

CDH13

Cadherin 13

Ec03469102_m1

58

Spanning 2
exons

3:3176261931825090
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CDON

Cell Adhesion
Associated, Oncogene
Regulated

ARWCXHM

85

CHODL

Chondrolectin

Ec06984006_m1

66

CLU

Clusterin

Ec03468570_m1

133

COL10A1

Collagen Type X Alpha 1
Chain

ARXGR3J

73

Ec03469676_m1

154

Ec03467411_m1

81

COL1A1
COL2A1

Collagen Type I Alpha 1
Chain
Collagen Type II Alpha 1
Chain

Spanning 2
exons

7:3601046536005823

Spanning 2
exons
Spanning 2
exons

26:17451675
-17451892
2:5655921556557872

Spanning 2
exons

10:65872577
-65868970

Spanning 2
exons
Spanning 2
exons

11:26002328
-26002234
6:6651913166518656

COL5A3

Collagen Type V Alpha 3
Chain

Ec06999559_g1

56

Spanning 2
exons

7:5167949651679953

COMP

Cartilage Oligomeric
Matrix Protein

Ec03468072_m1

111

Spanning 2
exons

21:39881053988046

CREB5

Camp Responsive
Element Binding
Protein 5

AR323D9

77

Spanning 2
exons

4:5976141859766406

CTGF

Connective Tissue
Growth Factor

ARDJYMK

105

Spanning 2
exons

10:79344899
-79344651

DCN

Decorin

Ec03468474_m1

102

Spanning 2
exons

28:18029682
-18025682

DIO2

Iodothyronine
Deiodinase Type II

Ec04320470_m1

86

Spanning 2
exons

24:25082308
-25074448

DLX5

Distal-Less Homeobox 5

ARCE42N

147

Spanning 2
exons

4:4025572540254648

ENTPD1

Ectonucleoside
Triphosphate
Diphosphohydrolase 1

Ec07040532_m1

81

Spanning 2
exons

1:3347430833473045

ENTPD2

Ectonucleoside
Triphosphate
Diphosphohydrolase 2

Ec06983692_g1

62

Spanning 2
exons

25:39221285
-39220720

FAM132A

C1q and TNF Related 12

AR323EC

90

Spanning 2
exons

2:4863643148636589

FAM20A

Golgi Associated
Secretory Pathway
Pseudokinase

Ec07054339_m1

59

Spanning 2
exons

11:12154761
-12155583

FGF1

Fibroblast Growth
Factor 1

Ec01092738_m1

104

Spanning 2
exons

14:33844480
-33856602

FGF18

Fibroblast Growth
Factor 18

Ec03248217_g1

59

Spanning 2
exons

14:90703149056898

FGFR3

Fibroblast Growth
Factor Receptor 3

Ec03470545_m1

118

Spanning 2
exons

3:120236405
-120235774

22

FRZB

Frizzled Related Protein

ARYMKNJ

79

Spanning 2
exons

18:60567720
- 60563791

FZD1

Frizzled Class Receptor
1

ARFVMTG

82

Single exon

4:3519320135193296

GALNT14

Polypeptide N-Acetyl
Galactosaminyl
Transferase 14

Ec06950408_m1

62

Spanning 2
exons

15:66761932
-66787897

GDF5

Growth Differentiation
Factor 5

Ec04321108_s1

89

Single exon

22:27084232
-27084125

GDF6

Growth Differentiation
Factor 6

Ec07097112_m1

102

Spanning 2
exons

9:4421693144202151

GLI3

GLI Family Zinc Finger 3

ARFVMTF

128

GUSBb

Glucuronidase Beta

Ec03470630_m1

73

Spanning 2
exons
Spanning 2
exons

4:1305472213053538
13:18879647
-18882340

IBSP

Integrin Binding
Sialoprotein

ARGZGDD

96

Spanning 2
exons

3:5143194151431805

IGF2

Insulin-Like Growth
Factor 2

Ec03469397_m1

158

Spanning 2
exons

12:34442429
-34440361

IGFBP5

Insulin-Like Growth
Factor Binding Protein 5

Ec03470296_m1

62

Spanning 2
exons

6:64003716386883

IGFBP7

Insulin-Like Growth
Factor Binding Protein 7

Ec03469608_m1

85

IHH

Indian Hedgehog

Ec03470108_m1

61

ITGA7

Integrin Subunit Alpha
7

Ec06982346_m1

96

Spanning 2
exons
Spanning 2
exons
Spanning 2
exons

ITGAV

Integrin Subunit Alpha
V

Ec03469608_m1

125

Spanning 2
exons

3:7768196677682663
6:83926338390869
6:7438475374382727
18:
6363209763636322

KCNJ8

Potassium Inwardly
Rectifying Channel
Subfamily J Member 8

AR7DRH4

94

Spanning 2
exons

6: 4919636349192450

LEF1

Lymphoid Enhancer
Binding Factor

AR7DRH3

90

Spanning 2
exons

2:117834151
-117834210

LOC100630
171

Regakine-1

Ec07014483_s1

86

Single exon

11:37560494
-37560588

MASP1

Mannan Binding Lectin
Serine Peptidase 1

Ec06960466_m1

73

Spanning 2
exons

19:27583128
-27580854

MET

MET Proto-Oncogene,
Receptor Tyrosine
Kinase

Ec02622441_m1

68

Spanning 2
exons

4:7411369874115265

MGP

N-Methylpurine DNA
Glycosylase

ARKA4G9

78

Spanning 2
exons

6:4350558143504668

23

MMP2

Matrix
Metallopeptidase 2

Ec03469994_m1

71

Spanning 2
exons

3:83440848345058

NEFL

Neurofilament Light

Ec06966469_m1

76

Spanning 2
exons

2:5393663053936597

NPY

Neuropeptide Y

Ec06946514_m1

75

Spanning 2
exons

4:5589949855901429

NTRK2

Neurotrophic Receptor
Tyrosine Kinase 2

Ec07025737_s1

104

Single exon

23:5298376 5298260

OMD

Osteomodulin

AR47WX6

118

Spanning 2
exons

23:55155149
-55155748

OSR2

Odd-Skipped Related
Transcription Factor 2

Ec07007011_m1

128

Spanning 2
exons

9:46596059 46596942

PANX3

Pannexin 3

ARAACGR

134

PDLIM1

PDZ and LIM Domain 1

Ec07040588_m1

65

Spanning 2
exons
Spanning 2
exons

7:3419515234197741
1:3395784033958350

PLAT

Plasminogen Activator,
Tissue Type

Ec06985220_g1

58

Spanning 2
exons

27:32773263278021

PLVAP

Plasmalemma Vesicle
Associated Protein

Ec06971069_m1

101

Spanning 2
exons

21:29657012963843

PRKG2

Protein Kinase cGMPDependent 2

AR9HJ3Z

90

Spanning 2
exons

3:5714731357150172

PTCH2

Patched 2

AREPT7H

61

RELN

Reelin

ARH6AXC

73

Spanning 2
exons
Spanning 2
exons

2:1363900413639168
4:42880134287009

RET

Ret Proto-Oncogene

Ec03468172_m1

130

Spanning 2
exons

13:42671164
-42670174

RPLP0b

Ribosomal Protein
Lateral Stalk Subunit P0

Ec04947733_g1

74

Spanning 2
exons

8:1627046916271594

RUNX2

RUNX Family
Transcription Factor 2

Ec03469741_m1

65

Spanning 2
exons

20:45071187
-45090120

RUNX3

RUNX Family
Transcription Factor 3

AR9HJ33

85

Spanning 2
exons

2:3037858730389531

S100A1

S100 Calcium Binding
Protein A1

ARU633W

107

Spanning 2
exons

5:4051335740512077

S100A4

S100 Calcium Binding
Protein A4

Ec07038302_m1

105

Spanning 2
exons

5:4058113740582018

S1PR3

Sphingosine-1Phosphate Receptor 3

AR9HJ32

57

Single exon

23:53100775
-53100700

SERPINE1

Serpin Family E
Member 1

Ec03469902_m1

56

Spanning 2
exons

13:93923249393407

SGMS2

Sphingomyelin

AR47WX9

74

SHC3

SHC Adaptor Protein 3

Ec06977865_m1

58

Spanning 2
exons
Spanning 2

2:117974497
-117969273
23:53055119

24

exons

-53062725

SLC38A1

Solute Carrier Family 38
Member 1

Ec06973498_m1

62

Spanning 2
exons

6:6515867465157159

SMPD3

Sphingomyelin
Phosphodiesterase 3

ARNKTM3

107

Spanning 2
exons

3:1931816519316482

SNAI1

Snail Family
Transcriptional
Repressor 1

AR47WX7

139

Spanning 2
exons

22:39029820
-39033420

SNAI2

Snail Family
Transcriptional
Repressor 2

ART2ADV

87

Spanning 2
exons

9:3526812435269118

SP7

Sp7 Transcription
Factor

AREPT7J

138

Single exon

SPARCL1

SPARC Like 1

Ec06992392_m1
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STAB1

Stabilin 1

Ec06952812_g1

55

TGFBI

Transforming Growth
Factor Beta Induced

ARMFX26

THBS4

Thrombospondin 4

TIMP2

Spanning 2
exons
Spanning 2
exons

6:7119822371198072
3:5166815551667472
16:36722312
-36721809

120

Spanning 2
exons

14:39336075
-39335345

Ec06947284_g1

58

Spanning 2
exons

14:86001213
-86000560

TIMP Metallopeptidase
Inhibitor 2

Ec03470558_m1

72

Spanning 2
exons

11:38463243848466

TLR2

Toll-Like Receptor 2

Ec03818334_s1

87

Single exon

TLR4

Toll-Like Receptor 4

Ec03468994_m1

99

Spanning 2
exons

2:8031466080314562
25:22400336
-22403588

TNFRSF21

TNF Receptor
Superfamily Member
21

Ec06970391_m1

63

Spanning 2
exons

20:46704716
-46683406

TNFSF11

TNF Superfamily
Member 11

ARAACGT

71

Spanning 2
exons

17:27570379
-27570216

TSPAN15

Tetraspanin 15

Ec07041353_m1

78

WNT9A

Wnt Family Member 9A

ARDJYMM

81

Spanning 2
exons
Spanning 2
exons

1:5809736158125779
14:94400510
-94401267

a

Commercially available primer-probe sets. ThermoFisher catalogue IDs start with ‘Ec’ and
their catalogue number is 4448892. Catalogue IDs for custom designed primer-probe sets
start with ‘A’ and their catalogue number is 4441114.
b
Three putative endogenous control genes
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2) Positive control RT-qPCR assessments
Prior to conducting the main microfluidic RT-qPCR analysis, a preliminary assessment was
conducted using a robotic ViiA™ 7 Real-Time PCR System (Thermo Fisher Scientific) in order
to verify 1) amplification of two endogenous controls (GUSB and RPLP0) in all 231 cDNA
samples (7 biological replicates × 3 cell lines × 11 time points, plus P4 monolayer samples) and
2) amplification of all 96 targeted gene loci by the TaqMan® primer-probe sets in a positive
control sample. The positive control sample was prepared by pooling equal parts of 1) a
pooled total RNA sample composed of 43 different equine tissue/cell sources (Hestand et al.,
2015), and 2) a 35-days-old equine fetus homogenate. In these test analyses, negative controls
included a no-reverse transcription sample and a no-template sample to confirm the absence
of contaminating genomic DNA or RNA in individual samples or the system. The entire 231
samples (10 ng of cDNA/reaction) expressed GUSB (cycle threshold (Ct) values of 21.44 ± 0.06)
and RPLP0 (Ct values of 18.21 ± 0.06). In addition, the positive control sample demonstrated
amplification in 95 of the targeted gene loci (Ct values of 17.68 – 30.85). The one exception
was primers specific for COL10A1 (Ct value of 35.92).

3) Microfluidic RT-qPCR
The 231 cDNA samples were prepared at a concentration of 10 ng/ul and divided into
three 96 well-microfluidic chips (96 × 96 Fluidigm Dynamic Array; Fluidigm). Seven 3-fold
dilution series (125, 41.67, 13.89, 4.63, 1.54, 0.51, and 0.17 ng/ul) of the positive control
sample were added onto each chip to evaluate PCR efficiency and to also function as an interplate control. The plates were then shipped to the Roy J. Carver Biotechnology Center, a
genomics core at the University of Illinois at Urbana-Champaign (Urbana, IL, USA). To
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quantitate steady state mRNA levels for the targeted 96 gene loci in all experimental samples,
a microfluidic RT-qPCR system (Biomark HD high throughput amplification system, Fluidigm)
was utilized and operated with manufacturer-recommended protocols (Fluidigm Corporation,
2018). After 14-cycles of pre-amplification, steady state mRNA levels were measured with this
microfluidic RT-qPCR system and the data processed using the Fluidigm Real-Time PCR
Analysis software.

Data analyses and statistics
The two most stable endogenous controls (GUSB and RPLP0) across the sample set (Figure
2.1) were used for the gene expression normalization within a sample (ΔCt = Ct of a gene of
interest – average Ct of GUSB and RPLP0). Then, the ΔCt of each target gene was calibrated
with ΔCt of the same target gene in the positive control sample (ΔΔCt = ΔCt in a sample – ΔCt
in the positive control). Finally, ΔΔCt values were converted to relative quantity (RQ=2-ΔΔCt;
fold changes based on expression in the positive control; Livak and Schmittgen, 2001). To
determine statistical differences between the data points (targeted gene × cell type × time
point), the fold change data were log-transformed and analyzed using SAS statistical software,
version 9.3 (SAS Institute Inc., Cary, NC). One-way multivariate analysis of variance was
conducted with Tukey's honest significance test for multiple comparison adjustments. The
significance threshold was defined as P<0.05.
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Figure 2.1. Steady state mRNA levels (Ct, mean ± SEM) of three prospective endogenous
controls (B2M, GUSB, and RPLP0) across the 336-hour experimental period. GUSB and RPLP0
displayed more stability across the three cell types and time course.
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Results
Genes processed in data analyses
Of the 93 targeted genes of interest, six loci were not processed for further data analyses;
five genes (ARHGEF15, CHODL, NPY, RET, and STAB1) had little or no relative expression based
on the control sample (RQs of <0.02), and IGF2 had low fluorescent intensity in two out of
three microfluidic chips which resulted in loss of 5 – 6 biological replicates. Thus, data from
87 genes were analyzed further.

These 87 genes were categorized into three groups based on their established functional
annotation: 1) 15 genes regulating transcription, 2) 51 genes involved in signal transduction,
and 3) 23 genes involved in ECM biology. Two genes (MASP1 and NEFL) were not categorized
into any of the three annotation groups. Four genes were included in two of the three
annotation groups; ENTPD1, ENTPD2, and LEF1 in both the transcription and signaling groups,
and THBS4 in both the signaling and ECM groups.

Kinetics of gene expression changes by cell type
Time point differences in steady state levels of mRNA for individual gene loci were
assessed by comparing values to baseline at 0h within a cell type. Significant upregulation and
downregulation events were noted (Figure 2.2). At the first time point, 1.5 hours, the
significant changes observed were all upregulation. The time points from 3 hours on had
instances of both upregulation and downregulation. Among the total of 261 gene × cell type
combinations (87 genes × 3 cell types), 110 combinations showed upregulation (Figure 2.2.a),
83 combinations showed downregulation (Figure 2.2.b), 22 combinations showed mixed
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patterns of upregulation and downregulation (Figure 2.2.c). Steady state mRNA levels were
stable across all time points in 46 cell type x gene loci combinations (Firgure 2.1.d).

30
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Figure 2.2. Changes in steady state mRNA levels in response to the chondrogenic stimulation
relative to the 0h time point. IZ = interzone cell; ANL = anlagen cell; FB = fibroblast. a)
Upregulated genes, b) downregulated genes and c) genes with mixed patterns of upregulation
and downregulation after inducing chondrogenesis. d) Genes with no response to the
chondrogenic stimulation.
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1) Monolayer vs. 0h
To assess the effect of trypsin digestion and centrifugation required for establishing cell
pellets from monolayers, steady state mRNA levels in P4 cell monolayers were compared to
that of P5 0h cell pellets. Among the 87 targeted loci, only four genes (APLNR, GDF5, S1PR3,
and TLR2) had significantly lower expression levels in monolayer cultures compared to 0h cell
pellets in one or more cell types (P<0.05; Figure 2.3). These genes are all categorized in the
signal transduction. Interestingly, GDF5 and S1PR3 subsequently displayed consistent upregulation following the onset of chondrogenic induction.

Figure 2.3. Genes with significantly different steady state mRNA levels between passage 4
monolayer cultures and passage 5 cell pellet cultures at 0h. IZ = interzone cell; ANL = anlagen
cell; FB = fibroblast.
a
The reference point (baseline) for comparison was 0h for the same sample.

2) Timing of initial differential expression relative to 0h within a cell type
Eighty-six out of the 87 targeted genes displayed a significant change with at least one
timepoint in response to the chondrogenic induction protocol. The lone exception was
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GALNT14, in which steady state mRNA levels did not change significantly at any time point in
either of the three cell types (Figure 2.2.d). Comparing the three functional annotation
categories, percentages of loci displaying their first onset of change (gene × cell type
combinations) were calculated at each time point (Table 2.2; Figure 2.4).
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Table 2.2. Timing of the first response to the chondrogenic induction protocol in new gene
× cell type combinations within each of the three functional annotation groups. Data are
reported as the percent (%) of gene loci within the annotation group with significant
changes.
Time point
Annotation
1.5h
3h
6h
12h
24h
48h
96h
168h 336h
group
Transcription
7.0
34.9
16.3
25.6
11.6
2.3
2.3
0.0
0.0
regulation
Signal
3.3
18.9
21.3
9.8
9.8
13.1
12.3
3.3
8.2
transduction
Extracellular
0.0
18.2
12.7
20.0
12.7
9.1
12.7
7.3
7.3
matrix
Total

3.3

20.9

18.6

14.9

10.2

10.7

11.2

3.7

6.5

Figure 2.4. Histogram of percentages of the first response to the chondrogenic stimulation in
new gene × cell type combinations within each of the three functional annotation groups.
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In the transcription regulation group, the first half (58.1% of the total) of gene × cell type
combinations showed their first chondrogenic responses within the first 6 hours, with the
mode observed at 3h (34.9% of the total). The other 41.9% of gene × cell type combinations
first responded to the chondrogenic stimulation between 12 – 96h. Only 4.6% of gene × cell
type combinations responded between 48 – 96h, and these were observed solely in fibroblast
cultures. It is interesting to note that in interzone and anlagen cell cultures, steady state mRNA
levels for all of the genes with transcription regulation functional annotation had changed
significantly within the first 24 hours following chondrogenic induction (Table 2.3). No
transcription regulating genes displayed their first change later than 96h in any cell type.

By comparison to the transcription regulation group, genes involved in signaling cascades
showed slightly delayed responses. Roughly half (53.3%) of the gene × cell type combinations
changed significantly within the first 12 hours. Genes in the signaling group also showed
relatively slower responses in fibroblast cultures.

Response to the chondrogenic induction protocol was more delayed for genes encoding
ECM proteins or involved in ECM metabolism. Indeed, no differences were observed in this
functional annotation group at the 1.5h time point. The first half (50.9%) of gene × cell type
combinations were observed between 3 – 12h (Table 2.3).

In the negative control dermal fibroblasts, responses to chondrogenic induction were
delayed compared to interzone and anlagen cells. Transcriptional regulatory genes all showed
their first responses within 24 hours in the chondrogenic cells, compared to some initial
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changes delayed until 96h in fibroblast cultures. In the signal transduction group, 8.3% or 2.1%
of the first responses were recorded at the last time point (336h) in interzone cell cultures
and anlagen cell cultures, respectively, while 15.4% of those was recorded at 336h in
fibroblast cultures. Also, the majority of first reactions in the ECM group were at 3h (23.5%)
and 12h (23.5%) in interzone cultures, 12h (28.6%) in anlagen cultures, and 96h (23.5%) in
fibroblast cultures.

Table 2.3. Timing of the first response to the chondrogenic induction protocol within
functional annotation group
(% of gene loci with significant changes)
Time point

Annotation group
Transcription
regulation
Interzone cell
Anlagen cell
Fibroblast

1.5h
6.7
7.1
7.1

3h
33.3
28.6
42.9

6h
20.0
14.3
14.3

12h
26.7
28.6
21.4

24h
13.3
21.4
0.0

48h
0.0
0.0
7.1

96h
0.0
0.0
7.1

168h
0.0
0.0
0.0

336h
0.0
0.0
0.0

Signal
transduction
Interzone cell
Anlagen cell
Fibroblast

1.5h
0.0
4.3
5.1

3h
27.8
17.0
12.8

6h
19.4
25.5
17.9

12h
5.6
14.9
7.7

24h
13.9
6.4
10.3

48h
11.1
17.0
10.3

96h
11.1
10.6
15.4

168h
2.8
2.1
5.1

336h
8.3
2.1
15.4

Extracellular
matrix
Interzone cell
Anlagen cell
Fibroblast

1.5h
0.0
0.0
0.0

3h
23.5
19.0
11.8

6h
5.9
14.3
17.6

12h
23.5
28.6
5.9

24h
17.6
4.8
17.6

48h
11.8
9.5
5.9

96h
5.9
9.5
23.5

168h
11.8
4.8
5.9

336h
0.0
9.5
11.8
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Relative differences between cell types at each time point
Steady state mRNA levels at each time point were compared in pairwise comparisons
between cell types, and the results categorized into four groups (Table 2.4; Figure 2.5). While
14 – 18 genes were already differentially expressed at 0h in the comparisons between cell
types, most genes (69 – 73 genes among the 87 targeted loci) did not show differences initially.
The focus of this study is on relative differences between interzone and anlagen cells.

Table 2.4. Four patterns of differential gene expression before and after inducing in vitro
chondrogenesis
Already different at baseline (0h)
Not different at baseline (0h)
Retained
Lost differences
Became
Remained
differences after
after
different after
similar after
Cell type
comparison chondrogenesis chondrogenesis chondrogenesis chondrogenesis
IZ vs. ANL
11 genes
3 genes
47 genes
26 genes
IZ vs. FB
14 genes
0 gene
41 genes
32 genes
ANL vs. FB
18 genes
0 gene
47 genes
22 genes
Common
genes in all
3 genes
0 gene
15 genes
7 genes
comparisons

Specific to
the
comparison
between
IZ and ANL
cultures

5 genes:

3 genes:

9 genes:

12 genes:

GDF6, MGP,
OMD, PDLIM1,
and RUNX2

COL2A1, COMP,
and DIO2

ALPK3, ASS1,
AQP1, CTGF,
FAM20A, FGF1,
ITGA7, PLVAP,
and TLR4

ADGRG1, ALPL,
APLNR, DCN,
ENTPD1,
FAM132A, FZD1,
GDF5, IGFBP5,
IGFBP7, MMP2,
and PLAT

IZ = interzone cell; ANL = anlagen cell; FB = fibroblast.
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Figure 2.5.a) Genes that were differentially expressed in the indicated pairwise cell type comparison at baseline (0h) and also retained differences
after inducing chondrogenesis

Figure 2.5.b) Genes that were differentially expressed in the indicated pairwise cell type comparison at baseline (0h) but lost differences after
inducing chondrogenesis

Upregulated in interzone cell culture ***, P<0.0001
Upregulated in anlagen cell culture
**, P<0.01
Upregulated in fibroblast culture
*, P<0.05
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Figure 2.5.c) Genes that were not differentially expressed in the indicated pairwise cell type comparison at baseline (0h) but responded
differently to the chondrogenic stimulation

Upregulated in interzone cell culture ***, P<0.0001
Upregulated in anlagen cell culture
**, P<0.01
Upregulated in fibroblast culture
*, P<0.05
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(continued Figure 2.5.c) Genes that were not differentially expressed in the indicated pairwise cell type comparison at baseline (0h) but
responded differently to the chondrogenic stimulation

Comparison between interzone and
anlagen cell cultures
(Time point, h)
Genes
0 1.5 3
SNAI2
CLU
CDH13
ENTPD2
ASS1
TGFBI
S100A4
SGMS2
WNT9A
SNAI1
ALPK3
CREB5
ANGPTL4
AQP1
TSPAN15
COL1A1
TIMP2
CTGF
PLVAP
ITGA7
GLI3
SLC38A1
ADAMTS5
TLR2
TLR4

6 12 24 48 96 168 336
*** ***
*** ***
*** ***
*** **
** ***
** ***
** ***
**
* ***
*
***
***
***
***
***
***
***
**
**
**
*
*
*
*
*

Comparison between interzone cell
and fibroblast cultures
(Time point, h)
Genes
0 1.5 3
GALNT14
FGFR3
RUNX2
FRZB
IGFBP7
ANGPTL4
APLNR
FGF18
TLR2

6 12 24 48 96 168 336
***
** ***
** **
* *
***
**
**
*
*

Comparison between anlagen cell
and fibroblast cultures
(Time point, h)
Genes 0 1.5 3
ENTPD2
PDLIM1
SNAI2
ANGPTL4
CDH13
GDF6
PANX3
APLNR
COL1A1
BMPR1A
ABI3BP
ADGRG1
CREB5
NTRK2
TLR2
IGFBP7
ITGAV
TSPAN15
TIMP2

6 12 24 48 96 168 336
*** ***
*** ***
*** ***
*** ***
*** ***
*** ***
*** *
** ***
** ***
**
**
* **
***
***
***
**
**
**
**

Upregulated in interzone cell culture ***, P<0.0001
Upregulated in anlagen cell culture
**, P<0.01
Upregulated in fibroblast culture
*, P<0.05
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Figure 2.5.d. Genes that were not differentially expressed in the indicated pairwise cell type
comparison at baseline (0h) and also were not different after the chondrogenic stimulation
Comparison between
interzone and anlagen
cell cultures
Genes
ENTPD1
OSR2
ADGRG1
APLNR
FAM132A
GDF5
IGFBP5
IGFBP7
PLAT
ADGRG2
BMP2
CDON
FRZB
FZD1
ITGAV
KCNJ8
LOC100630171
NTRK2
PTCH2
ALPL
DCN
MMP2
SPARCL1
COL10A1
GALNT14
NEFL

Comparison between
interzone cell and
fibroblast cultures
Genes
ALPK3
CREB5
OSR2
PDLIM1
SNAI2
SP7
ADGRG2
BMP2
BMPR1A
BOC
CDH13
CDON
DIO2
GDF6
ITGAV
KCNJ8
LOC100630171
NTRK2
PANX3
PLVAP
PTCH2
S100A1
TNFRSF21
TSPAN15
COL10A1
COL1A1
ITGA7
OMD
SMPD3
SPARCL1
TIMP2
MASP1

Comparison between
anlagen cell and
fibroblast cultures
Genes
ALPK3
GLI3
RUNX2
ABCC9
ADGRG2
BMP2
FRZB
IBSP
KCNJ8
LOC100630171
MET
PLVAP
PRKG2
PTCH2
S1PR3
COL10A1
GALNT14
OMD
SPARCL1
THBS4
TGFBI
NEFL

Figure 2.5. Four patterns of differential gene expression before and after inducing in vitro
chondrogenesis. Each pattern is shown in a), b), c), and d), respectively.
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1) Genes with differential expression levels prior to the chondrogenic stimulation
Among the cell type pairwise comparisons, there were three common genes (DLX5, LEF1,
and RUNX3) that had different initial expression levels at 0h and showed unique cell type
specific properties to the chondrogenic induction protocol. Specific to the comparison
between interzone and anlagen cultures, five genes (GDF6, MGP, OMD, PDLIM1, and RUNX2)
started with different expression levels and also retained differential profiles following the
chondrogenic induction (Table 2.4; Figure 2.5.a).

If initial mRNA levels of a gene were different in the comparisons to fibroblast cultures,
the gene also showed different expression levels after inducing chondrogenesis. However,
between interzone and anlagen cell cultures, three genes (COL2A1, COMP, and DIO2) with
different initial mRNA levels lost differences across all post-chondrogenic induction time
points (Table 2.4; Figure 2.5.b).

2) Genes with no differential expression levels prior to the chondrogenic stimulation
Among the 69 – 73 genes that initially had not different expression levels in pairwise celltype comparisons, 41 – 47 genes developed significant steady state mRNA differences after
inducing chondrogenesis. Between interzone and anlagen cultures, there were 47 genes in
this category, and only nine (ALPK3, ASS1, AQP1, CTGF, FAM20A, FGF1, ITGA7, PLVAP, and TLR4)
that were specific to the comparison between these two chondrogenic cell lines (Table 2.4;
Figure 2.5.c).

On the other hand, 22 – 32 genes still did not change in pairwise cell-type comparisons,
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seven of which showed no difference in any cell type comparison: ADGRG2, BMP2, COL10A1,
KCNJ8, LOC100630171, PTCH2, and SPARCL1. Among these seven genes, there was no gene
involved in transcription regulation. In addition, twelve genes were commonly regulated
under the chondrogenic stimulation specifically between interzone and anlagen cultures:
ADGRG1, ALPL, APLNR, DCN, ENTPD1, FAM132A, FZD1, GDF5, IGFBP5, IGFBP7, MMP2, and
PLAT (Table 2.4; Figure 2.5.d).
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3) Individual gene loci demonstrate clear examples of cell type specific differences
Cartilage biomarkers (COL2A1 and COMP) were upregulated in the chondrogenic cell lines
at later time points (Figure 2.6). While their steady state mRNA levels were also increased in
fibroblast cultures towards the end of the experimental period, the relative levels compared
to the chondrogenic cell cultures were consistently lower in non-chondrogenic cell cultures
(COL2A1, from 24h to 336h; COMP, at all post-chondrogenic induction time points; Figure
2.5.a and c).

a)

b)

Figure 2.6. Steady state mRNA levels of classic cartilaginous biomarkers across the
experimental period. Fold changes were calculated based on the positive control sample
(pooled equine adult tissue and fetus RNA). Mean ± SEM (n=7); a) COL2A1; b) COMP

There were examples of genes that resulted in unique regulation patterns in either
interzone or anlagen cell cultures compared to the other two cell types over the time course.
Changes in steady state mRNA levels of ABI3BP showed a clear example of downregulation
(Figure 2.7.a), and those of PRKG2 showed an example of minimal expression (Figure 2.7.b)
specifically in interzone cell cultures during the experimental period. In contrast, PANX3 was
upregulated only in anlagen cell cultures toward the later time points while its mRNA levels
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were consistently lower or not detected in the other two cell cultures across the time points
(Figure 2.8).

a)

b)

Figure 2.7. Steady state mRNA levels of example genes that were differentially regulated in
interzone cell cultures compared to the other cell types across the experimental period. Fold
changes were calculated based on the positive control sample (pooled equine adult tissue and
fetus RNA). Mean ± SEM (n=7); a) ABI3BP was downregulated and b) PRKG2 was not expressed
only in interzone cell cultures.

Figure 2.8. Steady state mRNA levels of an example gene that was differentially regulated in
anlagen cell cultures compared to the other cell types across the experimental period. Fold
changes were calculated based on the positive control sample (pooled equine adult tissue and
fetus RNA). Mean ± SEM (n=7); PANX3 was upregulated only in anlagen cell cultures towards
later time points.
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Discussion
The present study was conducted to test the hypothesis that divergent chondrogenic
pathways in interzone and anlagen cell cultures will be evident within the earlier time frame—
within the first 24 hours after inducing in vitro chondrogenesis. In all three cell types including
the negative control fibroblasts, changes in steady state mRNA levels in a subset of the
targeted genes started as early as 1.5 hours after initiating the chondrogenic induction. All
genes that showed responses at 1.5h had functional annotation categorized in regulatory
events such as transcription or signal transduction. Moreover, initial responses in transcription
regulatory events in the two chondrogenic cell lines occurred within the first 24 hours, while
delayed responses were observed in the negative control (Table 2.3). The earlier changes in
these regulatory genes likely diverge chondrogenic pathways in interzone and anlagen cell
cultures, and differences may provide insight into divergent aspects of their chondrogenic
fate. From the pairwise comparisons between interzone and anlagen cell cultures at each time
point, starting mRNA levels of 73 genes were not significantly different. For the 47 genes that
differentially responded to the TGF-1 chondrogenic induction at some point in the 336-hour
of experimental period, 12 significantly changed within the first 24 hours (Table 2.4; Figure
2.5.c). Thus, the results support the hypothesis tested in this study.

Relationship between early and delayed gene expression changes
The first responses to the chondrogenic induction measured at 1.5h were involved in
either transcription regulation or signal transduction while no ECM related genes changed
their mRNA levels at the first collection point. The majority of first responses were observed
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within the first 24 hours in all three annotation groups: at 3h in the transcription group, 6h in
the signaling group, and 12h in the ECM group. Most of the initial changes in transcription
regulatory category occurred within a day (0 – 24h), while about 40% of the first responses in
the signaling group and the ECM group occurred after 24 hours. In fact, no gene loci in the
ECM related genes had no response at the first collection point in any cell cultures (Table 2.2;
Figure 2.4). Taken together, the results demonstrate a sequence whereby genes encoding
proteins functionally annotated in transcription, signaling events, and ECM are expressed in
roughly that order: altered transcriptional events leading to subsequent changes in signaling
cascades and finally the effector genes involved in ECM biology.

The model derived from this observation is that transcription regulating genes might be
primary genes required for secondary changes in downstream signaling events and ECM
accumulation. To define “(early) primary” and “(delayed) secondary” genes from a
perspective of cell biology, an experiment designed to include protein synthesis inhibitors
must be performed (Yamamoto and Alberts, 1976). If a gene changes its expression levels
under the presence of protein synthesis inhibitors, it can be called “primary” response
because it does not require de novo protein synthesis to change its expression levels.
Therefore, to further elucidate these relationships and identify if the responses were either
primary or secondary, a mechanistic experiment will be required.

It is interesting to note that, all changes in mRNA levels observed at 1.5h (Table 2.2) were
upregulation compared to the baseline (Figure 2.2.a and c). On the other hand,
downregulation started to be detected by 3h. This may confirm that degradation of
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transcripts requires more time than de novo synthesis (Eser et al., 2014). Regulatory genes
may have relatively faster decay rates in order to rapidly alter signal transduction; all the
genes that showed their first responses as downregulation between 3 – 6h were involved in
either transcription or signaling events, except for two cases (Figure 2.2.b and c).

There were only a few genes that showed changes at the 0h time point compared to P4
monolayer cell cultures, indicating little subsidiary effects of the chondrogenic induction
protocol besides the chondrogenic stimuli treatment (Figure 2.3). These genes are generally
involved in cell migration and adhesion (Hashimoto et al., 2005, Scott et al., 2007, Zeng et al.,
2007, Shwartz et al., 2016, Ogle et al., 2017), and thus the results may suggest that being
lifted from monolayers and spun down to form pellets might require the cells to alter gene
expression regulating these biological processes regardless of cell types.

Differential gene regulation between cell types
Differences between chondrogenic and non-chondrogenic cell cultures
From the observations made in individual cell types over the time course, delayed
responses in all functional annotation categories were observed in the fibroblasts compared
to the either interzone or anlagen cells (Table 2.3). While this may well be attributed to
chondrogenic potential of the cell types and relative sensitivity to the induction medium, it is
important to note that the targeted gene loci were selected based in part on established
annotations related to chondrogenesis and expression in skeletal tissues. As such, there is a
selection bias and a full transcriptome analyses would help to sort this out.
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Consistent with their established functional annotations, COL2A1 and COMP, encoding
major cartilaginous ECM proteins, were significantly upregulated in the interzone and anlagen
cell pellets at later time points. The results with these biomarker effector genes confirmed
their chondrogenic potential (Figure 2.5.a and c; Figure 2.6).

Differences between interzone and anlagen cell cultures
Interzone and anlagen tissues in equine fetuses at day-45 of gestation are readily
distinguished morphologically with a dissecting microscope. Along with the morphogenic
distinction, 14 out of the 87 gene loci targeted started with different mRNA levels at 0h.
Among the 14 genes, 11 genes still expressed different profiles after inducing chondrogenesis
(Table 2.4; Figure 2.5.a) and five of them showed the differential patterns only between
interzone and anlagen cultures but not in the negative control fibroblasts. OMD and RUNX2
were upregulated in anlagen cell cultures after the chondrogenic induction, and their known
annotation is related to ECM production in the bone (Ninomiya et al., 2007, Mevel et al., 2019).
Thus, the results may confirm that anlagen cultures under chondrogenic stimulation
progressed towards the pathways leading to bone formation. On the other hand, MGP and
GDF6 were upregulated in interzone cultures, and their reported functional annotations are
inhibiting ectopic tissue calcification (Luo et al., 1997) and diarthrodial joint formation (Settle
et al., 2003), respectively. In addition, mRNA levels of PDLIM1, a transcription coactivator gene,
were greater in interzone cell cultures at the latest time points. From a previous RNA-seq
dataset generated in the MacLeod lab, this gene was not differentially expressed between
interzone and anlagen tissue lineages from 45-day-old equine fetuses and neonatal foals, but
the expression of PDLIM1 was 3.41 fold greater (P<0.0001) in interzone tissue compared to
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cartilaginous anlagen from 60-day-old fetuses (Adam et al., in preparation). The present
results and the previous data may suggest that this transcription regulatory gene might
become upregulated in interzone at a later stage during articular cartilage development.
Taken together, expression patterns of these genes in the culture model are consistent with
the articular and hypertrophic cartilaginous tissue outcomes of interzone and anlagen cells
respectively.

Interestingly, three genes that started with different steady state mRNA levels in interzone
and anlagen cells, lost those differences after inducing chondrogenesis across the entire
experimental period (Table 2.4; Figure 2.5.b). Two of the three, COL2A1 and COMP, are major
cartilaginous ECM genes. These data are consistent with the induction medium driving both
cell lines to produce common cartilaginous ECM under the same chondrogenic stimulation.

As noted above, steady state mRNA levels for 73 of the 87 targeted gene loci were not
significantly different at the initial 0h time point. In comparing cell types, gene expression
either diverged or changed in a similar way. Forty seven genes differentially responded to the
chondrogenic induction (Table 2.4; Figure 2.5.c), but only nine of these were specific to the
comparison between interzone and anlagen pellets. FGF1 was upregulated early (6h) in
anlagen cultures and justifies further investigation. For the other 26 genes, the changes
displayed profile similarities after the chondrogenic induction (Table 2.4; Figure 2.5.d). GDF5
is an established interzone biomarker (Bi et al., 1999, Hyde et al., 2007), but in this in vitro
model using primary cells derived from day 45 equine fetuses, its mRNA profiles were not
different between interzone and anlagen cultures at both pre- and post-chondrogenic
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induction time points. The discrepancy between the current data and the previous findings in
other species may be due to differences in developmental age. Similarly, while ALPL is known
to be involved in bone mineralization (Golub and Boesze-Battaglia, 2007), its mRNA levels
were not different between the two chondrogenic cell cultures. This may not be surprising
given that the culture system was not intended to model osteogenesis.

Several gene loci displayed clear cell type-specific expression profiles. Example of unique
steady state mRNA levels in interzone cell cultures were ABI3BP and PRKG2 (Figure 2.7).
ABI3BP is a novel ECM gene and is required to switch the cellular status from proliferation to
differentiation in mesenchymal stem cells (Hodgkinson et al., 2013). The mRNA levels of this
gene were initially greater in interzone cell cultures compared to the other cell lines (Figure
2.5.a), started to decrease by 96h (Figure 2.2.b), and became as low as the other cell lines at
the last time point. In literature, this gene was differentially upregulated in articular cartilage
compared to hypertrophic growth plate both in vivo and in vitro (Hissnauer et al., 2010). In
contrast, mRNA levels of PRKG2 were minimal and remained unchanged over time in
interzone cell cultures (Figure 2.2.d) while this gene became upregulated in the other two cell
lines at later time points (Figure 2.2.a). PRKG2 is known to be involved in mammalian skeletal
development, and its null mutation resulted in 23 – 30% decreased length of limb bones
(Pfeifer et al., 1996) due to impaired chondrocyte hypertrophy (Kawasaki et al., 2008). Thus,
the present data indicate that interzone cell cultures had less hypertrophic potential
compared to the other two cell types.

PANX3 was a locus specifically upregulated in anlagen cell cultures compared to the other
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cell cultures (Figure 2.8). This gene is expressed in cartilaginous anlagen of a developing limb
(Bond et al., 2011), and when PANX3 was knocked down, hypertrophic differentiation was
delayed and attenuated (Oh et al., 2015). Consistent with its functional annotation, the
patterns of its mRNA levels across the experimental period confirmed the greater
hypertrophic potential in anlagen cell cultures.

In summary, results demonstrated that while interzone and anlagen cells are both
chondrogenic, they display some clear differences in response to the same TGF-β1
chondrogenic induction signal. Data from this in vitro model had several gene expression
profiles broadly consistent with well-established developmental fates of interzone and
anlagen cells within limb buds.

Future direction
Although the current study reports interesting time point differences and examples of
genes that may render interzone and anlagen cell cultures unique, there are important
questions remaining: 1) how would the kinetics of gene expression change at a transcriptome
level and 2) what would be the key regulator(s) of differential chondrogenic pathways
between these cell lines?

The present study focused on the 93 selected genes that have differential gene expression
levels between interzone and anlagen tissues or functional annotations related to fetal
skeletal development. However, there are more than 20,000 structurally annotated protein
coding gene loci in mammals. Therefore, whole-transcriptome analyses at critical time points
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may also reveal important regulator or effector genes that have conventionally received less
attention. By conducting pathway analyses on the transcriptomic data, critical signaling
mechanisms that regulate divergent chondrogenic differentiation pathways may be identified.

Conclusion
In conclusion, the results confirmed the chondrogenic potential of interzone and anlagen
cells, but they also documented distinct functional responses to the same chondrogenic
stimulation. The new information elucidated by this study centers on expression kinetics of
the targeted genes with established functional annotation relevant to chondrogenesis,
cellular responses to TGF-β1, and the regulation of cellular differentiation. Overall,
transcription regulatory responses preceded the other responses in signal transduction or
ECM maintenance, and effector genes involved in ECM biology showed relatively delayed
responses compared to regulatory genes. The data demonstrated that ‘(early) primary’
regulatory gene expression changes start as early as 1.5 hours after inducing chondrogenesis,
followed by changes in expression profiles of ‘(delayed) secondary’ effector genes at later
time points. Further investigation is required at a transcriptome level to identify key
regulators and pathways that drive differential chondrogenesis in interzone and analgen cells
in different directions.
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Chapter 3. Transcriptomic divergence between equine fetal interzone and anlagen cells
during in vitro chondrogenic induction

Introduction
Different chondrogenic pathways are involved in developmental processes of limb
skeletal elements in mammals starting early in fetal development and continuing through
gestation and even into the postnatal period (Shimizu et al., 2007, Pitsillides and Ashhurst,
2008). The initial chondrogenesis occurs in the mesenchymal condensation of a limb bud
resulting in cartilaginous tissue formation. In developing limb tissues, SOX9 is expressed from
the proliferating chondrocytes (Ng et al., 1997) and promotes expression of cartilaginous
marker genes, COL2A1, ACAN, and COMP (Bi et al., 1999, Akiyama et al., 2002). Then, this
continuous—uninterrupted—cartilaginous anlage becomes segmented into several units,
which serve as templates of limb bones, separated by a different developmental tissue called
the interzone which develops into all of the structures and tissue types present in synovial
joints. Early developmental events of interzone are characterized by the decreased
expression of chondrogenic biomarkers such as SOX9, COL2A1, and ACAN, and increased
expression of interzone markers such as GDF5, WNT9A, CHRD, and ENPP2 (Bi et al., 1999,
Karsenty and Wagner, 2002, Pacifici et al., 2005). While chondrocytes in anlagen progress
through hypertrophic differentiation during endochondral ossification, a subset of the cells in
interzone tissue that paused chondrogenic differentiation resume chondrogenesis and
differentiate into articular chondrocytes. Even though several key marker genes in these
processes have been reported in the literature, details related to the kinetics of gene
expression have not been fully understood.
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Beyond understanding developmental processes of skeletogenesis, the importance of
comprehending comparative cell biology of interzone and anlagen cells likely has relevance
to stark differences in the intrinsic ability of articular cartilage and bone tissue to repair
structural defects. While bone fractures repair well by recapitulating the developmental
process, articular cartilage has a very limited capacity to heal lesions. To study the cell biology
of equine interzone and anlagen, primary cell cultures derived from fetal limb tissues
collected at day 45 of gestation were studied before and 21 days after the in vitro induction
of chondrogenesis (Adam, in preparation). In this previous RNA-seq study, transcriptomic
profiles of interzone and anlagen cell cultures were relatively similar at the start of the
experiment, but substantially diverged 21 days after being grown under the exact same
chondrogenic induction conditions.

In a follow-up set of experiments to understand the biology of these chondrogenic cell
lines, as reported in Chapter 2 of this thesis, the kinetics of gene expression profiles of 93
selected genes in equine fetal interzone and anlagen cell pellets grown in a chondrogenic
medium were evaluated by RT-qPCR at 10 time points, specifically 0, 1.5, 3, 6, 12, 24, 48, 96,
168, and 336 hours after inducing in vitro chondrogenesis. The results confirmed that both
cell lines are chondrogenic, but showed clear differences in expression profiles of certain
regulatory genes starting even with the first 1.5h sample, as well as those encoding ECM
components at subsequent time points. The new information obtained from the experiments
in Chapter 2 further elucidated the kinetics of gene expression in these cell cultures during
the 336-hour experimental period, although the findings were based on a finite number of
the targeted genes. Thus, comparing steady state RNA levels between interzone and analgen
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cells on a fully transcriptomic scale would provide additional knowledge of individual gene
loci and functional ontologies while providing the opportunity for a much more rigorous
assessment of important chondrogenic and other cell biology pathways.

Therefore, the objective of the present study was to elaborate chondrogenic divergence
between interzone and anlagen cell cultures at a whole transcriptome level under the same
chondrogenic induction conditions. By analyzing transcriptomic data, potential candidate
regulators that diverge the chondrogenic pathways between these two skeletal cell lines
might be identified. The hypothesis tested in this chapter was that chondrogenic divergence
between interzone and anlagen cell cultures will be initiated by differentially expressed
regulatory genes within the first 1.5 hours, and more distinctive characteristics represented
by the activation of different pathways and acquisition of distinguishing ECM profiles will
accumulate as time passes in culture.

Materials and Methods
Cell culture
Interzone cells, anlagen cells, and dermal fibroblasts (negative control) from day-45
equine fetuses were previously harvested (Adam et al., 2019) and used for chondrogenic
differentiation experiments as reported in Chapter 2 of this thesis. A subset of these RNA
samples were used for the present transcriptomic analysis. Briefly, three-dimensional cell
pellet cultures were established at passage 5 and treated with a chondrogenic induction
medium containing TGF-1 (10 ng/ml). Then, cell pellets were collected at 10 different time
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points during the 336-hour experimental period, followed by total RNA extraction for gene
expression analyses. The subset of these samples were analyzed further in the current chapter,
specifically six biological replicates at each of five collection points (0, 1.5, 3, 12, and 96h).
Including the baseline, these time points were prioritized based on the study results reported
in Chapter 2. By 1.5h, regulatory genes started to respond to the chondrogenic stimulation.
At 3h, the major peak of overall first gene expression responses was observed. A second major
peak of first responses of transcription regulatory genes was observed at 12h. Finally, most
effector genes involved in ECM maintenance were exhibiting changes in steady state RNA
levels by 96h after initiation of chondrogenic induction. More detailed procedures are
described in the Materials and Methods section in Chapter 2.

RNA sample preparation
For bulk RNA-seq, any potential genomic DNA contamination in the total RNA isolates was
removed using an RNase-Free DNase kit (cat No. 79254; Qiagen). The post-DNase step
concentration of RNA was measured by a Qubit® 3.0 Fluorometer (cat No. Q33216; Life
Technologies) with a Qubit® RNA Broad Range Assay Kit (catalog No. Q10211; Life
Technologies). Both purity and RNA structural integrity was assessed using a Bioanalyzer 2100
(Agilent Technologies) with an Agilent RNA 6000 Pico kit (catalog No. 5067-1513; Agilent
Technologies). All samples resulted in RIN values >8. The samples were diluted with nucleasefree water to 20 ng/ul and frozen at –80 °C. Then, 1,000 ng of each sample was shipped to the
Roy J. Carver Biotechnology Center (University of Illinois at Urbana-Champaign, Urbana, IL,
USA) for mRNA sequencing.
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Bulk RNA sequencing
Construction of cDNA libraries from the RNA samples was conducted using a TruSeq
Stranded mRNA kit (cat #. 20020595, Illumina). In the protocol, the samples were purified
using poly-T oligo-attached magnetic beads and fragmented into smaller pieces (average
library fragment size of 440 bp) by divalent cations under increasing temperature. The strand
orientation was distinguished using Actinomycin D. In turn, Illumina Read 1 adaptors (P5) were
ligated to the antisense strands, and Read 2 adaptors (P7) including sample-specific barcoding
sequences (i7 index) were added to the sense strands. After the adaptor ligation step, the
libraries were amplified by PCR for 14 cycles and quantitated by qPCR. The amplified individual
libraries (100 ng/each) were pooled. The pool was diluted to 5nM, and 9 ul of the pool was
loaded into an S4 lane on a NovaSeq 6000 (Illumina) for the sequencing. The cDNA libraries
were sequenced for 151 cycles from each end of the fragments (total 302 cycles) with
NovaSeq S4 reagents (cat. # 20027466; Illumina). The sequence Fastq files were generated
and demultiplexed with the bcl2fastq v2.20 Conversion Software (Illumina). Quality scores
were accessed by FastQC v0.11.9.

Data analysis pipeline
Once the resulting Fastq files were transferred to the University of Kentucky from the Roy
J. Carver Biotechnology Center, adaptor sequences were trimmed out by Trim Galore v0.6.5.
The trimmed reads were mapped onto the latest equine reference genome (EquCab 3.0,
GCA_002863925.1; Kalbfleisch et al., 2018) using Tophat (v2.0.8) and quantified with an
ENSEMBL equine gene structure annotation database (v98) through the Cufflinks (v 2.2.1)
pipeline (Trapnell et al., 2012). Read counts were normalized to the fragments per kilobase of
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transcript per million mapped reads (FPKM) unit.

Differential expression analysis
Using the CuffDiff function in Cufflinks (v 2.2.1), differentially expressed genes (DEGs)
were evaluated with focuses on 1) profiling kinetics of steady state mRNA changes within a
cell type, 2) identifying common chondrogenic traits of interzone and anlagen cells relative to
fibroblasts, and 3) characterizing differences between the two chondrogenic cell lines during
in vitro chondrogenesis. The thresholds defining differential expression were log2 fold change
(FC)>|1| and the false discovery rate (FDR) adjusted P-value<0.05. The DEGs were visualized
in a heatmap or a volcano plot using R packages (gplot, Warnes et al., 2015; EnhancedVolcano,
Blighe et al., 2019).

Gene ontology enrichment analysis
Gene ontology (GO) enrichment analyses were conducted with DEGs by the Functional
Annotation Tool from DAVID Bioinformatics Resources (v6.8; https://david.ncifcrf.gov; Huang
et al., 2009)) to systemically describe the DEGs with a focus on biological processes. The
results were either listed in tables or visualized using GOplot (Walter et al., 2015).

Hub gene analysis
Hub gene analyses were conducted using an R package, WGCNA (Weighted gene coexpression network analysis, v1.66), to identify modules of highly correlated genes with the
time sequence within a cell type. Gene significance (GS) of a gene was assessed based on the
correlation of the gene with the trait (in this case, the time course). Module eigengene (ME)
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groups were defined by module-trait relationship scores ranged from -1 to 1, and the moduletrait score closest to 1 represents the most correlated features with the trait. Module
membership (MM) of a gene was determined by the correlation of its expression profile with
each ME group. Genes that have GS>0.8 and MM>0.9 with the most significant ME group
were used to build a gene co-expression network within a cell type (Cytoscape, v2.8.3).

Upstream pathway prediction
Upstream regulators identified computationally as having an increased potential of being
responsible for differential gene expression profiles 1) between two consecutive time points
within a cell type and 2) between interzone and anlagen cell types at each time point were
predicted using the Ingenuity Pathway Analysis (IPA) software (Qiagen). The differential
expression data input cutoffs for this analysis were log2FC>|0.3| and FDR adjusted Pvalues<0.05. From the analysis results, when a P-value of overlap was less than 0.05 and an
activation z-score was greater than or equal to |2|, the predicted genes were likely to be
upstream regulators which distinguished between two conditions being compared: 1) a time
point vs. its previous time point within a cell type or 2) interzone cell cultures vs. anlagen cell
cultures at each time point.
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Results
Sequencing depth of all samples (90 samples total, reflecting 3 cell types × 5 time points
× 6 biological replicates) ranged from 29 – 45 million paired-reads per sample (average of 35
million paired-reads/sample; Table 3.1). Phred scores were greater than 30 at all base
positions in all 90 samples (base call accuracy > 99.9%; Figure 3.1). With an average mapping
efficiency of 95.0%, the sequencing of the entire sample set resulted in well-balanced
mapping rates onto the latest version of the equine reference genome (EquCab 3.0;
Kalbfleisch et al., 2018; Table 3.2).

Figure 3.1. Phred scores of the 90 samples assessed by FastQC v0.11.9. Each green line
represents each sample.
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Table 3.1. Sequencing depth of all samples, million paired-reads/sample
Interzone cell cultures
Anlagen cell cultures
Time point 0h 1.5h 3h
12h 96h
0h 1.5h 3h
12h 96h
Biological replicate
H1
31
40
36
34
35
39
34
36
34
33
H2
34
35
35
37
37
35
40
30
34
35
H5
32
34
33
38
33
38
40
37
37
32
H6
35
35
32
42
36
34
43
37
33
33
H9
32
39
38
34
32
37
37
32
34
37
H11
39
38
43
39
40
34
36
35
32
34

Table 3.2. Mapping efficiency of all samples, %
Interzone cell cultures
Time point 0h 1.5h 3h
12h
Biological replicate
H1
95.2 95.1 95.0 95.1
H2
95.2 95.4 95.4 95.0
H5
95.5 94.9 95.1 95.4
H6
94.6 94.7 94.9 95.0
H9
95.4 95.3 95.4 95.2
H11
95.2 95.2 95.1 95.0

96h

0h

95.1
95.2
94.7
94.4
95.1
94.9

95.1
95.2
95.4
94.0
95.3
93.2
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Anlagen cell cultures
1.5h 3h
12h 96h
94.8
95.4
95.2
95.0
95.1
94.8

94.9
95.5
95.4
94.9
94.5
95.0

95.0
95.4
95.4
94.7
95.3
94.9

95.1
95.0
95.0
94.9
95.0
94.5

0h
29
32
33
34
36
34

0h
95.6
95.2
94.4
95.2
95.1
95.1

Fibroblast cultures
1.5h 3h
12h
33
38
35
35
40
38

45
32
39
33
35
31

35
36
40
34
39
30

96h
40
38
35
32
37
36

Fibroblast cultures
1.5h 3h
12h

96h

95.3
95.4
95.3
95.1
95.3
94.7

94.6
94.7
94.9
94.6
94.8
94.7

95.3
95.2
95.3
94.5
94.1
95.4

94.9
95.0
94.7
94.4
94.8
94.6

Kinetics of gene expression profiles within a cell type
Differentially expressed genes were evaluated between paired time point comparisons
(0h vs. 1.5h; 1.5h vs. 3h; 3h vs. 12h; 12h vs. 96h) within a cell type. The numbers of DEGs
determined at a given time point compared to a previous time point are shown in Table 3.3.

The following subsections describe the kinetics of gene expression profiles in each cell
type evaluated by diverse analyses. First, expression patterns of total DEGs across the entire
experimental period were visualized. Also, GO enrichment analysis was conducted, and the
five most overrepresented biological process terms in each subsequent time comparison are
presented. Hub genes and their co-expression network were defined based on gene
expression patterns over time. Finally, upstream regulators were predicted in each time
sequence comparison.

Table 3.3. Number of differentially expressed genes (DEGs) within cell type when compared
to previous time point
Cell type
Interzone cell
Anlagen cell
Fibroblast
Total unique DEG entities across
2,822
3,784
3,212
the entire experimental perioda
Regulation pattern
UP
Down
UP
Down
UP
Down
Time point comparison
1.5h based on 0h
141
29
110
16
96
10
3h based on 1.5h
304
207
234
133
289
118
12h based on 3h
858
696
1,031
965
988
838
96h based on 12h
691
742
1,091
1,304
830
1,027
Total unique DEG entities across
the entire experimental period 1,861
1,532
2,242
2,252
2,026
1,861
b
in each regulation pattern
a
The numbers include both upregulated and downregulated DEGs
b
The numbers include DEGs within each regulation pattern, either upregulated or
downregulated.
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1) Interzone cell analyses
1-a) Expression patterns of DEGs during the experimental period
Along the time course, interzone cell cultures resulted in 2,822 DEGs: 1,816 genes were
upregulated, 1,532 genes were downregulated, and 538 genes changed relative directional
orientation (up- or downregulation) over the experimental period. While the gene expression
pattern changes between the baseline and the first collection point (1.5h) were not separated,
a clear distinction of transcriptomic patterns started to be observed by 3h (Figure 3.2.a). Some
genes that were expressed at a higher level during earlier time points became downregulated
at later time points, and the opposite was also observed. By 96h, the differential gene
expression profiles became almost reversed from the baseline. Towards the later time points,
a greater number of genes were differentially expressed at a time point compared to its
previous time point (Figure 3.2.b and c). Chronologically closer time comparisons shared more
common DEGs (Figure 3.2.b and c).

1-b) Gene enrichment analysis
The five most upregulated and downregulated overrepresented biological processes for
each time comparison are listed in Table 3.4 and 3.5, respectively. At the earlier time
sequences, transcription regulatory events were most significantly represented by the profiles
of both upregulated and downregulated DEGs. Towards the later time points, biological
processes involved in chondrogenic differentiation became distinctive among upregulated
DEGs.
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1-c) Hub genes and co-expression network
The most significant gene correlated with the time course was FOLR2 (GS=0.99; Pvalue=2.2E-24), and the top ten genes that were highly correlated with the time sequence are
listed in Table 3.6. All of the ten most significant genes were categorized into the Turquoise
group by ME identification. Among the 27 ME groups evaluated by WGCNA, the Turquoise
group had the greatest module−trait relationship (0.96; P-value=1E-17) with the time course
in interzone cell cultures (Figure 3.3). The co-expression network of the genes, which were
highly correlated with the Turquoise group, is exhibited in Figure 3.4. The gene that had the
highest MM with the Turquoise group was OLFML3 (MM=0.98; P-value=7.1E-22). Based on
existing knowledge, however, interactions of OLFML3 with the other members in the
Turquoise group were not demonstrated, therefore not shown in Figure 3.4.

1-d) Upstream regulator prediction
During the first 1.5 hours, a smaller number of upstream regulators were predicted in
both activation and inhibition status (Figure 3.5). The greatest number of computationally
predicted upstream regulators were observed between 3h and 12h. It is interesting to note
that TGFB1 was predicted to be an upstream regulator from the baseline to 1.5h (z-score=4.95;
P-value=2.8E-39) while the major chondrogenic factor that was used in the experiment was
the protein encoded by TGFB1.
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a) Heatmap

b) Upregulated DEGs

Figure 3.2. Differentially expressed
genes (DEGs; n= 2,822) over time
within interzone cell cultures. a)
DEGs plotted in a heatmap. On the
right side, time points (#h) and
biological replicates (H#) are
labeled. b) UpSet figure of
upregulated DEGs
(n=1,816)
between time points. c) UpSet
figure of downregulated DEGs
(n=1,532) between time points.
The set size graphs of the UpSet
figures represent the number of
DEGs in each time point
comparison. Note that each
comparison has a different set
size.

c) Downregulated DEGs
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Table 3.4. Top five biological process gene ontology (GO) terms of differentially upregulated
genes in interzone cell cultures during time courses
Time
course

GO ID
GO:0000122

GO:0045944
0h vs 1.5h

GO:0043410
GO:0045892
GO:1900745

1.5h vs 3h

Inflammatory response

GO:0060412

Ventricular septum
morphogenesis

GO:0007219

Notch signaling pathway

GO:0071407
GO:0060021
GO:0050680
GO:0071498
GO:0007155
GO:0019221
GO:0001958
GO:0070374

12h vs 96h

Negative regulation of
transcription from RNA
polymerase II promoter
Positive regulation of
transcription from RNA
polymerase II promoter
Positive regulation of
MAPK cascade
Negative regulation of
transcription, DNAtemplated
Positive regulation of
p38mapk cascade

GO:0006954

GO:0003151

3h vs 12h

Term

GO:0002062
GO:0032331

GO:0090090

Outflow tract
morphogenesis
Cellular response to
organic cyclic compound
Palate development
Negative regulation of
epithelial cell
proliferation
Cellular response to fluid
shear stress

Pvaluea
7.51E07
1.92E06

Differentially expressed genes from the dataset
DLX2, PLK3, EZR, IRF2BPL, NRARP, SMAD7,
EFNA1, RELB, NR4A2, LMCD1, PER1, FOXC2,
ID3, SOX9, JUNB, HIC1
IL6, RELB, F2RL1, CCNL1, NFKBIA, NR4A1, DLL1,
FADD, SOX9, JUNB, IL11, LIF, ADRB2, IRF2BPL,
VEGFA, ZC3H12A, PER1, SERTAD1

4.11E06

LIF, TNFRSF1B, ADRB2, IL6, RELT, PDGFB, IL11

4.91E05

GCLC, CRY2, CEBPB, PDGFB, CCDC85B, KLF10,
RELB, IRF1, ID3, SOX9

9.71E05

GADD45G, ZC3H12A, GADD45B, GADD45A

4.67E05

TLR10, CCL2, ELF3, TNFRSF25, CSF1, RELB,
AFAP1L2, NFKB1, TGFB1, CALCB, S1PR3,
TNFRSF1B, CCL20, CYP26B1

1.69E04
1.22E03
1.66E03
1.87E03
5.51E04

NOTCH1, HEYL, WNT11, ZFPM1, GJA5
S1PR3, NRARP, DTX1, HEYL, TMEM100, TGFB1,
ANGPTL4
HEYL, WNT11, ZFPM1, PLXND1, GJA5
ALPL, RGS20, CCL2, GLI2, TGFB1
MEF2C, DHRS3, SATB2, WDPCP, MEOX2,
HAND2, DLX5, ARID5B, INSIG1, IFT172, SNAI2

1.03E03

MEF2C, MTSS1, IFT122, CDKN2B, IFT172, GDF5,
MCC, TINF2

3.47E03

MEF2C, MTSS1, PTGS2, HAS2

Cell adhesion

6.13E03

Cytokine-mediated
signaling pathway
Endochondral
ossification

9.30E03
5.88E07

Positive regulation of
ERK1 and ERK2 cascade

1.47E06

Chondrocyte
differentiation
Negative regulation of
chondrocyte
differentiation
Negative regulation of
canonical Wnt signaling
pathway

8.56E06

HAPLN2, HAPLN1, HAPLN4, ICAM5, POSTN,
NCAM1, ITGA9, COMP, TGFBI, CNTN2, ACAN,
HAS2, HRC, SPP1
FLRT3, ASPN, STAT4, IL22RA1, LRRC4B, EPOR,
DCN, LRRC15, GHR
BMP4, CSGALNACT1, FGF18, DLX5, COL2A1,
MMP16, MMP13, SCX
BMP4, FGF18, BMP2, CCL2, F2RL1, CHI3L1,
CCL19, FGF10, CD74, CCL11, SPRY2, ARRB1,
PLA2G2A, ANGPT1, PDGFD, PLA2G5, F2R
BMP4, BMP2, WNT5B, OSR2, GDF5, COL2A1,
COL11A2, SCX

1.61E05

BMP4, RARG, GDF5, NKX3-2, SNAI2, GREM1

2.03E05

NKD1, NOG, AMER1, BMP2, WNT5B, DACT1,
PRICKLE1, SNAI2, FRZB, WWTR1, GREM1, GLI3,
GLI1

a

Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms.
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Table 3.5. Top five biological process gene ontology (GO) terms of differentially
downregulated genes in interzone cell cultures during time courses
Time
course

GO ID

Term

Pvaluea

Differentially expressed genes from the dataset

GO:0001759

Organ induction

0.016

SPRY1, SIX1

0.018

EGR1, SIX1, CITED2, ZNF2

0.023

HTR1B, EDN1

0.044

SPRY1, SIX1

0.049

SPRY1, RGS2

3.20E08

MEF2C, FOS, EGR2, ATF3, BTG2, NR4A1, FOXN2,
ANKRD1, CITED2

1.08E06

MEF2C, ATF7IP, SATB2, FGF9, EDN1, KLF11, NR4A2,
CBX4, NR4A3, GLI3, DLX2, OSR2, REL, IRF2BPL,
TRPS1, JUN, ID4, SKIL, LCOR

GO:0006355
0h vs 1.5h

GO:0042310
GO:0001657
GO:0043407
GO:0035914

GO:0000122
1.5h vs 3h
GO:0045444
GO:0008584

3h vs 12h

12h vs 96h

Regulation of
transcription, DNAtemplated
Vasoconstriction
Ureteric bud
development
Negative regulation
of MAP kinase
activity
Skeletal muscle cell
differentiation
Negative regulation
of transcription from
RNA polymerase II
promoter
Fat cell
differentiation
Male gonad
development

2.81E06
3.65E06
1.28E05

EGR2, ARID5B, GDF6, NR4A2, NR4A1, ID4, NR4A3,
KLF4
INHBA, COL9A3, FGF9, ARID5B, BCL2, KITLG, LHX9,
CITED2
MEF2C, INHBA, SATB2, OSR2, ARID5B, CSRNP1,
COL2A1, GLI3
IER3, IL6, EGR3, ACTC1, LIMS2, NUAK2, SOCS3,
SMAD6, BTC, ASNS, GLI2, IGF1R, ATF5, SPRY2,
STK40, PTK2B, ID1, CHST11, THOC6, AVEN, RARA,
MYC
FLT1, WNT5B, PDGFB, LYN, TGFBR1, FAM110C,
EDN1, MYADM, CCL26, CCL11, IGF1R, NOTCH1,
SEMA3E, CEMIP, PLAU

GO:0060021

Palate development

GO:0043066

Negative regulation
of apoptotic process

1.82E05

GO:0030335

Positive regulation of
cell migration

1.05E04

GO:0035994

Response to muscle
stretch

3.26E04

GO:0035556

Intracellular signal
transduction

3.68E04

GO:0006954

Inflammatory
response

5.46E04

GO:0001666

Response to hypoxia

2.17E06

GO:0006096

Glycolytic process

2.57E05

GPI, TPI1, ALDOC, PGAM1, HK1, PGK1, GAPDH, ENO1

GO:0007155

Cell adhesion

1.22E04

B4GALT1, ATP1B1, ACHE, ICAM5, PCDH10, ITGA1,
ACKR3, ITGA3, TINAGL1, ADGRG1, ITGAX, ITGA8,
SULF1, CNTN2, GP1BA, CNTN4, THBS2

GO:0002931

Response to ischemia

GO:0007507

Heart development

1.33E04
1.47E04

a

FOS, SLC8A1, NFKBIA, NFKB1, ANKRD1
SGK1, SOCS2, LYN, NUAK2, SPSB1, TGFBR1, PRKAG2,
PRKCI, CXCL8, PRKCG, RPS6KA5, HUNK, RASSF5,
STAC, TIAM2, CDC42BPA, GUCY1A2, SH2B3, RGS7,
NIM1K, PAG1, TEC, RASA2
TNFRSF21, TLR10, IL6, CCL2, ELF3, LYN, IL18, CSF1,
TLR1, ACKR1, ANXA1, CXCL8, NFKB1, BDKRB1,
CCL26, CCL11, TNFRSF1B, CCL20, RELT
CAV1, CRYAB, EGLN3, TGFB3, SMAD3, EGLN1, DDIT4,
VEGFC, HSP90B1, LONP1, MYOCD, VEGFA, LOXL2,
ALKBH5

HYOU1, CAV1, UCHL1, CAMK2A, FAIM2, CIB1
PDGFB, FOXJ1, SOD2, GATA2, ACVR2B, ADAP2, ECE1,
ADM, OSR1, JMJD6, GYS1, EPOR, LOX, BCOR

Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms.
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Table 3.6. Ten most highly correlated hub genes with time course in interzone cell cultures
during entire experimental period
MMb to
Gene
MEa group
Gene significance
P-value
P-value
Turquoise
FOLR2
Turquoise
0.988
2.19E-24
0.954
3.80E-16
ITGA10
Turquoise
0.983
5.42E-22
0.942
7.88E-15
PRELP
Turquoise
0.981
1.45E-21
0.967
4.23E-18
LOXL4
Turquoise
0.981
1.50E-21
0.931
8.56E-14
KCNN4
Turquoise
0.977
1.95E-20
0.955
2.87E-16
FMOD
Turquoise
0.976
4.26E-20
0.944
5.52E-15
COL24A1
Turquoise
0.975
6.34E-20
0.972
3.31E-19
PODNL1
Turquoise
0.971
4.93E-19
0.955
2.26E-16
GABRE
Turquoise
0.971
7.01E-19
0.960
5.97E-17
AEBP1
Turquoise
0.969
1.32E-18
0.958
8.74E-17
a
ME, Module eigengene
b
MM, Module membership

Figure 3.3. Module eigengene (ME) groups
with module−trait relationship scores in
interzone cell cultures over time. P-values
are shown in the parentheses. The higher
relationship score represents the greater
correlation between a ME group and the
time sequence.
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Figure 3.4. Hub gene co-expression network in interzone cell cultures during 96 hours of in
vitro chondrogenesis. Colored by module eigengene group.
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Figure 3.5. Upstream regulators predicted by Ingenuity Pathway Analysis (IPA) between subsequent time points in interzone cell cultures.
The activation status thresholds were activation z-score>|2| and P-value of overlap<0.05. Only genes that have log2 fold change (FC)≥|1| in
the dataset were presented in the figure. Positive z-scores represent activated upstream regulators, and negative values indicate inhibition.
When a predicted activation status (activation or inhibition) matched the regulation pattern analyzed from the dataset (positive
log2FC=upregulation; negative log2FC=downregulation), the prediction was accepted. aOthers include enzymes, kinases, and others. bSignal
transduction includes growth factors, ligands, receptors, and cytokines.
*
CPMX1 and MEOX2 are also hub genes in interzone cell cultures whose expression patterns are highly correlated with the time course.
**
In the data, log2FC of TGFB1 from 0h to 1.5h was 0.94.
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2) Anlagen cell analyses
2-a) Expression patterns of DEGs during the experimental period
Over the entire experimental period, 3,784 DEGs were observed in analgen cell cultures:
2,242 genes were upregulated, 2,252 genes were downregulated, and 710 genes were
overlapped between the lists of upregulated and downregulated DEGs. The transcriptomic
profiles were not discriminative from the baseline until 3h (Figure 3.6.a). Of note, one
biological replicate (Horse #6) at 0h and 1.5h had gene expression patterns more closely
clustered to those of its own at 3h than those of the other biological replicates at 0h and 1.5h.
Except for this case, the overall gene expression profiles were clustered by time point. A clear
distinction of the transcriptomic characteristics was observed by 12h, and the initial gene
expression patterns became almost opposite by 96h. Similar to interzone cell cultures, more
common DEGs were recorded between chronologically closer time point comparisons, and
fewer common DEGs were shared between time point comparisons with greater time gaps
(Figure 3.6.b, and 6.c).

2-b) Gene enrichment analysis
The five most overrepresented biological processes at each time sequence analyzed from
the upregulated and downregulated DEGs in anlagen cell cultures are listed in Table 3.7 and
3.8, respectively. Only 3 biological processes were found to be over-represented from the
downregulated DEGs at 1.5h based on 0h. During the first 1.5 hours, transcription regulatory
events were most significantly upregulated. Regulatory processes in signaling cascades were
observed during the entire experimental period. Finally, biological processes related to ECM
metabolism were overrepresented in the last time comparison (between 12h and 96h).
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2-c) Hub genes and co-expression network
The most significant hub gene correlated with the time sequence in analgen cell cultures
was SEMA6A (GS=0.99; P-value=6.4E-25), with the top ten listed in Table 3.9. The ME
identification categorized these ten genes into the Brown group, and this group had the
highest module−trait relationship (0.96; P-value=2E-17) with the time course in anlagen cell
cultures (Figure 3.7). The co-expression network of the hub genes that were greatly correlated
with the Brown group is shown in Figure 3.8. The gene that showed the highest MM with the
Brown group was GXYLT2 (MM=0.99; P-value=1.6E-24), however, interactions of this gene
with the other members in the Brown group are unknown. FMOD had the second highest MM
with the Brown group (MM=0.99; P-value=3.2E-23) and centered in the co-expression
network, interacting with 9 members in the Brown group.

2-d) Upstream regulator prediction
Similar to interzone cell cultures, greater upstream regulators were predicted towards the
later time sequences in both activation and inhibition status (Figure 3.9). Also, TGFB1 was
predicted to be an activated upstream regulator during the first 1.5 hours (z-score=4.19; Pvalue=9.4E-36). However, during the last time sequence (12h – 96h), inhibition of TGFB1 was
predicted (z-score=-3.45; P-value=5.7E-52).
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a) Heatmap

b) Upregulated DEGs

Figure 3.6. Differentially expressed
genes (DEGs; n=3,784) over time
within anlagen cell cultures. a)
DEGs plotted in a heatmap. On the
right side, time points (#h) and
biological replicates (H#) are
labeled. b) UpSet figure of
upregulated DEGs
(n=2,242)
between time points. The set size
graph represents the number of
DEGs in each time point
comparison. c) UpSet figure of
downregulated DEGs (n=2,252)
between time points. The set size
graphs of the UpSet figures
represent the number of DEGs in
each time point comparison. Note
that each time comparison has a
different set size.

c) Downregulated DEGs
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Table 3.7. Top five biological process gene ontology (GO) terms of differentially upregulated
genes in anlagen cell cultures during time courses
Time
course

GO ID
GO:0000122

GO:0045892
0h vs 1.5h

GO:0045944
GO:1900745
GO:0043153
GO:0071456
GO:0048589
GO:0006355

1.5h vs 3h
GO:0030206

GO:0043536

Negative regulation of
transcription from RNA
polymerase II promoter
Negative regulation of
transcription, DNAtemplated
Positive regulation of
transcription from RNA
polymerase II promoter
Positive regulation of
p38mapk cascade
Entrainment of
circadian clock by
photoperiod
Cellular response to
hypoxia
Developmental growth
Regulation of
transcription, DNAtemplated
Chondroitin sulfate
biosynthetic process
Positive regulation of
blood vessel
endothelial cell
migration
Cytokine-mediated
signaling pathway
Negative regulation of
JAK-STAT cascade
Negative regulation of
protein kinase activity
Regulation of Rho
protein signal
transduction

Pvaluea

Differentially expressed genes in the dataset

2.21E06

DLX2, PLK3, IRF2BPL, NRARP, SMAD7, EFNA1,
NR4A2, LMCD1, PER1, FOXC2, ID3, SOX9, JUNB,
HIC1

9.95E06

CRY2, CEBPB, PDGFB, ELF3, CCDC85B, KLF10, IRF1,
ID3, SOX9, SOX8

1.48E05

CRTC1, NFKBIA, NR4A1, DLL1, FADD, SOX9, SOX8,
JUNB, IL11, LIF, IRF2BPL, VEGFA, ZC3H12A, PER1,
NFATC1

5.39E05

GADD45G, ZC3H12A, GADD45B, GADD45A

1.17E04

CRY2, PER1, BHLHE40, SIK1

3.22E04
0.002
0.002

PDGFB, HMOX1, VEGFA, FAM162A, AQP1,
ANGPTL4
ADM, CHST11, SMAD3, GLI2
ZNF566, PPARG, HR, ZNF175, ABCG1, ZNF2,
RGS20, ZNF691, JMJD6, ZSCAN20, HEYL, ZNF404,
KDM3A, LIMD1, ALX3, CSDC2, NFATC1

0.007

CHST11, CHST3, CHSY1

0.012

PDGFB, VEGFA, ANGPTL4

5.70E04
7.06E04

Heart development

0.003

Collagen catabolic
process
Negative regulation of
chondrocyte
differentiation
Negative regulation of
canonical Wnt signaling
pathway

7.22E06

FLRT3, ASPN, IL22RA1, LRRTM1, LRRC4B, GP1BA,
EPOR, DCN, LRRC15, GREM2, CISH, GHR
FLRT3, ASPN, LRRTM1, LRRC4B, GP1BA, DCN,
LRRC15, CISH
FLRT3, ASPN, LRRTM1, LRRC4B, TRIB3, GP1BA,
DCN, LRRC15, CISH, TRIB2
PLEKHG4, DLC1, OBSCN, PLEKHG1, ARHGEF26,
ARHGEF25, TIAM1, PLEKHG5, ARHGEF9, EPS8L1,
FGD4
ZFP36L1, ADAP2, ADM, FOXJ1, TRPS1, COL3A1,
ACAN, GYS1, NFATC4, EPOR, CACNA1C, CXADR,
SOD2
CTSK, MMP9, MMP16, CTSS, MMP14, MMP13,
MMP2

1.94E05

CHADL, RARG, GDF5, NKX3-2, GLI2, SNAI2, SOX9,
GREM1

GO:0030198

Extracellular matrix
organization

8.37E05

GO:0001837

Epithelial to
mesenchymal transition

2.21E04

GO:0019221
GO:0046426
GO:0006469
3h vs 12h
GO:0035023

GO:0007507
GO:0030574
GO:0032331

12h vs 96h

Term

GO:0090090

0.003
0.003

2.90E05

a

NOG, BMP2, FOXO1, RGS19, LEF1, SOX9, GREM1,
FRZB, SNAI2, GLI1, DKK2, AMER1, WNT4, DACT1,
PRICKLE1, SOSTDC1
MPZL3, EGFL6, MMP9, OLFML2B, ADAMTSL4,
POSTN, SOX9, CSGALNACT1, SMOC2, TNFRSF11B,
FBLN1, COL27A1, KAZALD1
NOG, WNT4, HIF1A, LEF1, LOXL3, SOX9

Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms.
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Table 3.8. Top five biological process gene ontology (GO) terms of differentially
downregulated genes in anlagen cell cultures during time courses
Time course

GO ID
GO:0035914

0h vs 1.5h

GO:0070373
GO:0007179
GO:0035914
GO:0008543

1.5h vs 3h
GO:0006355
GO:0032496
GO:0045444

Term
Skeletal muscle cell
differentiation
Negative regulation of
ERK1 and ERK2 cascade
Transforming growth
factor beta receptor
signaling pathway
Skeletal muscle cell
differentiation
Fibroblast growth factor
receptor signaling
pathway
Regulation of
transcription, DNAtemplated
Response to
lipopolysaccharide
Fat cell differentiation

Pvaluea
6.65E04

Differentially expressed genes in the
dataset

0.028

SPRY1, DUSP6

0.034

FOS, CITED2

9.84E07

EGR1, FOS, ATF3, EGR2, BTG2, MYF5,
ANKRD1

8.15E05

FLRT3, FGF5, FLRT2, FGF7, FGF21

8.22E04

HES1, EGR1, HHEX, EGR3, EGR2, MEOX2,
ARID5B, MYF5, VGLL2, TLE1, NPAS4, MEIS1,
LHX9

0.008

CEBPB, PTGER4, DUSP10, TRIB1

0.009

EGR2, ARID5B, NR4A2, KLF4

GO:0006270

DNA replication
initiation

2.80E08

GO:0030335

Positive regulation of
cell migration

4.36E06

GO:0045740

Positive regulation of
DNA replication

GO:0006364

rRNA processing

8.47E06
7.45E04

GO:0032870

Cellular response to
hormone stimulus

0.001

GO:0071456

Cellular response to
hypoxia

1.13E06

GO:0000070

Mitotic sister chromatid
segregation

1.47E06

GO:0007059

Chromosome
segregation

9.19E06

GO:0007018

Microtubule-based
movement

2.77E05

GO:0007076

Mitotic chromosome
condensation

4.92E05

3h vs 12h

12h vs 96h

a

FOS, EGR2, CITED2

CCNE2, CCNE1, CDC45, MCM7, POLA2,
MCM2, MCM3, MCM10, MCM4, MCM5,
MCM6
WNT5B, FLT1, PDGFB, LYN, FAM110C,
TGFBR1, EDN1, F2RL1, FER, CCL26, IGF1R,
NOTCH1, SEMA3E, SEMA3D, ADRA2A,
CEMIP, HAS2, PDGFC, PDGFD, PLAU, F2R
IGF1R, DNA2, PDGFB, PCNA, FGF10, KITLG,
PDGFC, AREG, GLI2
DIS3, EBNA1BP2, CCDC86, RRP1B, RRP9,
BOP1, GTF2H5, MDN1, MRTO4
CGA, NPFFR2, ADRA2A, OXTR, JUNB, SLIT2,
SLIT3
P4HB, EPAS1, PTGS2, PINK1, PMAIP1,
NPEPPS, RORA, PRKCE, HYOU1, HMOX1,
VEGFA, MDM2, FAM162A, NDRG1, ANGPT4
CEP57, PLK1, CENPA, SPAG5, NEK2, ZWINT,
KIF18A, KIF18B, ESPL1, KNSTRN
CENPN, KIF11, NEK2, NEK10, BIRC5,
KNSTRN, BRCA1, ESCO2, SPC25, HJURP,
CDCA2, CENPW, SKA3, SKA1
KIF14, KIF23, KIF22, KIF4A, KIF3A, KIF11,
KIF15, KIF18A, KIF18B, CENPE, DNAH2,
KIF3C, KIF2C, KIF1B, DYNC1H1, KIF20A
NCAPH, NCAPG, NUSAP1, CDCA5, NCAPD3,
NCAPD2, SMC4

Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms.
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Table 3.9. Ten most highly correlated genes with time course in anlagen cell culture during
entire experimental period
MMb to
Gene
MEa group
Gene significance
P-value
P-value
Brown
SEMA6A
Brown
0.989
6.36E-25
0.977
3.22E-20
ANKRD35
Brown
0.981
1.33E-21
0.952
5.83E-16
PODNL1
Brown
0.979
8.50E-21
0.932
7.30E-14
AEBP1
Brown
0.978
1.44E-20
0.950
1.20E-15
ENSECAG00
Brown
0.978
1.45E-20
0.962
2.22E-17
000022553
PLEKHA4
Brown
0.972
4.80E-19
0.935
4.03E-14
COMP
Brown
0.971
5.05E-19
0.962
2.77E-17
MAPK7
Brown
0.970
1.15E-18
0.948
2.07E-15
CHST6
Brown
0.968
2.15E-18
0.980
3.82E-21
LTBP3
Brown
0.968
2.39E-18
0.951
8.04E-16
a
ME, Module eigengene
b
MM, Module membership

Figure 3.7. Module eigengene (ME) groups
with module−trait relationship scores in
anlagen cell cultures over time. P-values
are shown in parentheses. The higher
relationship score represents the greater
correlation between a ME group and the
time sequence.
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Figure 3.8. Hub gene co-expression network in anlagen cell cultures during 96 hours of in
vitro chondrogenesis. Colored by module eigengene group.

80

Figure 3.9. Upstream regulators predicted by Ingenuity Pathway Analysis (IPA) between subsequent time points in anlagen cell cultures. The
activation status thresholds were activation z-score>|2| and P-value of overlap<0.05. Only genes that have log2 fold change (FC)≥|1| in the
dataset were presented in the figure. Positive z-scores represent activated upstream regulators, and negative values indicate inhibition.
When a predicted activation status (activation or inhibition) matched the regulation pattern analyzed from the dataset (positive
log2FC=upregulation; negative log2FC=downregulation), the prediction was accepted. aOthers include enzymes, kinases, and others. bSignal
transduction includes growth factors, ligands, receptors, and cytokines.
*
NKX3-2 is also a hub gene in anlagen cell cultures whose expression pattern is highly correlated with the time course.
**
In the data, log2FC of TGFB1 from 0h to 1.5h was 0.93.
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3) Fibroblast analyses
3-a) Expression patterns of DEGs during the experimental period
In the fibroblast negative control group 3,212 DEGs were measured over time: 2,026 genes
were upregulated, 1,861 genes were downregulated, and 675 genes switched their regulation
patterns during the 96 hours. Similar to the other cell cultures, gene expression patterns were
less distinctive between the baseline and the first collection point (1.5h), and gradually
changed until 3h after the initiation of in vitro chondrogenesis (Figure 3.10.a). Notable
transcriptomic changes were accumulated towards the later time points. Fibroblast cultures
also had a greater number of common DEGs between closer time point comparisons, and
fewer DEGs were overlapped between distant time point comparisons (Figure 3.10.b and c).

3-b) Gene enrichment analysis
With an approach similar to the other cell types, overrepresented biological processes in
each time sequence were analyzed from upregulated and downregulated DEGs in fibroblast
cultures, and the five most significant GO terms are listed in Table 3.10 and 3.11, respectively.
Due to the small size of the downregulated DEG list (n=9) in the comparison between 0h and
1.5h, no downregulated biological processes were identified in this time sequence. Overall,
similar biological processes were overrepresented in fibroblast cultures to the chondrogenic
cell cultures: transcription regulatory events were observed at earlier time points, and
processes related to signaling transduction happened during the whole experimental period.
Also, the profiles of downregulated DEGs represented skeletal muscle cell and fat cell
differentiation processes between 1.5h and 12h, and these terms were also observed in
interzone and anlagen cell cultures between 1.5h and 3h (Table 3.5 and 3.9).
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3-c) Hub genes and co-expression network
The hub gene that was most correlated with the time sequence in fibroblasts was NEB
(GS=0.99; P-value=4.6E-26), and the ten most correlated genes with the time course are
shown in Table 3.12. The ME identification categorized nine genes out of these ten genes into
the Turquoise group, which had the highest module−trait relationship (0.98; P-value=1E-21)
with the time sequence (Figure 3.11). The other, ITGA10, was identified as a member of the
Red group with the second highest module-trait relationship (0.76; P-value=1E-06). The coexpression network of hub genes that were closely correlated with the Turquoise group is
shown in Figure 3.12. The gene showed the highest MM with the Turquoise group was HTRA1
(MM=0.99; P-value=1.9E-23), interacting with two hub genes, VCAM and BGN in the coexpression network.

3-d) Upstream regulator prediction
Predicted upstream regulators in fibroblast cultures during the experimental period are
shown in Figure 3.13. In common with the chondrogenic cell cultures, activation of TGFB1 was
predicted (z-score=4.04; P-value=4.7E-28) during the first 1.5 hours. Activation of KLF3
between 3h and 12h and SAA1 between 12h and 96h was observed as a common prediction
in all cell types. On the other hand, sixteen genes were predicted to be commonly inhibited
in the chondrogenic cell lines and the negative control at a point during the experiment: KITLG,
E2F2, F2RL1, TICAM1, EDN1, GPER1, IL6, AREG, TLR9, PLAU, SREBF1, CD38, PPARGC1A,
ACVR1C, ADORA2A.
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a) Heatmap

b) Upregulated DEGs

Figure 3.10. Differentially expressed
genes (DEGs; n=3,212) over time
within fibroblast cultures. a) DEGs
plotted in a heatmap. On the right
side, time points (#h) and biological
replicates (H#) are labeled. b) UpSet
figure of upregulated DEGs
(n=2,026) between time points. The
set size graph represents the
number of DEGs in each time point
comparison. c) UpSet figure of
downregulated DEGs (n=1,861)
between time points. The set size
graphs of the UpSet figures
represent the number of DEGs in
each time point comparison. Note
that each time comparison has a
different set size.

c) Downregulated DEGs
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Table 3.10. Top five biological process gene ontology (GO) terms of differentially
upregulated genes in fibroblast cultures during time courses
Time
course

GO ID
GO:0030335
GO:0045892

0h vs 1.5h

GO:1900745
GO:0032922
GO:0006357

GO:0006954

IRS2, PDGFB, FAM110C, ADRA2A, HAS2, SNAI1

0.001

CRY2, CEBPB, PDGFB, CCDC85B, KLF10, RELB,
IRF1

0.002

GADD45G, ZC3H12A, GADD45B

0.002

CRY2, RELB, PER1, BHLHE40

0.002

MAFF, ETS2, RELB, RFX2, RUNX3, ELMSAN1, ETV3

1.99E04

IRAK2, TNFRSF21, S1PR3, TLR10, TNFRSF1B,
HRH1, PTGIR, TNFRSF11A, CYP26B1, RELB,
NFKB1, AFAP1L2

0.001

HRH1, HRH2, BAIAP2, ITPKA

0.002

ZNF263, WNT4, CRY2, PDGFB, RELB, HR, LIMD1,
RFX3, CBFA2T3, SOX8, PPARGC1B

GO:0007155

Cell adhesion

0.002

GO:0010107

Potassium ion import
Ventricular septum
morphogenesis
Semaphorin-plexin
signaling pathway

0.005

KCNJ4, ATP1B2, ATP1A3, ATP1A4, KCNJ12, KCNJ2

0.005

SOX4, EGLN1, WNT11, CITED2, PITX2

Positive regulation of
cell migration

1.56E06

Collagen catabolic
process
Positive regulation of
phosphatidylinositol 3kinase signaling

2.96E06

SEMA5A, SEMA6C, SEMA4G, SEMA6D, SEMA4B,
SEMA4A
BMP2, WNT5B, F2RL1, SPHK1, LRRC15, MMP14,
SNAI2, AQP1, CCL26, SEMA5A, SEMA6D,
SEMA3G, SEMA3E, PDGFRA, CEMIP, PDGFC,
PDGFD, FGF1, F2R
CTSK, MMP9, CTSS, MMP14, MMP13, MMP2,
MMP11

4.86E04

PTPN6, WNT16, F2RL1, PDGFC, ANGPT1, DCN,
PDGFD, NRG1, F2R

GO:0070374

Positive regulation of
ERK1 and ERK2 cascade

5.39E04

GO:0006954

Inflammatory response

7.71E04

GO:0001666
GO:0042391

GO:0060412
GO:0071526

GO:0030335

GO:0030574

12h vs 96h

Inflammatory response

Differentially expressed genes in the dataset

0.006
8.96E04

GO:0045892

GO:0006355

3h vs 12h

Positive regulation of
cell migration
Negative regulation of
transcription, DNAtemplated
Positive regulation of
p38mapk cascade
Circadian regulation of
gene expression
Regulation of
transcription from RNA
polymerase II promoter

Pvaluea
7.69E04

Regulation of synaptic
plasticity
Negative regulation of
transcription, DNAtemplated
Regulation of
transcription, DNAtemplated
Response to hypoxia
Regulation of
membrane potential

GO:0048167
1.5h vs 3h

Term

GO:0014068

0.003

0.006

a

ZNF566, SOX13, HR, ZFP3, ZNF175, ZNF2, AHRR,
RGS20, NOTCH1, ZNF235, ZSCAN20, ZNF404,
HEYL, LHX4, LIMD1, RFX3, ZNF436
VEGFA, EGLN3, SMAD3, LIMD1, CBFA2T3, DDIT4
KCNMA1, HCN2, NEDD4, GRIK3, ATP1A4,
POPDC3, SLC26A10, KCNH3, SLC26A11, CHRNE
HAPLN2, HAPLN4, ACHE, ICAM5, ITGAE, PCDH10,
COL15A1, FERMT1, FES, PRKCE, COL5A1, NCAM1,
ITGA9, COMP, TGFBI, LMLN, HRC

NOX4, BMP2, C5AR2, CCL2, F2RL1, FGF10, CD74,
CCL26, SPRY2, PDGFRA, ANGPT1, PDGFC, PDGFD,
PLA2G5, F2R
C5AR2, RARRES2, BMP2, CCL2, IL2RA, TSPAN2,
TNFRSF25, TLR1, PTGS1, SPHK1, CXCL8, PTGFR,
CCL26, S1PR3, AGTR2, TNFRSF11B, CCR7,
BMPR1B

Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms.
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Table 3.11. Top five biological process gene ontology (GO) terms of differentially
downregulated genes in fibroblast cultures during time courses
Time
course

GO ID

0h vs 1.5h

No biological processes identified due to a small size of the DEG list (n=9) in this comparison

GO:0035914
GO:0045444
GO:0008543
1.5h vs 3h
GO:0051965

GO:0007264
GO:0035914
GO:0009791

GO:0048008
3h vs 12h
GO:0045740

GO:0030335

12h vs
96h

Term

Skeletal muscle
cell differentiation
Fat cell
differentiation
Fibroblast growth
factor receptor
signaling pathway
Positive
regulation of
synapse assembly
Small GTPase
mediated signal
transduction
Skeletal muscle
cell differentiation
Post-embryonic
development
Platelet-derived
growth factor
receptor signaling
pathway
Positive
regulation of DNA
replication
Positive
regulation of cell
migration

P-valuea

1.12E-05

FOS, ATF3, EGR2, NR4A1, ANKRD1, CITED2

4.64E-05

EGR2, GDF6, ARID5B, NR4A2, NR4A1, KLF4

0.001

FLRT3, FLRT2, FGF7, FGF21

0.005

FLRT3, FLRT2, BDNF, LRRTM1

0.015

RND3, RASL11A, RND1, RAB30, RGL1, ARL4A

8.76E-05
1.52E-04

SGPL1, NRP1, PDGFB, BCAR1, CSRNP1, PDGFC,
PTPN11

2.93E-04

IGF1R, DNA2, PDGFB, FGF10, KITLG, PDGFC, AREG

3.05E-04

Cellular response
to hypoxia

3.19E-07

GO:0001666

Response to
hypoxia

2.01E-05

GO:0006096

Glycolytic process

2.82E-05

GO:0018401

Microtubule
cytoskeleton
organization
Peptidyl-proline
hydroxylation to
4-hydroxy-Lproline

EGR1, HLF, FOS, NOTCH1, ATF3, BTG2, HIVEP3,
NR4A1, ANKRD1, SOX8
ATF5, SGPL1, KMT2A, BCL2, TGFBR1, CSRNP1,
CHST11, NR4A2, SLC18A2, HEG1, ASL, ITPR1

2.93E-04

GO:0071456

GO:0000226

Differentially expressed genes in the dataset

WNT5B, PDGFB, FAM110C, TGFBR1, F2RL1, EDN1,
CCL26, IGF1R, CORO1A, NOTCH1, DAB2, SEMA3E,
CEMIP, HAS2, PDGFC, PLAU
SLC8A3, P4HB, EPAS1, PTGS2, PINK1, NPEPPS,
RORA, PRKCE, HYOU1, HMOX1, VEGFA, NDRG1,
FAM162A, ANGPT4
CAV1, CRYAA, EGLN3, SMAD3, EGLN1, DDIT4,
VEGFC, HSP90B1, LONP1, MYOCD, VEGFA, P2RX2,
RYR2, LOXL2, ALKBH5
GPI, TPI1, ALDOC, PGAM1, ENO3, HK1, PGK1,
GAPDH, ENO1

4.09E-04

PRKCZ, EML1, CRMP1, MAP1A, CNTN2, NEFH,
MAP6, GAPDH, NEFL, MAP7D2, TACC1

6.48E-04

P4HB, P4HA1, EGLN3, EGLN1

a

Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms.
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Table 3.12. Ten most highly correlated genes with time course in anlagen cell culture during
entire experimental period
MMb to
Gene
MEa group
Gene significance
P-value
P-value
Turquoise
NEB
Turquoise
0.991
4.60E-26
0.983
4.07E-22
OLFML2B
Turquoise
0.989
1.26E-24
0.963
1.70E-17
GSTA4
Turquoise
0.984
1.24E-22
0.955
2.77E-16
NAAA
Turquoise
0.982
8.12E-22
0.969
1.30E-18
OMD
Turquoise
0.982
9.56E-22
0.973
2.38E-19
HTRA1
Turquoise
0.982
1.06E-21
0.986
1.87E-23
SLC29A1
Turquoise
0.979
6.44E-21
0.960
5.07E-17
IL1R1
Turquoise
0.979
8.39E-21
0.948
1.76E-15
ITGA10
Red
0.978
1.10E-20
0.944
5.48E-15
AMDHD2
Turquoise
0.978
1.38E-20
0.983
4.38E-22
a
ME, Module eigengene
b
MM, Module membership

Figure 3.11. Module eigengene (ME)
groups with module−trait relationship
scores in fibroblast cultures over time. Pvalues are shown in parentheses. The
higher relationship score represents the
greater correlation between a ME group
and the time sequence.
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Figure 3.12. Hub gene co-expression network in fibroblast cultures during 96 hours of in
vitro chondrogenesis. Colored by module eigengene group.
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Figure 3.13. Upstream regulators predicted by Ingenuity Pathway Analysis (IPA) between subsequent time points in fibroblast cultures. The
activation status thresholds were activation z-score>|2| and P-value of overlap<0.05. Only genes that have log2 fold change (FC)≥|1| in the
dataset were presented in the figure. Positive z-scores represent activated upstream regulators, and negative values indicate inhibition.
When a predicted activation status (activation or inhibition) matched the regulation pattern analyzed from the dataset (positive
log2FC=upregulation; negative log2FC=downregulation), the prediction was accepted. aOthers include enzymes, kinases, and others. bSignal
transduction includes growth factors, ligands, receptors, and cytokines.
*
In the data, log2FC of TGFB1 from 0h to 1.5h was 0.38.
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Common chondrogenic characteristics of interzone and analgen cell cultures
Differentially expressed genes in the interzone and anlagen experimental groups relative
to the negative fibroblasts were evaluated at each time point (interzone cell cultures vs.
fibroblast cultures and anlagen cell cultures vs. fibroblast cultures). The number of
upregulated and downregulated DEGs are listed in Table 3.13. Then, DEGs that were
commonly observed in both chondrogenic cell cultures compared to the negative control at
each time point are identified (Table 3.13) and processed through gene enrichment analysis
using the DAVID Functional Annotation Tool (v6.8; Huang et al., 2009; Table 3.14).

In this section, the DEGs were further classified; when a DEG’s expression was measured
in a condition (either chondrogenic cell lines or negative control) but not at all in the other
condition, this gene was considered as a candidate switch being turned on or off depending
on a condition. The numbers of common chondrogenic molecular switches at each time point
are present in Table 3.15.

90

Table 3.13. Number of differentially expressed genes (DEGs) in interzone and anlagen cell
cultures compared to the negative control at each time point
Upregulated
Common DEGs in
Interzone cell cultures
Anlagen cell cultures
Time point
chondrogenic cell lines
0h
450
[274]
769
1.5h
436
[239]
779
3h
434
[242]
708
12h
470
[274]
629
96h
645
[366]
617
Downregulated
Common DEGs in
Interzone cell cultures
Anlagen cell cultures
Time point
chondrogenic cell lines
0h
611
[447]
850
1.5h
662
[471]
864
3h
664
[472]
868
12h
895
[590]
921
96h
793
[550]
877
The numbers in the square brackets ([ ]) represent the number of commonly upregulated
or downregulated DEGs observed in both interzone and analgen cell cultures at each time
point. These numbers are included in the numbers of DEGs in each chondrogenic cell line
in the same row.

Table 3.14. Number of overrepresented biological process gene ontology (GO) terms
identified in the chondrogenic cell cultures compared to fibroblast cultures
0h
1.5h
3h
12h
96h
Total unique GO terms
Upregulated
26
33
28
58
70
128
Downregulated
43
33
59
48
50
133

Table 3.15. Number of differentially expressed genes (DEGs) and candidate molecular
switches in the chondrogenic cell cultures compared to fibroblast cultures
Upregulated
0h
1.5h
3h
12h
96h
Total DEGs
247
239
242
274
366
Molecular switches
[1]
[1]
[2]
[1]
[3]
Downregulated
0h
1.5h
3h
12h
96h
Total DEGs
447
471
472
590
550
Molecular switches
[9]
[7]
[3]
[7]
[10]
The numbers in the square brackets ([ ]) represent the number of genes whose expression
was exclusively turned on or off in the chondrogenic cell cultures. These numbers are
included in the numbers of DEGs in the cells above them.
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Candidate molecular switches exclusively turned on in chondrogenic cell lines
Compared to fibroblast cultures, there were 4 common genes that were only expressed
in interzone and anlagen cell cultures at the same time points (Table 3.16). At the base line,
there were no common genes exclusively expressed in the chondrogenic cell cultures. After
inducing chondrogenesis, GSC expression was turned on in both chondrogenic cell lines by
1.5h and until the last collection point (96h). Expression of a novel gene,
ENSECAG00000040027, was turned on by 3h. Exclusive expression of another novel gene,
ENSECAG00000034476, and HOXD13 was observed at 96h in the chondrogenic cell cultures.

Table 3.16. Genes that were exclusively expressed in both interzone and anlagen cell
cultures at the same time points while not expressed in fibroblast cultures
0h
1.5h
3h
12h
96h
ENSECAG
ENSECAG
None
GSC
GSC
00000040027
00000034476
GSC
GSC
HOXD13
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Candidate molecular switches exclusively turned off in chondrogenic cell lines
While expressed in fibroblast cultures, 19 genes were not expressed in both chondrogenic
cell cultures at the same time points (Table 3.17). These genes include four of the Homeoboxcontaining transcription factor genes in cluster B (HOXB4, HOXB5, HOXB8, and HOXB9). More
candidate molecular switches were turned off in the chondrogenic cell cultures towards the
baseline and the last time point (96h).

Table 3.17. Genes that were not expressed exclusively in both interzone and anlagen cell
cultures at the same time points while expressed in fibroblast cultures
0h
1.5h
3h
12h
96h
ENSECAG
ENSECAG
EN1
EN1
EN1
00000031562
00000031562
ENSECAG
ENSECAG
ENSECAG
HOXB4
HOXB4
00000031562
00000030268
00000034623
ENSECAG
HOXB5
HOXB5
HOXB9
HOXB5
00000039182
ENSECAG
HOXB8
NTM
HOXB9
00000043423
HOXB9
RBFOX1
SERPINB10
HOXB5
NTM
SIM1
SIM1
HOXB9
OLFM3
ZIC4
ZIC4
MMP26
RBFOX1
TLX3
ZIC4
TNFSF4
ZIC4
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Upregulated DEGs in chondrogenic cell lines
The profiles of commonly upregulated chondrogenic DEGs, including the switches,
resulted in 128 significant biological processes across the entire experimental period by gene
enrichment analysis (Table 3.14). A greater number of upregulated biological processes were
identified at later time points. Among the five collection time points, three GO terms were
consistently observed as significantly overrepresented biological processes in interzone and
analgen cell cultures compared to the negative control (Table 3.18). These processes are 1)
anterior/posterior pattern specification, 2) embryonic skeletal system morphogenesis, and 3)
positive regulation of chondrocyte differentiation.

Downregulated DEGs in chondrogenic cell lines
The commonly downregulated DEGs as well as the turned-off molecular switches in the
chondrogenic cell cultures presented 133 significant biological processes throughout the
whole experimental period (Table 3.14). The profiles of downregulated DEGs in the
chondrogenic cell lines relative to fibroblast cultures continuously overrepresented four
biological processes at the all collection points (Table 3.19). These processes are 1)
anterior/posterior pattern specification, 2) immune response, 3) negative regulation of cell
proliferation, and 4) regulation of cell migration.
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Table 3.18. Upregulated overrepresented biological processes in the chondrogenic cell lines
compared to fibroblast cultures at all time points
GO:0009952a, Anterior/posterior pattern specification
Time point Genes in the process
P-valueb
HOXD9, HOXA5, HOXA11, HOXA6, HOXA7, HOXA10,
0h
1.67E-05
HOXD13, HOXD10
1.5h
HOXA11, HOXA6, HOXA7, HOXA10, HOXD10
4.99E-03
HOXD9, HOXA5, HOXA11, HOXA6, HOXA7, HOXA10,
3h
1.69E-03
HOXD10
12h
HOXA11, HOXA6, HOXA7, HOXA10, HOXD13, HOXD10
1.13E-04
96h
RARG, HOXA5, HOXA11, HOXA10, HOXA9, GLI3, HOXD10
2.87E-03
GO:0048704, Embryonic skeletal system morphogenesis
Time point Genes in the process
P-Value
1.84E-04
0h
HOXD9, HOXA5, HOXA6, HOXA7, HOXD10
1.81E-03
1.5h
GSC, HOXA6, HOXA7, HOXD10
2.98E-03
3h
HOXD9, GSC, HOXA5, HOXA6, HOXA7, HOXD10
1.19E-05
12h
GSC, HOXA6, HOXA7, HOXD10
2.97E-02
96h
GSC, HOXA5, GLI3, HOXD10
GO:0032332, Positive regulation of chondrocyte differentiation
Time point Genes in the process
P-Value
1.20E-02
0h
HOXA11, SOX5, SOX6
5.22E-04
1.5h
HOXA11, SOX5, SOX6, SOX9
2.76E-05
3h
HOXA11, SOX5, SOX6, SOX9
5.14E-04
12h
HOXA11, GDF5, SOX5, SOX6, SOX9
7.55E-05
96h
HOXA11, SOX5, SOX6, SOX9, GLI3
a
GO:#, gene ontology ID
b
Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms.
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Table 3.19. Downregulated overrepresented biological processes in the chondrogenic cell
lines compared to fibroblast cultures at all time points
GO:0009952a, Anterior/posterior pattern specification
Time point Genes in the process
P-valueb
0h
1.5h
3h
12h

HOXB3, HOXC8, HOXC9, HOXB2, HOXC4, HOXB5, HOXB6, EMX2,
HOXB9
HOXB3, HOXC6, HOXB4, HOXC8, HOXC9, HOXC4, HOXB5, HOXB6,
EMX2
HOXB4, HOXC8, HOXC9, HOXC4, EMX2, HOXB9
HOXB3, HOXB4, HOXC8, HOXC9, HOXB2, HOXC4, HOXD3, HOXB5,
HOXB6, EMX2, HOXB9, ZBTB16
HOXC8, HOXB2, HOXC9, HOXC4, HOXD3, EMX2, HOXB9, ZBTB16

96h
GO:0006955, Immune response
Time point Genes in the process
C7, IL18, TGFBR3, OAS1, COLEC12, FAS, OAS2, TINAGL1, BMP6, B2M
0h
1.5h
3h
12h
96h

C7, HRH2, TGFBR3, OAS1, COLEC12, FAS, OAS2, TINAGL1, TNFAIP3,
BMP6, B2M, TNFSF8
TNFRSF21, C7, HRH2, IRF8, TGFBR3, OAS1, COLEC12, FAS, TNFAIP3,
BMP6, B2M
TNFRSF21, C7, IL18, IRF8, OAS3, OAS1, TNFRSF14, COLEC12, NGFR,
TNFAIP3, BMP6
CCL11, C7, TNFSF10, TNFSF4, HRH2, IL18, TNFRSF8, TGFBR3,
COLEC12, FAS, BMP6, TNFSF8, B2M

GO:0008285, Negative regulation of cell proliferation
Time point Genes in the process
0h
1.5h
3h
12h
96h

CEBPA, ATF5, CDKN1A, PODN, PTGES, PTH1R, TFAP2B, PTPRU,
SLC9A3R1, SKAP2, SLIT3, DPT
ATF5, CDKN1A, PODN, PTGES, BCL11B, PTH1R, TFAP2B, PTPRU,
SLC9A3R1, SKAP2, SLIT3, TP53INP1, DPT
CEBPA, PODN, PTH1R, KLF11, FGF10, PTPRU, SLC9A3R1, SKAP2,
SLIT3, ATF5, CDKN1A, PTGES, BCL11B, DPT, TP53INP1
CEBPA, PODN, PTH1R, FGF10, ZBTB16, PTPRU, PROX1, CDH5, SLIT3,
RERG, ATF5, PTK2B, BCL11B, KLF4
NOX4, B4GALT1, PODN, ADARB1, ZBTB16, CBFA2T3, SKAP2, SLIT3,
SPRY2, SPRY1, PTGES, PTK2B, BCL11B, SFRP4, ASPH, WNT9A

4.95E-04
7.33E-04
2.29E-05
4.60E-02
2.17E-03

P-Value
2.07E-02
4.01E-03
3.74E-02
1.13E-02
1.14E-02

P-Value
7.96E-03
4.58E-03
8.20E-03
5.18E-04
6.22E-04

GO:0030334, Regulation of cell migration
Time point Genes in the process
P-Value
LAMA2, LAMA1, PLXNC1, PLXNA4, PLXNA2, AMOT
4.35E-03
0h
LAMA2, LAMA1, PLXNC1, PLXNA4, PLXNA2, AMOT
5.59E-03
1.5h
LAMA2, LAMA1, PLXNC1, PLXNA4, PLXNA2, AMOT
1.24E-02
3h
LAMA2,
PLXNC1,
PLXNA4,
LAMA3,
PLXNA2,
DOCK10
5.59E-03
12h
LAMA2, PLXNC1, PLXNA4, AMOT, NTN1
4.18E-02
96h
a
GO:#, gene ontology ID
b
Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms.
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Distinct traits between interzone and anlagen cell cultures
Differential gene expression was evaluated at each time point between interzone and
anlagen cell cultures (Figure 3.14). More DEGs were observed at the earlier time points (772
– 710 genes between 0h and 3h), and less DGEs were counted towards the later time points
(543 – 551 genes between 12h and 96h; Table 3.20). Then, the DEGs were further categorized
if they were expressed exclusively in one type of cell culture while not expressed at all in the
other (Table 3.21). The ten most upregulated DEGs in interzone cell cultures and analgen cell
cultures compared to each other at each time point are listed in Table 3.22 and 3.23,
respectively. Gene enrichment analysis was conducted to identify overrepresented biological
processes that were upregulated in each cell type (Figure 3.15 and Table 3.24). Finally,
upstream regulators between the two chondrogenic cell cultures at each time point were
predicted by Ingenuity Pathway Analysis (IPA; Qiagen; Figure 3.16).

Table 3.20. Number of differentially expressed genes (DEGs) between interzone and
analgen cell cultures at each time point
0h 1.5h 3h
12h 96h
Total DEGs between interzone and anlagen cell cultures 772 770 710 543 551
Upregulated in interzone cell cultures
416 406 356 316 275
Exclusively expressed in interzone cell cultures [1]
[1]
[2]
[2]
[1]
356 364 354 227 276
Upregulated in anlagen cell cultures
Exclusively expressed in anlagen cell cultures [2]
[0]
[1]
[2]
[2]
The numbers of exclusively expressed genes in the square brackets ([ ]) are also included
in the numbers of upregulated or downregulated DEGs in the cell above them.
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Upregulated in
anlagen cell cultures

Upregulated in
interzone cell cultures
Statistical significance
threshold
(FDR adj. P-value<0.05)

Fold change
threshold
log2FC >|1|
a) 0h

b) 1.5h

Figure 3.14. Differentially expressed genes (DEGs) between interzone and anlagen cell
cultures at each time point plotted in volcano plots. Differential expression was determined
using fold change (FC) and statistical significance thresholds, log2FC>|1| and false discovery
rate (FDR) adjusted P-value<0.05, respectively. Note that -log10 P-values defining an FDR<0.05
threshold in each graph are different. The DEGs are shown in red dots. Exclusively expressed
genes in a cell type with infinite FC are not displayed in the volcano plots (continued on the
next page).
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c) 3h
HOXA13

d) 12h

e) 96h

(Figure 3.14 continued) Upregulated DEGs in interzone cell cultures are expressed in positive
log2FC while upregulated DEGs in anlagen cell cultures are expressed in negative log2FC. a) 0h,
n=769 DEGs; b) 1.5h, n=769 DEGs; c) 3h, n=707 DEGs; d) 12h, n=539 DEGs; e) 96h, n=548 DEGs.
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Candidate molecular switches exclusively expressed in one cell type
<Exclusively expressed genes in interzone cells>
From the baseline until 3h, ENSECAG00000037611 was only expressed in interzone (FDR
adjusted P-value=0.001; Table 3.21). At 3 and 12h, LY6G6C and C7H11orf52 were turned on
(FDR adjusted P-value=0.001), respectively while there was no expression in anlagen cell
cultures. Then, expression of ZIC3 was observed at 12h as well as at the last collection point
(FDR adjusted P-value=0.001).

<Exclusively expressed genes in anlagen cells>
Before inducing chondrogenesis, HOXB2 (FDR adjusted P-value=0.001) and H4C9 (FDR
adjusted P-value=0.003) were only expressed in analgen cell cultures (Table 3.21). Between
1.5h and 3h, HOXB2 expression was also detected in interzone cell cultures, but it was turned
off again by 12h and at 96h. Expression of ENSECAG00000038392 (FDR adjusted P-value<0.01),
HOXB3 (FDR adjusted P-value=0.001), and PLAC8B (FDR adjusted P-value=0.001) was
exclusively measured in analgen cell cultures at 3h, 12h, and 9h, respectively.

Table 3.21. Exclusively expressed genes in either interzone or analgen cell cultures
0h
1.5h
3h
12h
96h
ENSECAG000 ENSECAG000 ENSECAG000
C7H11orf52
ZIC3
Interzone
00037611
00037611
00037611
cell cultures
LY6G6C
ZIC3
ENSECAG000
H4C9
HOXB2
HOXB2
Anlagen cell
00038392
cultures
HOXB2
HOXB3
PLAC8B
The expression levels in the fragments per kilobase of transcript per million fragments
mapped read (FPKM) format, and false discovery rate adjusted P-values are shown in Table
3.22 and 3.23.
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Differentially expressed genes between interzone and anlagen cell cultures
The ten most upregulated genes in interzone and anlagen cell cultures are listed in Table
3.22 and 3.23, respectively. Gene enrichment analysis was conducted with the total DEGs
between the two chondrogenic cell cultures at each time point. Then, the ten most
overrepresented biological processes from the profiles of the DEGs between interzone and
analgen cell cultures at each time point were plotted into a circle plot (Figure 3.15 and Table
3.24). From the baseline until 3h, upregulated DEGs in anlagen cell cultures dominated in
greater numbers of the significant overrepresented biological processes. However, at the last
time point, only one process among the ten most significant processes was dominated by
upregulated DEGs in anlagen cell cultures; this biological process is endochondral ossification.
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Table 3.22. Ten most upregulated differentially expressed genes in interzone cell cultures
compared to anlagen cell cultures at each time point
Expression levels, FPKMa
Time
Genes
log2FCb
adj. P-valuec
point
Interzone
Anlagen
ENSECAG00000037611
2.94
0.00
infd
0.001
SLC13A4
81.98
0.84
6.60
0.001
COL9A3
5.40
0.09
5.88
0.001
CADPS
14.00
0.24
5.88
0.001
COL11A2
2.62
0.06
5.52
0.013
0h
ZIC2
8.69
0.22
5.29
0.024
HAPLN1
5.99
0.17
5.15
0.001
COL2A1
17.18
0.62
4.80
0.001
CLEC3A
5.96
0.25
4.60
0.001
ABI3BP
87.94
3.67
4.58
0.001
ENSECAG00000037611
2.59
0.00
inf
0.002
CLEC3A
0.59
0.00
7.25
0.044
SLC13A4
68.66
0.70
6.61
0.001
CADPS
14.81
0.26
5.85
0.001
COL9A3
2.65
0.06
5.44
0.001
1.5h
ZIC2
7.00
0.20
5.11
0.001
SFRP4
0.57
0.02
4.81
0.025
ABI3BP
88.27
3.75
4.56
0.001
GCNT2
2.26
0.10
4.54
0.006
CCDC3
3.43
0.17
4.36
0.003
ENSECAG00000037611
2.28
0.00
inf
0.004
LY6G6C
1.23
0.00
inf
0.001
SLC13A4
50.92
0.91
5.81
0.001
RPL11
11.54
0.21
5.75
0.047
ZIC2
8.22
0.16
5.66
0.001
3h
CADPS
16.98
0.34
5.63
0.001
IL6
17.13
0.55
4.97
0.001
ABI3BP
88.35
4.00
4.46
0.001
TFAP2A
2.38
0.15
4.03
0.001
ENSECAG00000038866
7.61
0.53
3.84
0.017
ZIC3
0.64
0.00
inf
0.001
C7H11orf52
0.96
0.00
inf
0.001
SLC13A4
127.92
2.59
5.63
0.001
12h
CADPS
13.25
0.36
5.22
0.001
ZIC2
12.14
0.37
5.04
0.001
RPL11
13.65
0.43
4.98
0.001
ENSECAG00000031929
4.10
0.14
4.87
0.001
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PLA2G2A
6.80
0.25
4.79
0.047
HOXA13
3.48
0.18
4.28
0.001
CDH1
4.33
0.26
4.06
0.001
ZIC3
0.96
0.00
inf
0.001
ZIC2
10.23
0.17
5.88
0.016
ADAMTS15
2.27
0.05
5.46
0.001
THBS4
19.09
0.51
5.22
0.001
ENSECAG00000033567
6.91
0.24
4.88
0.006
96h
ENSECAG00000031929
5.83
0.20
4.85
0.001
HOXA13
6.68
0.26
4.67
0.001
ENSECAG00000034282
4.61
0.19
4.63
0.001
DRA
2.45
0.10
4.57
0.026
ABI3BP
30.03
1.33
4.49
0.001
a
FPKM, fragments per kilobase of transcript per million fragments mapped read
b
FC, fold change
c
False discovery rate adjusted P-value
d
inf; Gene expression was not detected in anlagen cell cultures, therefore resulted in
infinite fold change.
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Table 3.23. Ten most upregulated differentially expressed genes in anlagen cell cultures
relative to interzone cell cultures at each time point
Expression levels,
Time
FPKMa
Genes
log2FCb
adj. P-valuec
point
Interzone
Anlagen
H4C9
0.00
1.08
infd
0.003
HOXB2
0.00
0.67
inf
0.001
LRRC4C
0.04
1.04
-4.740
0.023
HOXC8
0.10
2.52
-4.658
0.003
CXCL8
8.43
140.48
-4.058
0.001
0h
IGFBP3
2.82
39.98
-3.824
0.001
ESM1
0.31
4.25
-3.760
0.001
MEIS1
0.68
8.83
-3.695
0.001
NLRP3
0.07
0.83
-3.596
0.011
ENSECAG00000036672
0.66
7.67
-3.532
0.001
TRPA1
0.02
0.88
-5.491
0.012
HOXC8
0.05
2.25
-5.385
0.012
HOXC6
0.51
10.54
-4.369
0.009
ESM1
0.19
3.16
-4.074
0.001
IGFBP3
2.93
39.57
-3.756
0.001
1.5h
CXCL8
7.68
102.08
-3.733
0.001
JAM2
0.49
6.49
-3.716
0.001
PIP5K1B
0.14
1.60
-3.561
0.014
ENSECAG00000029063
0.14
1.60
-3.505
0.006
ENSECAG00000015143
1.43
16.07
-3.490
0.001
ENSECAG00000038392
0.00
1.34
inf
0.009
HOXC6
0.59
12.87
-4.443
0.003
HOXC8
0.16
2.62
-4.042
0.004
JAM2
0.47
6.53
-3.780
0.001
PDGFD
1.08
13.10
-3.595
0.001
3h
IGFBP3
2.75
32.14
-3.546
0.001
TRPA1
0.05
0.59
-3.539
0.001
HOXC4
0.12
1.40
-3.529
0.001
MEIS1
0.41
4.66
-3.503
0.001
CXCL8
2.81
29.53
-3.392
0.001
HOXB2
0.00
0.96
inf
0.001
HOXB3
0.00
0.75
inf
0.001
HOXC6
0.76
25.41
-5.058
0.001
12h
HOXC8
0.15
3.44
-4.525
0.001
SMPD3
0.04
0.80
-4.253
0.023
HOXC4
0.15
2.26
-3.897
0.001
ENSECAG00000039489
0.06
0.90
-3.891
0.017
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NRN1
20.85
246.23
-3.562
0.001
IRX6
0.05
0.55
-3.551
0.013
EYA2
0.72
8.14
-3.489
0.001
PLAC8B
0.00
1.17
inf
0.001
HOXB2
0.00
1.46
inf
0.001
KIF19
0.37
14.41
-5.269
0.001
HOXC6
0.51
16.09
-4.992
0.001
HOXC4
0.08
2.46
-4.887
0.006
96h
SMPD3
0.59
13.81
-4.548
0.001
IFIT3
0.27
5.74
-4.428
0.018
HOXC8
0.12
2.40
-4.261
0.001
FAM20A
0.03
0.60
-4.222
0.022
DLX6
0.07
1.24
-4.104
0.002
a
FPKM, fragments per kilobase of transcript per million mapped reads
b
FC, fold change
c
False discovery rate adjusted P-value
d
inf; Gene expression was not detected in anlagen cell cultures, therefore resulted in
infinite fold change.
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Figure 3.15. Gene ontology (GO) enrichment analysis on differentially expressed genes (DEGs)
between interzone and anlagen cell cultures at each time point, plotted by GOCircle plot. The
GO IDs and corresponding terms are listed in Table 3.24. The inner ring is a bar chart colored
by z-score, and the height of the bars represents the significance of the GO term determined
by −log10(adjusted P-value). The outer ring shows dotted plots of the log2 fold change (FC) for
the DEGs in each term. Upregulated DEGs in interzone cell cultures are shown in red dots
while upregulated DEGs in anlagen cell cultures are shown in blue dots. Exclusively expressed
genes in a cell type were excluded because of infinite FC. a) 0h, n=769 DEGs; b) 1.5h, n=769
DEGs; c) 3h, n=707 DEGs; d) 12h, n=539 DEGs; e) 96h, n=548 DEGS.
106

Table 3.24. Gene ontology (GO) IDs and corresponding terms present in Figure 3.15
Gene ontology ID Term
0h 1.5h 3h 12h 96h
GO:0001501
Skeletal system development
12h
GO:0001503
Ossification
12h
GO:0001525
Angiogenesis
0h 1.5h
96h
GO:0001569
Patterning of blood vessels
12h
GO:0001649
Osteoblast differentiation
0h 1.5h
96h
GO:0001958
Endochondral ossification
96h
GO:0002062
Chondrocyte differentiation
0h
12h 96h
GO:0002063
Chondrocyte development
96h
Mesenchymal to epithelial transition
GO:0003337
0h
involved in metanephros morphogenesis
GO:0006260
DNA replication
0h 1.5h 3h
GO:0006270
DNA replication initiation
0h 1.5h 3h
GO:0007010
Cytoskeleton organization
0h
GO:0007018
Microtubule-based movement
3h
GO:0007059
Chromosome segregation
3h
GO:0007155
Cell adhesion
0h 1.5h 3h 12h
GO:0021772
Olfactory bulb development
1.5h
GO:0030155
Regulation of cell adhesion
3h
GO:0030198
Extracellular matrix organization
1.5h
GO:0030199
Collagen fibril organization
12h
GO:0030335
Positive regulation of cell migration
1.5h
12h
GO:0030501
Positive regulation of bone mineralization
96h
GO:0030855
Epithelial cell differentiation
12h
GO:0034501
Protein localization to kinetochore
1.5h 3h
GO:0042127
Regulation of cell proliferation
0h
3h
GO:0042472
Inner ear morphogenesis
96h
GO:0042733
Embryonic digit morphogenesis
96h
Cellular response to fibroblast growth
GO:0044344
12h
factor stimulus
Positive regulation of epithelial cell
GO:0050679
0h
proliferation
Positive regulation of peptidyl-tyrosine
GO:0050731
1.5h
phosphorylation
GO:0051256
Mitotic spindle midzone assembly
3h
GO:0051301
Cell division
3h
GO:0060325
Face morphogenesis
12h
Positive regulation of ERK1 and ERK2
GO:0070374
96h
cascade
Positive regulation of canonical Wnt
GO:0090263
96h
signaling pathway
The cells are colored by the z-score scale shown in Figure 3.15. Red colors represent
upregulation in interzone cells, and blue colors represent upregulation in anlagen cells.
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Predicted upstream regulators
Upstream regulators were estimated by analyzing differences of gene expression levels
between the chondrogenic cell cultures at each time point using the IPA software (Figure 3.16).
Twelve upstream regulators were predicted to be more activated in interzone cell cultures
while twenty-three upstream regulators were predicted to be more activated in analgen cell
cultures over the experimental period. The upstream analysis projected NUPR1 as an
activated regulator in interzone cell cultures and E2F1 in anlagen cell cultures at 0h, 1.5h, and
3h. In analgen cell cultures, RUNX2 was expected as an upstream regulator at the baseline,
1.5h, and 96h.
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Figure 3.16. Prediction of upstream regulators that differentially regulate the chondrogenic pathways between interzone and analgen
cultures by Ingenuity Pathway Analysis (IPA). The activation status thresholds were activation z-score>|2| and P-value of overlap<0.05. Only
genes that have log2 fold change (FC)≥|1| in the dataset were presented in the figure. Positive z-scores represent activated upstream
regulators in interzone cell cultures, and negative values indicate activation in analgen cell cultures. When a predicted activation in a cell
type matched the regulation pattern analyzed from the dataset (positive log2FC=upregulation in interzone cell cultures; negative
log2FC=upregulation in anlagen cell cultures), the prediction was accepted. aOthers include enzymes, kinases, and others. bSignal
transduction includes growth factors, ligands, receptors, and cytokines.
*
In the data, log2FC of SOX9 at 96h was -0.96.
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Discussion
The present study tested the hypothesis that differentially expressed regulatory genes
during the first 1.5 hours will initiate chondrogenic divergence between interzone and anlagen
cell cultures, and further distinctions will accumulate as time passes in culture, represented
by the activation of different pathways that leads to different ECM profiles. Accepting this
hypothesis, the transcriptomic analyses in the current chapter demonstrated the kinetics of
gene expression changes over 96 hours in the experimental and control cell cultures,
characterized common molecular properties of the two chondrogenic cell lines compared to
the negative control fibroblasts, and identified cell type-specific signatures in interzone and
anlagen cell cultures.

Kinetics of gene expression patterns during 96 hours of in vitro chondrogenesis
TGF-β1 induced chondrogenesis
It should be mentioned that the upstream regulator prediction analysis projected TGFB1,
which encodes the experimental stimulus (TGF-β1), as a common activated upstream
regulator only between the baseline and the first collection point (1.5h) in all three cell types
(Figure 3.5, 3.9, and 3.13). This result confirms that each one responded to the experimental
chondrogenic stimulation induced by the TGF-β1 treatment during the first 1.5 hours. Since
TGF-β1 is auto-regulated and this analysis is based on computational prediction, an important
question arises: would different chondrogenic factors also activate TGF-β1 pathways during in
vitro chondrogenesis? A mechanistic study with other chondrogenic inductive stimuli, such as
IGF1, or blocking TGF-β1 signal is required to answer the question.
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In addition, the hub gene analysis identified LTBP3 as a common hub gene in all three cell
cultures (Figure 3.4, 3.8, and 3.12), and its expression was differentially upregulated at 96h
compared to 12h in each cell type (log2FC=1.13 in interzone cell cultures; log2FC=1.19 in
anlagen cell cultures; log2FC=1.45 in fibroblast cultures; FDR adjusted P-value<0.001). This
gene encodes an ECM component, and one of its important functions is to regulate the activity
of the TGF-β family (Robertson et al., 2015). By binding to TGF-β propeptides, LTBP3 maintains
their latent state, being stored in extracellular space. In the experimental setting, all three cell
cultures were continuously exposed to the TGF-β1 treatment, and thus, the result presenting
LTBP3 as a common hub gene may indicate that TGF-β signaling mediation commonly
occurred in all three cell cultures and was highly correlated to the time course.

Overall expression patterns of differentially expressed genes
All three cell cultures, including the negative control, shared similar expression pattern
changes of their own DEGs responding to the chondrogenic stimulation during the 96-hour
experimental period. Fewer DEGs were detected between 0h and 1.5h (106 – 170 DEGs), and
greater DEGs were detected between 12h and 96h (1,433 – 2,395 DEGs; Table 3.3). In most
cases, except the upregulated DEGs at 96h from 12h in interzone cell and fibroblast cultures,
the numbers of DEGs between two consecutive time points within a cell type kept increasing
throughout the time sequence. This result may imply exponential responses to an upstream
change in the downstream; a transcription factor can regulate expression of multiple genes,
a ligand can interact with different receptors, various signaling cascades can be turned on or
off from the same upstream signal, and all of these processes orchestrate complex gene
expression. Thus, the transcriptomic changes might accumulate over time, being represented
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by the increased numbers of DEGs towards the delayed time points.

It is also interesting to note that most of the DEGs upregulated at the earlier time points
became downregulated at the later time points, and vice versa. Between the baseline and the
first collection point (1.5h), the DEG expression patterns in all cell types were more correlated
with biological replicates than time points (Figure 3.2.a, 3.6.a, and 3.10.a). After 3 hours being
grown in the chondrogenic medium, gene expression profiles were distinctively clustered by
time point. The chondrogenic stimulation gradually shifted the regulation patterns
(upregulated and downregulated) of DEGs to the opposite towards the end of the
experimental period. When comparing the baseline gene expression to that of 96h, a very
clear trend of upregulated genes and downregulated genes switching the patterns was
observed in all three cell cultures.

Overrepresented biological processes in the time course
While the DEG expression pattern changes during the 96-hour in vitro chondrogenesis
were similar among the cell types, overrepresented biological processes in each cell culture
were evaluated to further characterize common and cell type-specific responses to the
chondrogenic stimulation (Table 3.4, 3.5, 3.7, 3.8, 3.10, and 3.11). From the baseline to the
first collection point (1.5h) after inducing chondrogenesis, the upregulated DEG profiles in all
cell types were highly related to transcription regulatory events. Between 1.5h and 3h, skeletal
muscle cell and fat cell differentiation processes were significantly downregulated in all cell
types under the chondrogenic stimulation. Since mesenchymal stem cells derived from
embryonic mesoderm have multipotency to differentiate into myocytes, adipocytes,
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osteocytes, as well as chondrocytes, the downregulation of skeletal muscle cell and fat cell
differentiation processes may confirm that all cell lines were receiving chondrogenic
stimulation, and this stimulation initiated the downregulation of the other cell lineage
differentiation pathways. Towards the last collection point (96h), it is noticeable that biological
processes related to ECM metabolic events and involving ECM genes were overrepresented
in all cell cultures. Altogether, the gene ontology analysis demonstrated the model of
molecular event changes that was derived from Chapter 2 in which altered transcriptional
events would lead to subsequent changes in signaling cascades and eventually in ECM biology.

Chondrogenic characteristics observed in both interzone and analgen cell cultures
Common chondrogenic characteristics of the two skeletal cell lines were evaluated by
analyzing the overlapping DEGs from the comparisons of each chondrogenic cell type to the
negative control at each time point. These common chondrogenic DEGs also include the
candidate molecular switches that were exclusively turned on or off in both chondrogenic cell
lines, but not in the negative control fibroblasts (Table 3.16 and 3.17). Along with the DEGs,
several interesting common hub genes correlated with the time course and projected
upstream regulators are proposed in this section.

Presumptive chondrogenic molecular switches
GSC was exclusively expressed in chondrogenic cell lines but not in fibroblast cultures at
all time points after inducing chondrogenesis (1.5 – 96h). This gene is a marker of mesoderm
during gastrulation (Blum et al., 1992) and mesenchymal cell lineages in fetal limb buds (Gaunt
et al., 1993). A gain-of-function experiment conducted in a chick embryo suggested that GSC
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participated in limb formation and patterning through regulating expression of HOXA and
HOXD clusters (Heanue et al., 1997). In the dataset, HOXD13 expression was also exclusively
observed in the chondrogenic cell cultures by the last time point (96h). This gene is expressed
in distal regions of limb buds and regulates digit patterning (Nelson et al., 1996). The exclusive
expression of GSC and one member of the posterior HOX genes in cluster D might suggest that
the chondrogenic cell cultures retained some regulatory processes observed during the fetal
limb formation.

On the other hand, there were greater numbers of genes that were not expressed in the
chondrogenic cell lines while exclusively expressed in fibroblasts. These genes include several
central and posterior Homeobox transcription factor genes in cluster B (HOXB4, HOXB5,
HOXB8, and HOXB9). In addition, EN1 was recorded as a candidate molecular switch turned
off in the skeletal cell lines at four time points including the baseline (0, 3, and 12h).

Both GSC and EN1 are members of Homeobox transcription factor gene families, acting as
a transcription repressor, and they were expressed in the opposite way between the
chondrogenic cell lines and the negative control. Thus, a gain-of-function or loss-of-function
study might elaborate if these genes are involved in the cellular fate decision whether to
commit chondrogenic differentiation. Also, further research on the regulatory processes of
these two genes and their relationship with other HOX gene families as well as other genes
involved in development might bring important information to understand the regulation of
chondrogenic pathways during the limb development.
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Overrepresented biological processes in chondrogenic cell lines
Gene enrichment analysis identified 128 upregulated and 133 downregulated
overrepresented biological processes in the chondrogenic cell lines based on the negative
control across the entire experimental period (Table 3.14). It is notable that a greater number
of significant biological processes were observed towards the later time points (from 69
processes at 0h to 120 processes at 96h). This result might suggest that under the
chondrogenic inductive stimulation, further differences between the skeletal cell lines and the
non-skeletal fibroblast cultures were developed over time.

Among the biological processes that were upregulated in the chondrogenic cell lines,
three GO terms were repeatedly observed at all collection points (Table 3.18). Noticeably,
several central and posterior Homeobox transcription factor genes in clusters A and D were
consistently upregulated in the chondrogenic cell cultures based on the negative control and
categorized into these three common biological processes identified at all time points. In the
meantime, the commonly downregulated DEGs in the chondrogenic cell cultures showed four
common biological processes that were overrepresented across the whole experimental
period (Table 3.19).

Before inducing chondrogenesis and also at all post-chondrogenic induction time points,
the positive regulation of chondrocyte differentiation process was identified as one of the
overrepresented biological processes from the common upregulated DEG profile in interzone
and analgen cell cultures compared to the negative control. This process includes the SOX
gene family (SOX5, SOX6, and SOX9). SOX6 negatively regulated RUNX2—an osteogenic
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transcription factor—and activated S100A1, which inhibits chondrocyte terminal
differentiation (Saito et al., 2007), and therefore prevented chondrocytes from entering prehypertrophic stages (Smits et al., 2004). At the earlier stages of embryonic development, SOX9
is expressed in mesenchymal cells and a mesenchymal condensation—the cartilaginous tissue
prior to hypertrophic differentiation (Decker et al., 2014). When SOX9 was knocked out, it
resulted in apoptosis (Akiyama et al., 2002) as well as decreased mesenchymal condensation
and chondrocyte formation (Bi et al., 1999). Also, SOX9 is required for SOX5 and SOX6
expression (Akiyama et al., 2002) although SOX5 and SOX6 are not essential for chondrogenic
differentiation unlike SOX9 (Liu and Lefebvre, 2015). Thus, expression profiles of these genes
in the dataset might demonstrate close relationships between SOX genes and chondrocyte
differentiation and also confirm chondrogenic differentiation in interzone and analgen cell
cultures.

Of note, both upregulated and downregulated DEGs in the chondrogenic cell lines resulted
in anterior/posterior pattern specification as an overrepresented biological process. In this
process defined by the upregulated DEG profile, HOX genes in clusters A and D were involved.
On the other hand, the downregulated DEGs in this biological event were HOX genes in
clusters B and C as well as EMX2, a Hox-related gene. It is noteworthy that some central and
posterior HOX genes in cluster B were exclusively turned off in the chondrogenic cell lines
while they were expressed in the negative control (Table 3.17).

Homeobox genes encoding transcription factors are highly conserved between species
and known to regulate embryonic development and morphogenesis. While the HOX families
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are involved in axial skeleton patterning, the posterior HOX paralogs (HOX9-13) are also
involved in the development of appendicular skeleton, the limb skeletal elements (Pineault
and Wellik, 2014). The posterior HOX genes in clusters A and D are expressed in forelimb buds,
and the posterior HOX genes in cluster C are expressed in hindlimb buds along the
proximodistal axis. From the dataset, the central and posterior HOX gene clusters A and D
were upregulated in chondrogenic cell lines while the anterior and central HOX gene clusters
B and C were either switched off or downregulated. The contrasting HOX gene expression
patterns between the chondrogenic cell lines and the negative control may confirm the origin
of the cells. In addition, GSC was turned on in both interzone and analgen cell cultures at all
time points after inducing chondrogenesis, and this gene is involved in limb formation and
patterning through regulating expression of HOX clusters A and D, but GSC did not affect
expression of HOX cluster C (Heanue et al., 1997). Thus, further investigation in regulatory
events involving the HOX gene families might elaborate the current knowledge of
chondrogenic differentiation pathways during limb development.

Common chondrogenic hub genes correlated with the time sequence
The chondrogenic cell lines shared 53 hub genes highly correlated with the time sequence,
and IGF2, SNAI2, and COMP are examples of them (Figures 3.4 and 3.8). IGF1 is a hub gene in
only interzone cell cultures and interacts with another hub genes highly related to IGF2 and
SNAI2 (Figure 3.4). Both IGF isoforms can bind both IGF receptors (IGF1R and IGF2R) and
activate downstream, but the downstream pathways of these receptors have different effects.
IGF1R have been reported to induce hypertrophy in skeletal myocyte (Musarò et al., 1999)
and chondrocyte (Rokutanda et al., 2009, Sun and Beier, 2014). On the other hand, IGF2R lacks
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kinase domains, and thus, it is known to result in no downstream signaling events, only
attenuating the IGF1R pathway by sequestering IGF ligands. However, both IGF receptors were
not differentially expressed in any comparisons from the dataset. Further research on the IGF
ligands and receptors would be beneficial to better understand the roles of the IGF signaling
pathways in chondrogenic differentiation.

Although SNAI2 was a common hub gene highly correlated with the time course in the
chondrogenic cell lines, SNAI1—another Snail transcription factor involved in epithelialmesenchymal transition—was not identified as a hub gene in either of cell cultures. However,
SNAI1 was differentially upregulated at 1.5h compared to the baseline in both interzone and
analgen cell cultures (log2FC=3.27 and 2.77 in interzone and analgen cell cultures, respectively;
FDR adjusted P-value=0.003). SNAI2 and SNAI1 compensate the loss of each other and
regulate chondrogenic differentiation during limb formation (Chen and Gridley, 2013). Also,
TGF-β sustained upregulation of both SNAI2 and SNAI1 in human corneal epithelial cell
cultures (Aomatsu et al., 2011). Therefore, the profiles of Snail transcription factors in the
chondrogenic cell lines may suggest that SNAI1 might be responsible for the initial responses
to the TGF-β1 treatment, and SANI2 expression might interact with other molecular responses
to the chondrogenic stimulation along the experimental period.

COMP, a classic cartilaginous biomarker, was a hub gene in the chondrogenic cell lines, but
not in fibroblast cultures, and the expression levels were increased over time. Also, its
expression was significantly higher in the skeletal cell cultures at all post-chondrogenic
induction time points compared to the negative control (1.5 – 96h; log2FC ranged from 2.00 –
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4.85; FDR adjusted P-value<0.01). Thus, the expression profiles of COMP evaluated in the
study may confirm that interzone and analgen cell cultures indeed underwent chondrogenic
differentiation, accumulating cartilaginous ECM.

Common chondrogenic upstream regulators
While no common chondrogenic upstream regulators were predicted until 3h, inhibition
of MYC, TBX2, NOTCH1, SMAD7 (involved in transcription regulation), CCL2, CCL11, CSF1, TLP7,
and MFSD2A (involved in signaling transduction) was projected in the chondrogenic cell lines
between 3h and 12h. One of the inhibited upstream regulators, SMAD7, represses canonical
TGF-β pathways regulated by Smad2/3 and Smad1/5/8 (Wang et al., 2014). The SMAD2/3
involved pathway induces cartilaginous phenotypes. On the other hand, the SMAD1/5/8
downstream pathway exhibits hypertrophic marker genes, such as COLX and MMP13.

Between the two last collection points (12h and 96h), NKX3-2 activation was predicted in
both chondrogenic cell cultures. This gene was also a hub gene in anlagen cell cultures, but it
was not significantly correlated with the time course in interzone cell cultures. In the literature,
NKX3-2 was not expressed in cells at the surface of developing bones, including cells that
would differentiate into articular chondrocytes; on the other hand, its expression was
detected in proliferative chondrocytes at pre-hypertrophic stages (Church et al., 2005). When
GO enrichment analysis was conducted on the upregulated DEGs in interzone cell cultures at
96h compared to 12h, endochondral ossification and negative regulation of chondrocyte
differentiation were significantly overrepresented (Table 3.4). NKX3-2 was one of the players
in the overrepresented process of “negative regulation of chondrocyte differentiation.”
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However, the expression levels of NKX3-2 were significantly lower in interzone cell cultures
compared to anlagen cell cultures at all collection points (log2FC ranged from |2.12 – 3.62|;
FDR adjusted P-value<0.01). Based on the literature, the findings from the current study may
suggest that interzone cell cultures might obtain pre-hypertrophic characteristics, at least at
a minimal level, towards the last time point while anlagen cell cultures constantly presented
greater hypertrophic characteristics over time.

Differential transcriptomic signatures between interzone and anlagen cells
The transcriptomic signatures in interzone and anlagen cell cultures demonstrated the
chondrogenic divergence directed towards articular and hypertrophic developmental
pathways, respectively. The candidate molecular switches that were identified between these
chondrogenic cell lines may be responsible for the decisions whether to commit one of the
different chondrogenic programs. Furthermore, predicted upstream regulators within a cell
type over the time course or between the cell types at each time point provided further
evidence that interzone and anlagen cells were indeed diverged into their corresponding
developmental pathways.

Exclusively expressed genes in interzone cell cultures
Among four exclusively expressed genes in interzone cell cultures over time,
ENSECAG00000037611 (from 0h – 3h) is a novel gene, and C7H11orf52 (at 12h) encodes an
uncharacterized protein (Table 3.21). The exclusive expression of ENSECAG00000037611 was
continuous during the first 3 hours after inducing chondrogenesis, therefore this gene might
be an interesting gene for a further investigation to define its role in chondrogenic inductive
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mechanisms, especially in the articular chondrogenic pathway.

Expression of LY6G6C was turned on in interzone cell culture at 3h. This gene is a member
of a cluster of leukocyte antigen-6 (LY6) and encodes proteins containing Ly6/uPAR (LU)
domains in integral membrane receptors. The LU domains have various biological functions in
eukaryotes, and one of their important roles is being the extracellular ligand-binding domain
in the TGF-β receptor family, including TGF-βR1, BMPR1A, TGF-βR2, and BMPR2 (Leth et al.,
2019). Not only TGF-β1 was the experimental stimulus, but also is a key upstream regulator
of chondrogenic differentiation pathways. Interacting with different TGF-β receptors, this
cytokine can activate both canonical and non-canonical pathways and regulate both articular
and hypertrophic chondrogenic differentiation (Wang et al., 2014). Therefore, localizing this
specific LU domain encoded by LY6G6C in different TGF-β receptors may better describe its
role in interzone cell-specific chondrogenic pathways.

Exclusively expressed genes in anlagen cell cultures
Members of the anterior HOX gene cluster B were exclusively expressed in anlagen cell
cultures at the baseline (HOXB2) and at delayed time points (HOXB2 and HOXB3 at 12h and
96h; Table 3.21). Another gene exclusively expressed in anlagen cells is PLAC8B, which was
turned on by 96h. In addition to HOXB2 that has been reported to regulate self-renewal
processes (Phinney et al., 2005), PLAC8B is assigned to a GO term of “chromatin binding.” Thus,
the results may suggest that regulating DNA replication and proliferation might be important
processes in anlagen cell cultures under the chondrogenic stimulation.
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Differentially regulated biological processes and gene expression between chondrogenic cell
lines
During the first 3 hours after inducing chondrogenesis, the DEG profiles between the
chondrogenic cell lines represented a higher number of biological processes that were
significantly upregulated in analgen cell cultures (Figure 3.15 and Table 3.24). Similar to what
the exclusive gene expression in analgen cell cultures may suggest, DNA replication was
upregulated in anlagen cell cultures between 0h and 3h compared to interzone cell cultures.
At the baseline, regulation of cell proliferation and positive regulation of epithelial cell
proliferation were overrepresented by the upregulated DEG profile in anlagen cells compared
to interzone cells. Also, chromosome segregation and cell division were upregulated in
anlagen at 3h. Altogether, more proliferative events might occur in anlagen cell cultures at the
earlier stages after inducing in vitro chondrogenesis. The present findings are aligned with the
biology; proliferating anlagen chondrocytes enter the hypertrophic final differentiation in a
developing limb bud.

In contrast, towards the later time points, the DEG profiles between interzone and analgen
cell cultures represented greater biological processes upregulated in interzone cell cultures.
Cell adhesion and collagen fibril organization were upregulated in interzone cell cultures at
12h. Positive regulation of ERK1/2 cascade, embryonic digit morphogenesis, chondrocyte
development, and chondrogenic differentiation processes involved greater DEGs upregulated
in interzone cell cultures at 96h. At the same time, DEGs upregulated in anlagen cells
dominated in a GO term—ossification—at 12h and in endochondral ossification at 96h. The
results may confirm that anlagen cell cultures entered the chondrogenic pathways that would
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lead towards the bone forming processes.

In Chapter 2, FGF1 was upregulated in anlagen cultures from 6 – 48h compared to
interzone cultures. Along with this previous finding, from this RNA-seq dataset, differential
expression of FGF1 between the two chondrogenic cell lines was detected at 12h
(log2FC=|3.43|; FDR adjusted P-value=0.001) and at 96h (log2FC=|1.89|; FDR adjusted Pvalue=0.001), and the gene was upregulated in anlagen cells. When human mesenchyme
stromal cells were co-cultured with chondrocytes from osteoarthritic cartilage, FGF1
expression was increased in mesenchymal cells and promoted proliferation of osteoarthritic
chondrocytes (Wu et al., 2013). When FGF1 activity was inhibited, proliferation of
chondrocytes was also downregulated. In addition, FGF1 expression was detected from the
proliferative and hypertrophic zones of fetal growth plate but not from the resting zone (Krejci
et al., 2007). Thus, based on the previous studies, the present finding may suggest that
anlagen cell cultures might undergo proliferation by 12h after inducing chondrogenesis and
might become further hypertrophic over time.

Several HOX genes in clusters B and C were either exclusively expressed (HOXB2 and
HOXB3; Table 3.21) or significantly upregulated (HOXC4, HOXC6, HOXC8, and HOXC9; Table
3.23) in anlagen cell cultures compared to interzone cell cultures. On the other hand, some
posterior HOX genes in clusters A and D (HOXA11, HOXA13, HOXD11, and HOXD13) were
upregulated in interzone cell cultures. It is worth mentioning that other HOX genes in cluster
B around the central position were not expressed at all in both chondrogenic cell lines (HOXB4,
HOXB5, HOXB8, and HOXB9; Table 3.17) while some anterior HOX genes (HOXB2 and HOX3)
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were only expressed in anlagen cell cultures but not in interzone cells. In addition, differential
expression of HOX genes in cluster C around the central region (HOXC4, HOXC6, HOXC8, and
HOXC9) were differentially upregulated in anlagen cultures compared to interzone cell
cultures. It is known that the HOX genes’ function is more similar to that of their paralogs in
different chromosomes relative to that of other HOX genes that are closely located in the
same chromosome. Therefore, the roles of HOXC4-9 in anlagen cell cultures might be related
to non-chondrogenic pathways. Further research is required to better describe the
mechanisms of HOX genes regulating limb development.

Also, one example of an interesting DEG between the two fetal skeletal cell cultures is
TGFGR3. While multiple TGF-β ligands can interact with multiple TGF-β receptors, the
downstream events of TGF-β are mediated by different combinations of receptors, resulting
in different chondrogenic outcomes. Among different TGF- receptor genes, TGFBR3 was
differentially upregulated in interzone cell cultures at 12h (log2FC=1.01; FDR adjusted Pvalue=0.001). TGFBR3 interacts with ALK5 and transduces the noncanonical SMADindependent pathway (Iwata et al., 2012), and this receptor provides stable ligands to the
receptor combination of TGFBR2 and ALK5, which facilitates the SMAD2/3 mediated canonical
TGF-β pathway (Shi and Massagué, 2003). SMAD2/3 are phosphorylated in this signaling
cascade and become active transcription regulators, upregulating COL2A1 and ACAN
expression. In addition, phosphorylated SAMD3 inhibits SMAD1/5/8, which induces
hypertrophic differentiation, resulting in articular cartilage phenotypes (Chen et al., 2012,
Wang et al., 2014). Thus, upregulation of TGFBR3 in interzone cell cultures may indicate that
interzone cells at 12h might be directed to articular chondrogenic pathways. However, SMAD3
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expression was differentially downregulated in interzone cell cultures at 12h (log2FC= |1.07|;
FDR adjusted P-value=0.005), and the other TGF-β receptor genes or SMAD genes were not
differentially expressed between the two chondrogenic cell cultures at any collection time
points. To better understand TGF-β signaling pathways involved in chondrogenesis may
require further research on phosphorylation and protein level evaluation.

Upstream regulator prediction
<Upstream regulators in interzone cell cultures between time points>
Between the baseline and 1.5h, NOTCH1 and GATA1 involved pathways were predicted to
be activated upstream of interzone cell cultures (Figure 3.5). Both NOTCH1 and GATA1
downregulate chondrogenesis. When NOTCH signaling was constitutively activated,
formation of chondrogenic nodules was significantly reduced in mice fetal limb bud
mesenchymal cells (Tian et al., 2015). GATA1 was reported to be induced by BMPs and
correlated with BMPs’ anti-chondrogenic activity, reducing expression of collagen type 2
(Karamboulas et al., 2010). Predicted activation of NOTCH1 and GATA1 regulatory pathways
in interzone cell cultures during the first 1.5 hours might represent temporarily paused
chondrogenesis in interzone tissue during earlier stages of limb development.

The activation of MEOX2 was projected as an upstream event in interzone cell cultures
between 3h and 12h. Also, this gene was evaluated as a hub gene correlated with the time
course in interzone cell cultures. Its expression levels were significantly increased between 3h
and 12h (log2FC=3.73; FDR adjusted P-value=0.015) and between 12h and 96h (log2FC=2.40;
FDR adjusted P-value<0.001) in interzone cell cultures. MEOX2 regulates chondrogenesis in
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fetal axial skeleton as an upstream of PAX genes (Mankoo et al., 2003). Therefore, the results
may suggest that chondrogenesis might resume in interzone cell cultures, 3 hours after
introducing the TGF-1 stimulation, and MEOX2 might be an interesting gene for further
investigation to better understand the articular chondrogenic differentiation pathway.

During the last time sequence (12h to 96h), COL9A1 was predicted as an activated
upstream in interzone cell cultures. This gene encodes an ECM component of hyaline cartilage.
Also, the null mutation of this gene resulted in increased ossification in mice femoral heads
and also enhanced invasion of vessels (Heilig et al., 2018). Therefore, this predicted upstream
between the two last time points in interzone cell cultures, treated with TGF-1, may indicate
that the cells might be towards the articular chondrogenic pathway in this experimental
setting.

<Upstream regulators in anlagen cell cultures between time points>
In analgen cell cultures, SOX10 activation was projected as an upstream event from 1.5h
to 3h (Figure 3.9). SOX10 was expressed in hypertrophic cutaneous scars (Febres-Aldana and
Alexis, 2020) and in hypertrophic nerve trunks (Sham et al., 2001). Also, some genes involved
in hypertrophic differentiation during endochondral ossification—DLX5 and DLX6—were
predicted as upstream regulators between 3h and 12h in anlagen cell cultures. Both DLX5 and
DLX6 were involved in hypertrophic differentiation, and DLX5 was able to compensate the
absence of DLX6 expression (Zhu and Bendall, 2009). Between the two last time points (12h
and 96h), SP7, a classic marker of bone, was an activated upstream regulator. By cooperating
with RUNX2, this gene upregulated MMP13 expression and cartilage mineralization
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(Nishimura et al., 2012). Thus, the results altogether may indicate that analgen cell cultures
might enter pathways towards hypertrophic differentiation at a relatively earlier time point
(between 1.5h and 3h) and remain in the pathways leading to bone formation throughout the
experimental period.

<Upstream regulators between interzone and anlagen cell cultures at each time point>
Including the baseline, NUPR1 was predicted to be an active regulator in interzone cell
cultures compared to anlagen cell cultures during the first 3 hours (Figure 3.16). In the
literature, it downregulated cell survival pathways, inducing chondrocyte apoptosis (Tan and
Yammani, 2019). The present result agreed with a previous RNA-seq study conducted with
murine tissues from mandibular condyle articular and mature zones (Zhou et al., 2018). The
authors also analyzed the data using IPA, and NUPR1 was predicted as an upstream regulator
distinguishing articular cartilage and the mature zone, which is located between articular
cartilage and hypertrophic cartilage.

E2F1 was predicted as an active upstream regulator in anlagen cell cultures during the
earlier time points (from the baseline until 3h). In a previous study, its overexpression
prevented chondrocytes from hypertrophic differentiation and interrupted endochondral
ossification (Scheijen et al., 2003). On the other hand, one of the activated upstream
regulators in anlagen cell cultures at the baseline and 1.5h was SPP1. This gene encoding
osteogenic glycoprotein attaches osteoclasts to bone matrix and is required for
biomineralization (Peacock et al., 2011). While SOX9 binds to SPP1 and inhibits transactivation,
at 96h, SOX9 was predicted to be an upstream gene, and at the same time, SPP1 was not
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predicted to be an upstream regulator in analgen cell cultures. RUNX2 (at 0h, 1.5h, and 96h)
and RUNX3 (at 12h), well-established bone biomarkers, were two of the predicted active
upstream regulators in anlagen cell cultures treated with the TGF-β1 treatment. Thus, the
results may verify that anlagen cell cultures in the experimental setting might be heading
towards the bone forming-hypertrophic chondrogenic pathway.

Future direction
This RNA-seq study identified several important DEGs, candidate molecular switches, and
upstream regulators that were either common in the chondrogenic cell lines or specific to
different chondrogenic pathways. Since the current data were generated by measuring mRNA
levels, a new question arises: if the transcripts were translated to proteins. To be functional in
biological processes, transcripts need to be translated, and the resulting proteins need to be
in an active form. Therefore, a cross-validation at a protein level would further confirm the
biological relevance of the new information obtained from the present study. Also, the
functional annotations and regulatory mechanisms of transcriptomic signatures that were
proposed in this chapter could be elucidated by mechanistic studies. In addition, with the
emergent high-throughput sequencing technologies that have enabled evaluation of gene
expression at a single cell level, profiling characteristics of subpopulations of each cell
preparation would add beneficial information to better understand the biology behind these
chondrogenic pathways.
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Conclusion
In summary, the transcriptomic data generated from equine fetal interzone and analgen
cell pellet cultures during the 96-hour of in vitro chondrogenesis characterized kinetics of gene
expression of each cell type. In agreement with the study conducted in Chapter 2,
transcription regulatory responses were initiated by 1.5h after inducing chondrogenesis,
alterations in signaling transduction were observed throughout the experimental period, and
ECM-related signatures became more evident towards the latest time point (96h). The study
provided evidence that the transcriptomic profile of interzone cell cultures might be directed
to articular chondrogenic pathways, and that of analgen cell cultures might be towards
hypertrophic pathways, leading to bone formation, while both cell cultures shared some
common chondrogenic characteristics. Furthermore, this study proposed candidate
molecular switches, important DEGs, and predicted upstream regulators between interzone
and anlagen cell cultures, and various Homeobox transcription factor genes are some of the
examples. The transcriptomic signatures of interzone and analgen cell cultures defined by the
current study further described the chondrogenic divergence of these two cell lines.
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Chapter 4. A pilot single cell RNA-seq study: Evaluation of chondrogenic divergence between
equine fetal interzone and analgen cell cultures at the single cell level

Introduction
Experimental in vitro chondrogenic differentiation models frequently utilize TGF-β
containing induction media and measure classic cartilaginous biomarkers, such as cartilagespecific ECM genes or proteins after 14-21 days (McCarthy et al., 2012, Rakic et al., 2018,
Adam et al., 2019). One such study from our laboratory compared equine fetal interzone and
analgen cell pellets and demonstrated a clear distinction of histological characteristics (Adam
et al., 2019). While anlagen cell pellets showed relatively homogenous histology in sagittal
sections, interzone cell pellets usually exhibited a heterogenous zonal structure.

To investigate these differences further, a preliminary histology analysis was conducted
on equine interzone and anlagen cell pellets (500,000 cells/pellet) that were grown in the
TGF-β1 chondrogenic induction medium and collected at three different time points, 1d (24h),
2d (48h), and 21d (Figure 4.1). In agreement with the previous study (Adam et al., 2019), day21 anlagen cell pellets displayed homogenous proteoglycan staining across the entire section
as well as relatively stable cellular morphology and arrangement. In contrast, and also
consistent with the previous findings, interzone cell pellets after 21 days presented the
distinctive zonal configuration. In the periphery region, ECM was rich in proteoglycan, and
cells were densely arranged parallel to the surface. Across the intermediate zone,
proteoglycan staining and cell density became decreased towards the core. The histology in
the core region was relatively variable among technical replicates; some exhibited lower cell
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density and latticed ECM while others showed evidence of cellular necrosis. The cellular
morphology, orientation, and ECM proteoglycan staining observed in day-21 interzone cell
pellets have some resemblance to the architecture of articular cartilage—almost suggesting
an organoid structure.

In contrast to the 21d time point, anlagen pellets at 1d (24h) and 2d (48h) had significantly
less proteoglycan staining (Figure 4.1). Differences between interzone and analgen cell pellets
were minimal in terms of cell size and histology at days 1 and 2.
500 µm

Time point

1d (24h)

Cell type

2d (48h)

21d

a)

b)

c)

d)

e)

f)

Interzone cell pellets
(500,000 cells/pellet)

Anlagen cell pellets
(500,000 cells/pellet)

Figure 4.1 Cell pellet proteoglycan staining. Passage 5 equine fetal interzone and analgen cell
pellets were collected after 1, 2, and 21d of culture in chondrogenic induction medium and
stained with Safranin-O and Fast Green. Proteoglycan in the extracellular matrix stains red,
while regions devoid of proteoglycan stains blue-green.

The different levels of variation and intensity of proteoglycan staining between 21d
interzone and anlagen cell pellets may indicate different cell subpopulations and cellular
heterogeneity. With the complexity of gene expression profiles in kinetic data reported in the
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previous chapters, in which changes induced by TGF-β1 were demonstrated as early as 1.5
hours after the initiation of in vitro chondrogenic induction, different cell subpopulations
might be present by the 1d or 2d time points. Since differential expression of ECM effector
genes was delayed, cell subtype differences may well be present even though histological
staining characteristics are still similar.

In this pilot study, single cell RNA-seq analysis was conducted to further describe the
differential chondrogenic pathways between interzone and anlagen cell cultures by profiling
their cell subpopulations. The hypotheses tested in the study were that 1) interzone cell
cultures will develop relatively heterogenous cell subpopulations while anlagen cell cultures
will display less heterogenous subpopulations, and 2) these fetal skeletal cell lines will not
only share common chondrogenic cell subpopulations but also show unique cell
subpopulations that distinguish the two cell types.

Materials and Methods
Cell culture
Primary interzone and analgen cells collected from a single 45-day equine fetus (Adam et
al., 2019) were used for the present study. Passage 5 cell pellets were established following
the protocol described in Chapter 2 and cultured in the TGF-1 chondrogenic induction
medium. Samples were collected at two time points, 24 and 48 hours. These two time points
were selected with consideration of gene expression profiles and for logistical considerations
related to the technical ability to reestablish single cell suspensions from chondrogenic cell
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pellet cultures. Regenerating cell suspensions was feasible until 48h without substantially
compromising the cell number recovery rate or cell viability.

Single cell suspension preparation
The preparation of cell suspensions for the single cell cDNA library construction followed
protocols recommended by the manufacturer (10X Genomics, Pleasanton, CA). Briefly, cell
pellets, five per cell-type and time point, were washed with PBS to remove the chondrogenic
medium. The five replicates were then transferred as a group into a cell strainer with a luerlock flow controller (pluriStrainer® 5 µm; catalog No. 43-50005-13; pluriSelect Life Science,
Germany) connected to a 50 ml conical tube. The pellets were incubated for 2.5 hours at 37°C
in 1.5 ml of a collagenase cocktail, DMEM containing 20% (v/v) FBS, 0.2% (w/v) collagenase II
(catalog No. LS004177; Worthington Biochem), 0.1% (w/v) collagenase type 4 (catalog No.
LS004186; Worthington Biochem), and 2mM CaCl2 (catalog No. 10043-52-4; Fisher Scientific).
The collagenase medium was then drained through the filter by opening the luer-lock.
Retained cells were washed twice with PBS, retrieved into a fresh 50 ml conical tube, and
resuspended in DMEM.

The cell counting was conducted by both an automated cell counter (EVE™ Automated
Cell Counter; catalog No. EVE-MC; NanoEnTek) and a manual hemocytometer with trypan
blue staining. Cell viability was >95% and the concentration of cells in DMEM adjusted to 1,000
cells/µl, within the range recommended by 10X Genomics. The targeted number of cells for
barcoded library construction was 5,000 cells for each sample. Per manufacturer
recommendations, the starting cell number was set to 1.7 times greater per sample.
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Single cell cDNA library construction
Barcoded gel beads are the key feature in 10X Genomics’ single cell gene expression
system. These beads comprised 1) an Illumina Read 1 primer site, 2) a 16 bp 10X barcode
(specific to each cell), 3) a 10 bp unique molecular identifier (UMI; specific to each transcript),
and 4) an oligo-dT sequence. To construct single cell cDNA libraries using a Chromium Single
Cell 3’ Library & Gel Bead v2 Kit (cat No. 120267; 10X Genomics) and following the company’s
protocols, the cell suspensions, barcoded gel beads, partitioning oil, and reverse-transcription
reagents were channeled through a microfluidic chip using a Chromium controller (cat No.
110203; 10X Genomics). In this process, individual cells were captured with one barcoded gel
bead and the RT reagents in the partitioning oil, forming a Gel bead-in-EMulsion (GEM).
Within each GEM, RNA transcripts were released by cell lysis and then captured by oligo-dT
sequences on the barcoded bead. A reverse transcription reaction was then conducted using
a Veriti® 96-Well Thermal Cycler (cat No. 4375786; Thermo Fisher) for 45 min at 53°C and for
another 5 min at 85°C. Finally, all of the GEM droplets were broken open to generate a pool
of cell-specific barcoded cDNAs for each experimental group—interzone or anlagen cell type
and either the 24h or 48h time point. The cDNAs in each sample were then amplified for 12
cycles in the Veriti® 96-Well Thermal Cycler, followed by an assessment of cDNA quality and
quantity using the Agilent High Sensitivity DNA Kit (catalog No. 5067-4626; Agilent
Technologies) reagents and a Bioanalyzer 2100 (Agilent Technologies) instrument.

After the amplification step, cDNA molecules were randomly fragmented. For fragments
that contained the Read 1 primer sequence, Illumina P5 flow cell binding sequences, Illumina
Read 2 primer sites, sample indexes, and Illumina P7 sequences were added using a Chromium
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i7 Multiplex Kit (cat No. 120262; Table 4.1). Indexing PCR was conducted for 13 cycles in the
Veriti® 96-Well Thermal Cycler. Final library concentration and quality were evaluated by a
Qubit® 3.0 Fluorometer (cat No. Q33216; Life Technologies) with a Qubit® dsDNA HS Assay Kit
(catalog No. Q32854; Life Technologies) and by a Bioanalyzer 2100, respectively (Table 4.2 and
Figure 4.2).
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Table 4.1. 10X Genomics’ sample indexes
Index
Sample ID
Index sequences (four oligonucleotides/sample)
location
Interzone cells, 24h
SI-GA-A1
GGTTTACT CTAAACGG TCGGCGTC AACCGTAA
Interzone cells, 48h
SI-GA-A2
TTTCATGA ACGTCCCT CGCATGTG GAAGGAAC
Anlagen cells, 24h
SI-GA-A3
CAGTACTG AGTAGTCT GCAGTAGA TTCCCGAC
Anlagen cells, 48h
SI-GA-A4
TATGATTC CCCACAGT ATGCTGAA GGATGCCG
Chromium i7 Multiplex kit (cat No. 120262)

Table 4.2. cDNA library concentration and average size of fragments
Sample ID
Concentrationa, ng/µl
Average fragment sizeb, bp
Interzone cells, 24h
47.6
498
Interzone cells, 48h
31.2
505
Anlagen cells, 24h
37.0
515
Anlagen cells, 48h
41.6
538
a
Library concentration was measured by a Qubit® 3.0 Fluorometer (cat No. Q33216; Life
Technologies) with a Qubit® dsDNA HS Assay Kit (catalog No. Q32854; Life Technologies).
b
Average fragment size was evaluated by a Bioanalyzer 2100 (Agilent Technologies) using
an Agilent High Sensitivity DNA Kit (catalog No. 5067-4626; Agilent Technologies).

a)

b)

Figure 4.2. Automated electrophoresis analyses conducted for
amplified library quality assessment using a Bioanalyzer 2100
(Agilent Technologies). IZ = interzone cells; ANL = anlagen cells.
a) Gel like image; b) Electropherogram
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RNA-sequencing
Aliquots of the four cDNA libraries (100 ng each) were pooled into a single tube totaling
400 ng in 20 µl (20 ng/µl) and sent to the Roy J. Carver Biotechnology Center (University of
Illinois at Urbana-Champaign, Urbana, IL, USA). The cDNA libraries were then sequenced
(NovaSeq 6000, Illumina) on an S4 lane generating paired end reads, 2×150 nucleotides in
length. Three read files were generated per sample: Read1 (reads for barcodes and UMIs),
Read2 (reads for the transcripts), and Index1 (sequences of indexes) files. This is why the
libraries in this system have to be sequenced in paired end reads. Also, the workflow does not
include a fragmentation step for transcripts before being assigned to the UMIs; rather, poly-A
tails of transcripts are captured by a gel bead in their full length. Therefore, levels of gene
expression are expressed in UMI counts, and no further normalization for gene length is
required.

Data analysis pipeline
Raw reads data were processed using the Cell Ranger software (v 3.0.2; 10X Genomics).
In the layout for this software, STAR (v2.7) was used for aligning reads onto the latest horse
reference genome (EquCab 3.0, GCA_002863925.1; Kalbfleisch et al., 2018), and an ENSEMBL
equine gene annotation file (v97) was used for expression quantification. Gene expression
levels were expressed in UMI counts. Fold-change was calculated based on the ratio of the
normalized mean UMI counts of a gene in each cell cluster relative to all of the other clusters.
The thresholds defining DEGs were FDR adjusted P-value<0.05 and log2FC>|1|.
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For non-linear dimensionality reduction analysis, uniform manifold approximation and
projection (UMAP) was conducted using an R package, Seurat v 3.0 (Stuart et al., 2019). Then,
the results were visualized by the Loupe Cell Browser (v 3.1.1; 10X Genomics). Expression of
selected chondrocyte biomarkers (COL2A1, COMP, and ACAN), interzone cell biomarkers
(GDF5, WNT9A, and ENPP2), and biomarkers of chondrocyte hypertrophic differentiation
(COL10A1, MMP13, and DLX5) were visualized in UMAP graphs to evaluate subpopulations of
cells with those characteristics. Gene ontology enrichment analysis was conducted by the
Functional

Annotation

Tool

from

DAVID

Bioinformatics

Resources

(v6.8;

https://david.ncifcrf.gov; Huang et al., 2009) to describe cell clusters with a focus on biological
processes.
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Results
While the targeted number of cells/sample was 5,000 cells, the recovered cell numbers
ranged from 2,032 – 2,845 cells (Table 4.3). Although the cell number recovery rates were low
(47 – 54%), other parameters indicated the abundance and high quality of the sequencing
dataset. Ratios of GEMs containing 100% cell-associated UMIs based on the total cell number
were greater than 72.5% in all samples, suggesting that most cells formed proper GEMs with
100% cell-originated UMIs. The percentages of fraction reads in cells, which indicates how
many of the reads were integrated with barcodes that were associated with cells, ranged from
91.4 – 93.0%. This result confirmed that the vast majority of reads were associated with cells.
Also, the mean reads/cell numbers that ranged from 219,117 – 332,136 were more than
sufficient for a gene expression profiling study, suggested in the manufacturer’s user guide,
where the recommended minimum mean reads/cell number was 50,000. The average
mapping efficiency from the four samples was 90.1%, and only reads that were mapped
confidently to the genome (84.6 – 88.2% of the total reads) were processed through the
downstream analyses.
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Table 4.3. Sequencing results
Cell type
Time point
Total cell number
Number of GEMs containing 100%
cell-associated UMIsb
Ratio of GEMs with 100% cellassociated UMIs based on total
cell number, %
Mean reads/cell
Fraction reads in cells, %
Mapping efficiency, %
Reads mapped confidently to
genome, %
a
GEM, Gel bead-In Emulsion
b
UMIs, Unique molecular identifiers

Interzone cell cultures
24h
48h
2,750
2,633

Anlagen cell cultures
24h
48h
2,032
2,845

2,255

2,107

1,474

2,094

82.0

80.0

72.5

73.6

273,499
92.7
91.8

227,277
93.0
90.5

332,136
91.4
88.3

219,117
92.3
89.9

88.2

86.7

84.6

86.0

Cell subpopulations within a sample
The analysis of each sample yielded 7-8 cell clusters (Table 4.4). Differentially expressed
genes (DEGs) were identified in each cluster compared to the other clusters within a sample
(Table 4.5), and the top five DEGs with the greatest fold change in each sample are listed in
Table 4.6 – 4.9. Although the profiles of each cluster were different, subpopulation diversity
or homogeneity was not remarkably different between interzone and anlagen samples in
terms of the number of identified cell clusters and the distribution of cell numbers across the
clusters.
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Table 4.4. Number of cells in each cluster within sample
Interzone cell cultures
Anlagen cell cultures
24h
48h
24h
48h
Total
2,750
Total
2,633
Total
2,032
Total
Cluster 1
581
Cluster 1
477
Cluster 1
447
Cluster 1
Cluster 2
467
Cluster 2
433
Cluster 2
414
Cluster 2
Cluster 3
378
Cluster 3
412
Cluster 3
332
Cluster 3
Cluster 4
352
Cluster 4
385
Cluster 4
266
Cluster 4
Cluster 5
295
Cluster 5
385
Cluster 5
255
Cluster 5
Cluster 6
278
Cluster 6
372
Cluster 6
166
Cluster 6
Cluster 7
247
Cluster 7
169
Cluster 7
152
Cluster 7
Cluster 8
152

2,845
543
478
431
399
397
357
240

Table 4.5. Number of differentially expressed genes in each cluster within sample
Interzone cells, 24h
Interzone cells, 48h
Cluster #
Upregulation Downregulation Cluster #
Upregulation Downregulation
Cluster 1
20
49
Cluster 1
32
70
Cluster 2
2
89
Cluster 2
74
44
Cluster 3
1
59
Cluster 3
1
38
Cluster 4
25
0
Cluster 4
53
0
Cluster 5
85
8
Cluster 5
4
132
Cluster 6
16
43
Cluster 6
149
48
Cluster 7
74
22
Cluster 7
0
0
Cluster 8
0
0
Anlagen cells, 24h
Anlagen cells, 48h
Cluster #
Upregulation Downregulation Cluster #
Upregulation Downregulation
Cluster 1
20
162
Cluster 1
67
27
Cluster 2
0
95
Cluster 2
57
64
Cluster 3
33
45
Cluster 3
509
0
Cluster 4
97
34
Cluster 4
13
36
Cluster 5
458
0
Cluster 5
1
34
Cluster 6
0
0
Cluster 6
0
27
Cluster 7
0
0
Cluster 7
0
0
Differential expression was determined at thresholds where statistical significance and fold
change (FC) are P-value<0.05 and log2FC>|1| (>1, upregulation; <-1, downregulation),
respectively.
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Table 4.6. Top five upregulated and downregulated differentially expressed genes in each cluster of interzone cell pellet sample at 24h

log2FC = log2(flod change)
***, P<0.0001; **,P<0.01; *, P<0.05; P-values are adjusted for false discovery rate.
Five genes with the greatest fold change were listed. Positive log2FC values represent upregulation, and negative log2FC values represent
downregulation.
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Table 4.7. Top five upregulated and downregulated differentially expressed genes in each cluster of interzone cell pellet sample at 48h

log2FC = log2(flod change)
***, P<0.0001; **,P<0.01; *, P<0.05; P-values are adjusted for false discovery rate.
Five genes with the greatest fold change were listed. Positive log2FC values represent upregulation, and negative log2FC values represent
downregulation.
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Table 4.8. Top five upregulated and downregulated differentially expressed genes in each cluster of anlagen cell pellet sample at 24h

log2FC = log2(flod change)
***, P<0.0001; **,P<0.01; *, P<0.05; P-values are adjusted for false discovery rate.
Five genes with the greatest fold change were listed. Positive log2FC values represent upregulation, and negative log2FC values represent
downregulation.
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Table 4.9. Top five upregulated and downregulated differentially expressed genes in each cluster of anlagen cell pellet sample at 48h

log2FC = log2(flod change)
***, P<0.0001; **,P<0.01; *, P<0.05; P-values are adjusted for false discovery rate.
Five genes with the greatest fold change were listed. Positive log2FC values represent upregulation, and negative log2FC values represent
downregulation.
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Biomarker expression
Steady state mRNA levels of established gene biomarkers in three different categories
(chondrocyte, interzone, and hypertrophic chondrocyte) was visualized in UMAP graphs
plotted for each sample (Figure 4.3, 4.4, and 4.5, respectively). Each dot in the graphs
represents each cell and is colored by the maximum expression level (Log2 max feature UMI
count) of the three biomarker genes in each category.

<Chondrocyte biomarkers>
In all samples, chondrocyte biomarker genes (COL2A1, COMP, and ACAN) were highly
expressed in most of the cell subpopulations, although a couple of cell clusters had fewer cells
expressing these transcripts (Figure 4.3). Expression of these ECM genes were higher at 48h
compared to 24h in both cell types, interzone and analgen.

<Interzone biomarkers>
Steady state levels of transcripts from interzone biomarker gene loci (GDF5, WNT9A, and
ENPP2) were higher in the interzone cell cultures compared to anlagen samples (Figure 4.4).
The expression of WNT9A was minimally detected in four clusters within the interzone cell
samples at 24h and 48h (individual data not shown), while no cells from anlagen cell cultures
at either time point expressed WNT9A. The clusters of cells that expressed greater
chondrocyte biomarkers also showed greater expression of interzone marker genes.

146

<Chondrocyte hypertrophy biomarkers>
While COL10A1 was not expressed in any sample, the two other chondrocyte hypertrophy
biomarker genes (MMP13 and DLX5) were expressed at higher levels in anlagen cell cultures
compared to interzone cell cultures over the experimental period (Figure 4.5). MMP13
expression in interzone cell cultures was not detected at 24h and minimal at 48h. In analgen
cell cultures, expression of MMP13 at both time points were modest compared to expression
of DLX5 (individual data not shown).

147

4.3.a) Chondrocyte biomarker gene expression in interzone cell cultures at 24h

4.3.b) Chondrocyte biomarker gene expression in interzone cell cultures at 48h

log2 Max Feature UMI counts
0
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4.3.c) Chondrocyte biomarker gene expression in anlagen cell cultures at 24h

4.3.d) Chondrocyte biomarker gene expression in anlagen cell cultures at 48h

Figure 4.3. Chondrocyte biomarker gene (COL2A1, COMP, and ACAN) expression in each
sample, plotted by uniform manifold approximation and projection (UMAP) analysis. a)
Interzone cells at 24h; b) Interzone cells at 48h; c) Anlagen cells at 24h; d) Analgen cells at 48h
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4.4.a) Interzone biomarker gene expression in interzone cell cultures at 24h

4.4.b) Interzone biomarker gene expression in interzone cell cultures at 48h

log2 Max Feature UMI counts
0
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4.4.c) Interzone biomarker gene expression in anlagen cell cultures at 24h

4.4.d) Interzone biomarker gene expression in analgen cell cultures at 48h

Figure 4.4. Interzone biomarker gene (GDF5, WNT9A, and ENPP2) expression in each sample,
plotted by uniform manifold approximation and projection (UMAP) analysis. a) Interzone cells
at 24h; b) Interzone cells at 48h; c) Anlagen cells at 24h; d) Analgen cells at 48h
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4.5.a) Chondrocyte hypertrophy biomarker gene expression in interzone cell cultures at 24h

4.5.b) Chondrocyte hypertrophy biomarker gene expression in interzone cell cultures at 48h

log2 Max Feature UMI counts
0
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4.5.c) Hypertrophy marker gene expression in anlagen cell cultures at 24h

4.5.d) Chondrocyte hypertrophy biomarker gene expression in anlagen cell cultures at 48h

Figure 4.5. Chondrocyte hypertrophy biomarker gene (MMP13 and DLX5) expression in each
sample, plotted by uniform manifold approximation and projection (UMAP) analysis. a)
Interzone cells at 24h; b) Interzone cells at 48h; c) Anlagen cells at 24h; d) Analgen cells at 48h
153

Aggregation of the entire sample set
To evaluate both common traits and differential signatures across the sample set, the
single cell RNA-seq data from all samples were aggregated for the differential gene expression
analysis and the dimensionality reduction analysis. By pooling the data from the four samples,
the transcriptomic profiles of the entire sample set resulted in 13 cell clusters with
measurements of 0 – 393 DEGs relative to the other clusters’ gene expression profiles (Table
4.10). The five most differentially upregulated and downregulated genes in each cluster were
tabulated (Table 4.11).

The gene expression patterns were visualized into UMAP graphs. Each dot in the graphs,
representing each cell, is colored by cluster (Figure 4.6.a) or by sample (Figure 4.6.b). The
UMAP analysis indicated that Cluster 8, 9, and 13 are characterized by commonly regulated
genes among the samples (Figure 4.6.c and d). On the other hand, Cluster 6 and 12 were
highly represented by interzone cells, while Cluster 2 and 4 were dominantly occupied by
anlagen cells.
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Table 4.10. Number of differentially expressed genes in each cluster of the aggregate of all
four samples
Upregulation
Downregulation
Cluster 1
5
137
Cluster 2
28
135
Cluster 3
28
32
Cluster 4
37
147
Cluster 5
18
41
Cluster 6
15
86
Cluster 7
121
18
Cluster 8
0
0
Cluster 9
311
0
Cluster 10
0
0
Cluster 11
60
4
Cluster 12
1
3
Cluster 13
393
0
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Table 4.11. Five most upregulated and downregulated differentially expressed genes in each cluster of the aggregate of all four samples

log2FC = log2(flod change); P-values are adjusted for false discovery rate; ***, P<0.0001; **,P<0.01; *, P<0.05
The five most upregulated DEGs and the five most downreuglated DEGs in each cluster are listed. Positive log2FC values represent
upregulation, and negative log2FC values represent downregulation.
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4.6.a) Colored by cluster

4.6.b) Colored by sample
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4.6.c) Separated view by sample, colored by cluster

4.6.d) Separated view by cluster, colored by sample

Figure 4.6. Non-linear dimensionality reduction analysis (uniform manifold approximation and
projection; UMAP) conducted on the aggregate of all four samples. IZ = interzone cell cultures;
ANL = anlagen cell cultures; a) Colored by cluster; b) Colored by sample; c) Separated view by
sample, colored by cluster; d) Separated view by cluster, colored by sample
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Common gene expression patterns among the interzone and anagen samples
Among the DEGs from the cell clusters, in which all four samples overlapped, a gene
ontology (GO) enrichment analysis was conducted on only upregulated DEGs in Cluster 9 and
13 (Table 4.10). The ten most overrepresented biological processes of Cluster 9 and 13 are
listed in Table 4.12 and Table 4.13, respectively. In both clusters, cell migration was one of the
most significant biological processes. The upregulated DEG profile in Cluster 9 showed positive
regulation of chondrocyte differentiation as an overrepresented biological process, and the
upregulated DEG profile in Cluster 13 showed positive regulation of epithelial to mesenchymal
transition, by which mesenchymal progenitor cells for skeletal elements arise within the
presumptive sites of limbs, as an overrepresented biological process.

In these three cell clusters—Cluster 8, 9, and 13, the relative expression levels of
chondrocyte biomarkers were lower compared to the other clusters, including the cell typespecific subpopulations (Figure 4.7.a). Simultaneously, the expression of either interzone
markers (Figure 4.7.b) or hypertrophic markers (Figure 4.7.c) was also relatively lower in these
cell subpopulations.
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Table 4.12. Overrepresented biological processed from upregulated differentially expressed
gene profile in Cluster 9 of the aggregate of all four samples
GOa ID
Term
Genes
P-Valueb
ARC, PLCG1, PTK7, CDC42BPA,
GO:0016477 Cell migration
TNK2, LAMC1, EPHB3, NFATC2,
1.55E-05
MMP14, USP24
Substrate adhesionMICALL2, LAMC1, LAMB1,
GO:0034446
8.64E-05
dependent cell spreading
EPHB3, MERTK, FN1
CCNE2, TARDBP, JUND, TSC2,
GO:0051726 Regulation of cell cycle
0.002
PUM1, GADD45B
GO:0030217 T cell differentiation
EGR1, DLL4, SOX4, RUNX2
0.002
Endodermal cell
GO:0035987
COL6A1, LAMB1, MMP14, FN1
0.004
differentiation
Positive regulation of DNA
damage response, signal
GO:0043517
SPRED2, ANKRD1, ATR
0.004
transduction by p53 class
mediator
SRSF2, PRPF4B, TARDBP, PTBP1,
GO:0008380 RNA splicing
0.009
MBNL1
Positive regulation of
GO:0032332 chondrocyte
SOX5, LOXL2, RUNX2
0.009
differentiation
Neuron projection
MICALL2, APP, BTG2, CAMSAP2,
GO:0031175
0.012
development
LAMB1
Positive regulation of fat
GO:0045600
ZFP36, SH3PXD2B, CEBPB, ID2
0.012
cell differentiation
a
GO, gene ontology
b
Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms, and all entities listed in the table have P-value<0.05.
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Table 4.13. Overrepresented biological processed from upregulated differentially expressed
gene profile in Cluster 13 of the aggregate of all four samples
GOa ID
Term
Genes
P-Valueb
Histone H3-K27
HIST1H1E, HIST1H1D, HIST1H1C,
GO:0098532
4.90E-05
trimethylation
EPHB3
TSPYL1, H1F0, HIST1H2BB,
GO:0006334 Nucleosome assembly
HIST1H1E, HIST1H1D, HIST1H1C,
1.47E-04
HIST1H1B, HIST1H1A
ARC, PLCG1, ARF4, PTK7, CSPG4,
GO:0016477 Cell migration
4.52E-04
MMP14, NFATC2, SNAI1, USP24
MAPK1, MAFB, BCL2L11, SLC46A2,
GO:0048538 Thymus development
5.16E-04
CTNNB1, CITED2
ZFP36, ERF, FZD8, HIST1H1E,
Negative regulation of
HIST1H1D, HIST1H1C, HIST1H1B,
GO:0000122 transcription from RNA
SMAD3, CTNNB1, OSR1, HEXIM1,
0.001
polymerase II promoter
ID1, SQSTM1, DLL4, ID4, RBM15,
VLDLR
ATF5, CDKN1B, PLK2, NUAK2,
Negative regulation of
GO:0043066
OSR1, ID1, ARF4, PIM3, MYC,
0.001
apoptotic process
SLC40A1, CITED2, ANGPTL4
Adherens junction
GO:0034333
ZNF703, CTNNB1, VCL
0.006
assembly
GO:0016584 Nucleosome positioning
HIST1H1E, HIST1H1D, HIST1H1C
0.008
T cell differentiation in
GO:0033077
ZFP36L2, FZD8, MAFB, CTNNB1
0.008
thymus
Positive regulation of
GO:0010718 epithelial to
ZNF703, SMAD3, EPHB3, SNAI1
0.012
mesenchymal transition
a
GO, gene ontology
b
Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms, and all entities listed in the table have P-value<0.05.
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4.7.a) Chondrocyte biomarker gene expression in the aggregate of samples

4.7.b) Interzone biomarker gene expression in the aggregate of samples
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4.7.c) Chondrocyte hypertrophy biomarker gene expression in the aggregate of samples

log2 Max Feature UMI counts
0

6.5

Figure 4.7. Biomarker gene expression in the aggregate of samples, plotted by uniform
manifold approximation and projection (UMAP) analysis, with a separated view by sample.
The areas demarcated by the blue line indicate Cluster 8, 9, and 13, in which all four samples
overlapped. IZ = interzone cell cultures; ANL = anlagen cell cultures; a) Chondrocyte biomarker
genes (COL2A1, COMP, and ACAN); b) Interzone biomarker genes (GDF5, WNT9A, and ENPP2);
c) Chondrocyte hypertrophy biomarker genes (MMP13 and DLX5)
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Characteristics of interzone cells
No cluster had a clear distinction between interzone cell cultures at 24h and 48h (Figure
4.6.d). Cluster 5 and 12 had relatively greater interzone cells at 24h compared to 48h, and
Cluster 6, 10, and 11 had relatively greater interzone cells at 48h compared to 24h. Among
these clusters, only Cluster 6 and 12 dominantly consisted of interzone cells with a minimal
number of analgen cells. Interzone cells at 48h were dominant in Cluster 6, and relatively
similar proportions of interzone cells at both time points were observed in Cluster 12.

Gene ontology enrichment analysis was conducted with the DEGs from Cluster 6 and 12
to evaluate interzone cell-specific characteristics. Out of the ten most significant biological
processes represented by the downregulated DEG profile in Cluster 6 (Table 4.14), eight GO
terms are related to mitosis: 1) cell division, 2) mitotic nuclear division, 3) mitotic
chromosome condensation, 4) mitotic cytokinesis, 5) microtubule-based movement, 6)
mitotic sister chromatid segregation, 7) mitotic spindle organization, and 8) mitotic
metaphase plate congression. Cluster 6 had only 15 upregulated DEGs, and Cluster 12 had one
upregulated DEG and three downregulated DEGs; thus, no overrepresented biological
processes were identified due to the small size of the DEG lists.

The majority of interzone biomarker (GDF5, WNT9A, and ENPP2) expressing cells were
located within the cell type-specific areas in both interzone and analgen cell cultures at both
time points (Figure 4.7.b).

164

Table 4.14. Top ten overrepresented biological processed from downregulated differentially
expressed gene profile in Cluster 6 of the aggregate of all four samples
GOa ID
Term
Genes
P-Valueb
SPC24, CCNB1, SPC25, CCNB2,
GO:0051301 Cell division
TPX2, CKS2, UBE2C, ASPM, REEP4, 1.76E-08
CDCA3
SPC24, SPC25, CCNB2, PLK1,
GO:0007067 Mitotic nuclear division
3.71E-07
NUF2, CENPW, ASPM, REEP4
Mitotic chromosome
GO:0007076
NCAPG, NUSAP1, NCAPD3, SMC4
1.75E-05
condensation
GO:0000281 Mitotic cytokinesis
CKAP2, PLK1, NUSAP1, STMN1
1.55E-04
GO:0042026 Protein refolding
HSPA6, HSPA1A, HSPA8
0.001
Microtubule-based
GO:0007018
KIF11, KIF18A, KIF20B, CENPE
0.002
movement
Mitotic sister chromatid
GO:0000070
CDCA8, PLK1, KIF18A
0.003
segregation
Mitotic spindle
GO:0007052
CCNB1, SPC25, STMN1
0.005
organization
Mitotic metaphase plate
GO:0007080
CCNB1, CDCA8, KIF18A
0.008
congression
Response to endoplasmic
GO:0034976
HYOU1, PDIA6, CXCL8
0.018
reticulum stress
a
GO, gene ontology
b
Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms, and all entities listed in the table have P-value<0.05.
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Characteristics of analgen cells
Cluster 2 and 4 were mostly composed of anlagen cells at 48h, with these clusters
containing much fewer analgen cells at 24h or interzone cells at either time point (Figure
4.6.d). On the other hand, anlagen cells at 24h were dominant in Cluster 5 although several
interzone cells were also observed in this cluster.

Gene enrichment analyses were conducted with DEGs from Cluster 2 and 4. Seven and
one significantly overrepresented biological processes were identified from the upregulated
DEG profiles of Cluster 2 and 4, respectively (Table 4.15 and 4.16). The ten most
downregulated biological processes in Cluster 2 and 4 are also shown in the tables. In both
cell clusters, regulatory processes involved in mitotic events were significantly downregulated:
upregulation of positive regulation of cell cycle arrest (Cluster 2) and downregulation of
mitotic sister chromatid segregation, microtubule-based movement, microtubule bundle
formation, mitotic cytokinesis (Cluster 2), mitotic nuclear division (Cluster 4), cell division, and
mitotic chromosome condensation (Cluster 2 and 4).

Similar to the interzone biomarker gene expression (Figure 4.7.b), most of hypertrophic
biomarkers (COL10A1, MMP13, and DLX5) were observed in the cell type-specific areas in
both types of cell cultures at both time points (Figure 4.7.c).

166

Table 4.15. Top ten overrepresented biological processed from differentially expressed gene
profile in Cluster 2 of the aggregate of all four samples
GOa ID
Term
Genes
P-Valueb
(Upregulatedc)
GO:0060428 Lung epithelium development
HMGA2, ERRFI1
0.009
GO:0043405 Regulation of MAP kinase activity TRIB3, TRIB1
0.011
Negative regulation of
GO:0045892
ATF5, TRIB3, HMGA2, TGFB1
0.012
transcription, DNA-templated
Positive regulation of transcription
GO:2000679
HMGA2, TGFB1
0.022
regulatory region DNA binding
GO:0008016 Regulation of heart contraction
S100A1
0.026
Epithelial to mesenchymal
GO:0001837
HMGA2, TGFB1
0.035
transition
Positive regulation of cell cycle
GO:0071158
HMGA2, TGFB1
0.041
arrest
(Downregulated)
Mitotic chromosome
NCAPG, NUSAP1, NCAPD3,
GO:0007076
3.83E-05
condensation
SMC4
GO:0085020 Protein K6-linked ubiquitination
UBE2S, UBE2T, BARD1
7.13E-04
Positive regulation of ubiquitin
GO:1904668
PLK1, CDC20, UBE2S
9.93E-04
protein ligase activity
Anaphase-promoting complexGO:0031145
CDC20, UBE2C, UBE2S
0.001
dependent catabolic process
Mitotic sister chromatid
GO:0000070
CDCA8, PLK1, KIF18A
0.005
segregation
KIF11, KIF18A, KIF20B,
GO:0007018 Microtubule-based movement
0.006
CENPE
GO:0001578 Microtubule bundle formation
PRC1, PLK1, MAP1B
0.008
CDCA8, CDC20, ASPM,
GO:0051301 Cell division
0.011
CDCA3
GO:0000281 Mitotic cytokinesis
CKAP2, PLK1, NUSAP1
0.012
GO:0035519 Protein K29-linked ubiquitination UBE2S, UBE2T
0.014
a
GO, gene ontology
b
Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms, and all entities listed in the table have P-value<0.05.
c
Upregulated differentially expressed genes resulted in only seven significant biological
process.
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Table 4.16. Top ten overrepresented biological processed from differentially expressed gene
profile in Cluster 4 of the aggregate of all four samples
GOa ID
Term
Genes
P-Valueb
c
(Upregulated )
Cytokine-mediated
GO:0019221
CCL2, PODNL1, IFNAR1
0.009
signaling pathway
(Downregulated)
SPC24, CCNB1, SPC25, CCNB2,
GO:0051301 Cell division
GNAI3, TPX2, AURKA, UBE2C,
4.34E-06
ASPM, CDCA3
Negative regulation of
GO:2000378 reactive oxygen species
HK2, BNIP3, PINK1, VDAC1
2.37E-04
metabolic process
SPC24, SPC25, CCNB2, PLK1, NUF2,
GO:0007067 Mitotic nuclear division
2.40E-04
GEM, ASPM
CAV1, PLOD1, CRYAB, EGLN3,
GO:0001666 Response to hypoxia
3.49E-04
ALKBH5, DDIT4
Positive regulation of
GATA2, ADM, SFRP2, SERPINE1,
GO:0045766
7.05E-04
angiogenesis
RHOB, HSPB1
Collagen fibril
GO:0030199
SFRP2, P4HA1, LOX, SERPINH1
0.002
organization
Negative regulation of
HMGB2, STC2, CRYAB, PINK1,
GO:0010629
0.003
gene expression
UPK3B
Positive regulation of
PID1, CKAP2, NAMPT, HMGB2,
GO:0045944 transcription from RNA
HES1, HDAC5, CDH13, SFRP2, IRF7,
0.003
polymerase II promoter
SIX1, PSIP1, KDM3A, TOP2A
Defense response to
GO:0050829
HMGB2, ADM, SERPINE1, DEFB1
0.004
Gram-negative bacterium
Mitotic chromosome
GO:0007076
NCAPG, NUSAP1, SMC4
0.004
condensation
a
GO, gene ontology
b
Modified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation
terms, and all entities listed in the table have P-value<0.05.
c
Upregulated differentially expressed genes resulted in only one significant biological
process.
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Discussion
The first single cell RNA-seq study was published in 2009 (Tang et al., 2009), but this
technology is still emerging and is relatively novel in the field of transcriptome research. In
this pilot study, while asking scientific questions, this advanced technique was also evaluated
for use in our laboratory with the experimental settings and typical specimens that the lab
has been employing.

While the targeted cell number was 5,000 cells/sample, the numbers of recovered cells
ranged from 2,032 – 2,845 (recovery rates of 47 – 54%). These lower recovery rates might be
due to the characteristics of the sample type. The specimens studied in this experiment were
chondrogenic cell pellets, which produced and accumulated ECM over time. To prepare single
cell suspensions, the cell pellets had to be disaggregated by enzymatic digestion as well as
filtration through a porous membrane. Even though cell pellets underwent those steps,
remaining debris might affect the GEM formation.

Despite the lower cell number recovery rates, greater than 91.4% of the total reads were
associated with cells in all samples. In addition, the total transcripts count/cell in all samples
surpassed 200,000 reads/cell, which was well above the recommended minimum number of
reads/cell (50,000 reads/cell) from the manufacturer’s protocol. Thus, the sequencing
generated abundant and high-quality data from the sample set (Table 4.3).
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Subpopulations of cells in each sample
The data do not support the first hypothesis tested in the study that interzone cell cultures
will develop relatively heterogenous cell clusters while anlagen cell cultures will result in
relatively homogenous cell clusters. In terms of subpopulation homogeneity, there was no
significant evidence that either cell lines at either time points had greater heterogeneity (Table
4.4). Also, chondrocyte biomarker gene expression (COL2A1, COMP, and ACAN) was observed
from the majority of cell clusters in interzone and analgen cell cultures at 24h and 48h (Figure
4.3) with a few clusters showing lower levels. In agreement with findings in the previous
chapters, the expression of these cartilaginous ECM genes was greater at 48h compared to
24h in both cell cultures, confirming that the cell lines were progressing towards a
chondrogenic phenotype.

The interzone biomarker genes (GDF5, WNT9A, and ENPP2) selected for visualization are
regulatory genes, unlike the ECM effector genes chosen for chondrocytes. Interestingly,
though, the localization was generally concordant (Figures 4.3 and 4.4). This co-localization
may suggest retention of interzone biomarkers in the subset of cells destined to form articular
cartilage or downregulation in cell subsets moving towards non-cartilaginous joint tissues.
Levels were lower in anlagen cell cultures, especially, WNT9A which was not detectable. The
overall intensity of the interzone marker gene expression was not remarkably different
between the time points. Since in vivo GDF5 and WNT9A expression drops significantly
postnatally in mouse limb joints (Koyama et al., 2008), the equine primary cells used in the
current study are consistent with an earlier stage of differentiation.
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The chondrocyte hypertrophic biomarkers (MMP13, and DLX5) were present at higher
levels in the anlagen samples (Figure 4.5), consistent with this tissue progressing to
osteogenesis. Overall, however, COL10A1 and MMP13 were less informative. COL10A1 was
not detectable and the MMP13 expression limited. In contrast, steady state mRNA levels of
DLX5, a transcription factor gene, were relatively high in anlagen cell cultures and increased
over time. These results may indicate that the anlagen cell cultures were at earlier stages of
hypertrophic differentiation. Similar to the interzone biomarker gene expression, DLX5 was
also expressed from the cell clusters that expressed the cartilage ECM genes. This finding is
consistent with both the interzone- and hypertrophic biomarkers being closely linked to
chondrogenic differentiation in the two skeletal cell lines.

Shared features and unique properties between interzone and analgen cells
The second hypothesis tested in the current experiments was that interzone and anlagen
cells will share common chondrogenic characteristics, but also show cell type-specific
properties. Supporting this hypothesis, the data clearly demonstrate both similarities and
differences.

Common gene expression patterns between interzone and anlagen cells
Analyzing gene expression data from the four-sample aggregate, 13 cell clusters were
identified, and all four samples overlapped in Cluster 8, 9, and 13 (Figure 4.6.c and d).
Interestingly, the only common overrepresented GO term in these cell subpopulations was
“cell migration” (Table 4.12 and 4.13). This result is consistent with data reported in Chapter
2 and may reflect the establishment of cell pellets. Cells were lifted from monolayers and
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lightly centrifuged to aid in pellet formation, which might increase the expression of genes
that regulate cell migration, regardless of cell types.

Cluster 9 is interesting because it shows an overrepresentation of positive chondrocyte
differentiation regulators as a significant biological process, while expression of chondrocyte
ECM biomarkers was relatively low. Perhaps the cells in Cluster 9 were regulating
chondrogenesis in other cells, or alternatively were just earlier in the differentiation process.
Among the significant biological processes analyzed from the upregulated DEG profile in
Cluster 13, positive regulation of epithelial to mesenchymal transition was observed and is
consistent with cellular processes undoubtedly also occurring during limb bud formation
(Gros and Tabin, 2014).

Differences between interzone and anlagen cells
When plotting the gene expression in the aggregate of all samples, the chondrocyte
biomarker gene expression (COL2A1, COMP, and ACAN) was higher in cell type-specific areas:
Cluster 2 and 4 for anlagen samples, and Cluster 6 and 12 for interzone samples (Figure 4.7.a).
Also, expression of interzone (GDF5, WNT9A, and ENPP2) and hypertrophic (MMP13 and DLX5)
biomarkers had the same pattern especially at the 48h time point. When comparing the
profiles of the most overrepresented biological processes from the interzone cell-specific
cluster (Cluster 6) and the analgen cell-specific clusters (Cluster 2 and 4), mitosis-related
biological events were consistently downregulated. In addition, positive regulation of cell
cycle arrest was upregulated in Cluster 2. More samples will be needed to investigate these
relationships further.
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There are several examples of genes that may diverge chondrogenic pathways between
interzone and anlagen cell cultures. Among the DEGs in the analgen cell-specific clusters
within the aggregate of all samples (Cluster 2 and 4, which were dominated by anlagen cells
at 48h), DEFB1 was the most downregulated gene (log2FC=-5.62 in Cluster 2; log2FC=-5.99 in
Cluster 4; P-value<0.0001; Table 4.11). At the same time, DEFB1 was the only upregulated DEG
(log2FC=1.74; P-value=0.019; Table 4.11) in Cluster 12, in which interzone cells at both time
points were dominant. This gene encodes a TLR ligand and activates downstream by
interacting with a receptor, TLR4. Its signal activates RAC1 in MAPK pathways and HSP27 in
that order (Melas et al., 2014). HSP27, a chaperone involved in proper protein folding, was
significantly expressed in normal articular cartilage when compared to osteoarthritic cartilage
(Lambrecht et al., 2010). Along with DEFB1, HSP27 was differentially downregulated in Cluster
4 (log2FC=-1.22; P-value=0.006). Altogether, these results may suggest that DEFB1 might
participate in interzone-specific signaling pathways leading to articular cartilage formation,
and these pathways might be significantly downregulated in anlagen cells.

On the other hand, CXCL8 was a key upregulated gene (log2FC=1.98; P-value=6.96E-06) in
Cluster 4 within the aggregate of all samples, but this gene was differentially downregulated
(log2FC=-3.55; P-value=<0.001) in Cluster 6 (Table 4.11). CXCL8 was also an upregulated DEG
in anlagen cell cultures compared to interzone cell cultures before and after inducing in vitro
chondrogenesis from the study reported in Chapter 3 (Table 3.23). In a previous study,
although the expression of CXCL8 was detected in normal articular chondrocyte cultures,
when its protein was excessively added (10 ng/ml) to the cultures, it increased MMP13
expression and calcification (Merz et al., 2003). In agreement with the literature as well as the
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result from the previous chapter, the data may indicate that anlagen cell cultures showed
greater levels of hypertrophic potential compared to interzone cell cultures.

Future direction
By profiling transcriptomic signatures at the single cell level, the present study showed
that both interzone and anlagen cell cultures at 24h and 48h consisted of several cell
subpopulations with different gene expression patterns. Although this study characterized cell
clusters within a sample and within the aggregate of the sample set, spatial arrangement of
these cell subpopulations and potential paracrine interactions between them are yet to be
defined. These undefined properties could be further described when a spatial single cell
RNA-seq is conducted on cell pellet sections. As shown in the histology images generated from
the preliminary staining experiment (Figure 4.1), different ECM compositions and cellular
arrangement were observed in a zonal structure on the day-21 interzone cell pellet section.
In addition, the current dataset revealed that several genes were differentially upregulated in
some cell clusters while differentially downregulated in other cell clusters within the same
sample. Thus, the evaluation of spatial gene expression would provide a better understanding
of the spatial arrangement of cell subpopulations and the molecular interaction between
them in interzone and analgen cell pellet cultures during chondrogenic differentiation.

Obviously, the current pilot experiments would greatly benefit from additional biological
replicates. The observations are interesting, but clearly require more primary data to elucidate
fully.
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Conclusion
This pilot transcriptomic study conducted at the single cell level proposes the single cell
RNA-seq technology as a highly informative new approach for studying gene expression in
chondrogenic cell pellet cultures. With the abundant and quality sequencing data generated,
this study demonstrated subpopulations of cells in both interzone and anagen cell cultures
grown in a chondrogenic induction medium containing TGF-1 for 24 and 48 hours. Although
interzone and analgen cell cultures at both time points did not display different degrees of
heterogeneity in cell subpopulations, the sample set showed common traits as well as cell
type-specific differences. It is interesting to note that the cell type-specific clusters exhibited
greater cartilaginous ECM marker expression as well as either interzone-like characteristics or
hypertrophic potentials compared to the clusters that were overlapped by all four samples.
On the other hand, the gene expression pattern in the overlapping clusters presented positive
regulation of chondrocyte differentiation as its significant biological process. Therefore, the
data may suggest that upstream signal transduction and cartilaginous ECM production might
be organized by different cell subpopulations during chondrogenesis. In conclusion, the
present study added further evidence that interzone and analgen cell cultures progress down
different chondrogenic pathways.
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Chapter 5. Overall summary and future directions
In this dissertation project, two studies and a pilot experiment were conducted to
investigate chondrogenic divergence of equine fetal interzone and anlagen cells in tissue
culture using various high throughput gene expression analytic technologies. Tissue culture
protocols were held constant in all three studies. Interzone and analgen cells collected from
gestational day 45 equine fetuses were grown in 3-dimensional cell pellet cultures, and the in
vitro chondrogenesis was induced by TGF-1, which is a well-established chondrogenic factor.
Kinetics of gene expression changes were evaluated in each chapter over different
experimental periods using different methods.

In the first study, 93 targeted genes were selected for characterizing expression kinetics
over 336 hours in Chapter 2. These genes are either involved in biological processes related
to fetal skeletal development or differentially expressed between equine interzone and
anlagen tissue lineages. By profiling their expression under the chondrogenic at ten different
time points (0, 1.5, 3, 6, 12, 24, 48, 96, 168, and 336h), this study yielded important new
information on changes in steady state mRNA levels between the cell lines, and importantly
also the timing of those in changes in response to the in vitro chondrogenic induction.

Both shared and cell type-specific differences before and after inducing chondrogenesis
were observed. Before inducing chondrogenesis, 73 out of 87 targeted genes were not
differentially expressed between interzone and anlagen cells, while 14 genes already had
different gene expression levels at the baseline. Among 73 genes that were not differentially
expressed at 0h, 47 genes responded differently to the TGF-1 treatment over time.
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The first responses to the chondrogenic induction stimulus occurred within the first 1.5
hours. Interestingly, these initial gene loci all had functional annotation related to either
transcription regulation or signal transduction. In fact, all transcription regulatory genes that
were selected for the panel changed their expression patterns within the first 24 hours in the
two chondrogenic cell lines, while the alterations in signaling events were relatively evenly
distributed across all time points during the 336-hour experimental period. On the other hand,
effector genes maintaining ECM composition had more delayed responses. No ECM effector
genes changed their basal mRNA level at the first collection point (1.5h), with the earliest
effects in this functional annotation group observed at 3h. Taken together, the results
accepted the hypothesis that divergent chondrogenic pathways between interzone and
anlagen cell cultures will become evident within the first 24 hours after inducing in vitro
chondrogenesis.

From the findings in Chapter 2, five time points, including the baseline, were selected (0,
1.5, 3, 12, and 96h) for full mRNA transcriptome assessment based on the following reasons.
By 1.5h, regulatory responses to the chondrogenic stimulation were initiated. At 3h, a peak of
initial gene expression responses was recorded. A second major peak of first responses in
transcription regulatory genes occurred at 12h. Finally, most of effector genes regulating ECM
profiles (85.4%) responded by 96h. The method used to evaluate the transcriptome was RNAsequencing.

Data from the Chapter 3 support that chondrogenic differentiation in interzone cell
cultures are in the direction of an articular chondrocyte phenotype, while analgen cell cultures
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are directed more towards a cartilage that will progress through hypertrophic differentiation.
At the same time, a number of the gene expression changes in response to induced
chondrogenesis are shared between these two cell lines. This study identified interesting
DEGs and candidate molecular regulators that may diverge chondrogenic pathways between
the two skeletal cell lines. In agreement with the Chapter 2 data, the Chapter 3 results support
accepting the hypothesis that differential responses of regulatory genes start changing
expression patterns within the first 1.5 hours, and more distinctive transcriptomic signatures
between interzone and anlagen cells will accumulate as chondrogenesis progresses.

In Chapter 4, a pilot single cell RNA-seq experiment was conducted to characterize cell
subpopulations in interzone and anlagen cell cultures at 24h and 48h by testing two
hypotheses. The first hypothesis was that interzone cell cultures will develop relatively
heterogenous cell subpopulations while anlagen cell cultures will retain more cellular
homogeneity. However, the data indicated that interzone and anlagen cell cultures at both
time points resulted in 7 – 8 cell subset clusters, and the distribution of cell numbers in the
clusters was not notably different among the sample set, rejecting this hypothesis.

The second hypothesis tested in this pilot experiment was that interzone and anlagen cell
cultures share common chondrogenic characteristics and also show unique traits within a cell
type. By plotting the expression of well-established cartilage biomarkers, the chondrogenic
potential of interzone and anlagen cells was confirmed. Visualizing the interzone biomarker
expression and the hypertrophy biomarker expression demonstrated that interzone cells
retained interzone-like characteristics while anlagen cells retained hypertrophic potential in
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culture. The expression of genes representing common chondrogenic potential and cell typespecific traits became greater at 48h compared to 24h. It is interesting to note that groups of
cells that showed either interzone-like or hypertrophic characteristics had greater expression
of cartilaginous ECM biomarkers compared to cell subsets that were overlapped, suggesting
the same cell subsets that achieve unique features also accumulate functional outcomes of
chondrogenic differentiation generally. In sum, the second hypothesis was accepted.

Overall, data in this dissertation research were generated with a balanced sample set
composed of paired cell types (interzone cells, anlagen cells, and fibroblasts) between the
biological replicates. The studies conducted provide new information on divergent
chondrogenic pathways between fetal interzone and anlagen cells at the molecular level from
the perspective of time course kinetics and have derived a molecular regulatory model (Figure
5.1). Early regulation of the different chondrogenic pathways may involve activation of NUPR1
in interzone cells and RUNX2 in analgen cells within the first 3 hours after inducing
chondrogenesis (Figure 3.16). In interzone cell cultures, chondrogenic differentiation might
temporarily pause immediately after treating the chondrogenic inductive medium containing
TGFβ-1, represented by activated NOTCH1 and GATA1 signaling (between 0h and 1.5h; Figure
3.5). Then, interzone cells may resume chondrogenesis with the activated MEOX2 regulation
between 3h and 12h. At later stages, the expression of COL9A1, which composes the ECM of
hyaline cartilage, may indicate that interzone cells are in the chondrogenic pathways forming
articular cartilage. On the other hand, anlagen cells appear to be directed to hypertrophic
differentiation pathways at earlier stages (between 1.5h and 12h) with activated SOX10, DLX5,
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and DLX6 signals, and subsequently, the activation of SP7 may induce ECM mineralization at
later stage (Figure 3.9), consistent with the biology of cartilaginous anlagen of limbs.
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Interzone cell

COL9A1
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Kinetic signature
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Figure 5.1. Molecular regulatory model in interzone and analgen cell cultures during in vitro chondrogenesis. Within the first 3 hours, there
is evidence for the activation of cell type-specific regulators that initiate divergence of the two different chondrogenic pathways (Figure 3.16).
The interzone cells in culture appear to pause chondrogenesis immediately after treatment with the chondrogenic stimuli, but then resume
at 3h (Figure 3.5). Analgen cells, in contrast, progress towards a hypertrophic differentiation pathway (Figure 3.9). The distinguishing
extracellular matrix profiles between interzone and anlagen cells became apparent at the later time points.
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New knowledge obtained from the present research lays a foundation for mechanistic
experiments and perhaps future translational clinical studies. The mechanistic experiments
will be required to validate the model of molecular regulation (Figure 5.1) and elucidate the
roles of candidate regulator genes that may dictate the cellular fates of these two fetal skeletal
cell lines; a loss-of-function or gain-of-function study would add value to the present findings.

Concurrent to the proposed model, genes loci that are of higher biological interest were
identified: DEGs, including candidate molecular switches between the chondrogenic cell lines,
hub genes correlated with the time course, predicted upstream regulators, etc. Mechanistic
studies would elaborate their biological relevance to the divergent chondrogenic pathways of
interzone and anlagen cells. For example, some genes that were analyzed as potential
molecular switches between the two cell lines were novel genes without known functional
annotations at the current moment. Hypotheses to study functional roles in these differential
chondrogenic pathways could be tested by conducting loss-of-function or gain-of-function
experiments. Also, molecular interactions or hierarchy in signaling cascades of these
interesting genes could be evaluated, adding more useful information. Although weighted
gene co-expression network analysis (WGCNA) demonstrated interactions between some key
hub genes in co-expression networks, the function of other hub genes have not well
characterized in scientific literature and therefore could not be fully assessed in co-expression
networks despite their greater relationship with other hub genes. In the same way,
computational predictions of upstream regulators based on the differential expression data
require mechanistic validation experiments to understand the relevant biology further.
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In the present studies, a majority of primary data centered on measurements of steady
state mRNA levels. Individual transcripts, however, still need to be translated, transported,
and in some cases modified to be functional in biological processes. Although the expression
of RNA and protein is correlated with each other via the central dogma, relationships between
mRNA, protein, and biological activity are not always concordant (Liu et al., 2018). Steady
state levels of mRNA are a function of both de novo synthesis and transcript degradation, and
translation requires additional time which can add another source for discrepancy between
the mRNA and protein levels. Not only do transcription and translation occur in different
compartments in cells, but intron excision prior to translation also takes at least 5 – 10 minutes
(Singh and Padgett, 2009) and can be regulated. Furthermore, proteins can exist in various
forms with activation status regulated through post-translational modifications. Therefore,
future cross-validation of the current RNA-based observations with protein expression and
biological function would be valuable in efforts to more fully elucidate the biological
relationships.

In addition, spatial expression evaluation at the transcript and/or protein levels would
enrich the current understanding. A new method generating substantial interest in many
biomedical areas is spatial single cell RNA-seq analyses to elucidate cell subpopulation
arrangements in situ. In the current application, this would demonstrate morphological
relationships of cell subgroups (clusters) within the interzone and anlagen cell pellets, with
the clear potential to tie this back the developmental tissues themselves in fetal limbs.
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In conclusion, this dissertation research confirmed and elaborated differential signatures
of fetal interzone and anlagen cells. By suggesting important candidate molecular regulators
that may direct these two skeletal cell lines towards articular cartilage development or
hypertrophic chondrogenesis, the present studies propose future research directions, with
hopes to improve the clinical approaches for supporting articular cartilage regeneration.

184

References
ADAM, E. N., JANES, J., LOWNEY, R., LAMBERT, J., THAMPI, P., STROMBERG, A. & MACLEOD, J.
N. 2019. Chondrogenic differentiation potential of adult and fetal equine cell types.
Veterinary Surgery, 48, 375-387. doi:10.1111/vsu.13183
AKIYAMA, H., CHABOISSIER, M.-C., MARTIN, J. F., SCHEDL, A. & DE CROMBRUGGHE, B. 2002.
The transcription factor Sox9 has essential roles in successive steps of the chondrocyte
differentiation pathway and is required for expression of Sox5 and Sox6. Genes &
development, 16, 2813-2828. doi:10.1101/gad.1017802
ALFORD, J. W. & COLE, B. J. 2005. Cartilage restoration, part 1:basic science, historical
perspective, patient evaluation, and treatment options. The American Journal of
Sports Medicine, 33, 295-306. doi:10.1177/0363546504273510
AOMATSU, K., ARAO, T., SUGIOKA, K., MATSUMOTO, K., TAMURA, D., KUDO, K., KANEDA, H.,
TANAKA, K., FUJITA, Y., SHIMOMURA, Y. & NISHIO, K. 2011. TGF-β induces sustained
upregulation of SNAI1 and SNAI2 through Smad and Non-Smad pathways in a human
corneal epithelial cell line. Investigative Ophthalmology & Visual Science, 52, 24372443. doi:10.1167/iovs.10-5635
BERIS, A. E., LYKISSAS, M. G., PAPAGEORGIOU, C. D. & GEORGOULIS, A. D. 2005. Advances in
articular cartilage repair. Injury, 36, S14-S23. doi:10.1016/j.injury.2005.10.007
BI, W., DENG, J. M., ZHANG, Z., BEHRINGER, R. R. & DE CROMBRUGGHE, B. 1999. Sox9 is
required for cartilage formation. Nature genetics, 22, 85-89. doi:10.1038/8792
BLIGHE, K., RANA, S. & LEWIS, M. 2019. EnhancedVolcano: Publication-ready volcano plots
with enhanced colouring and labeling. R package version 1.2.0. doi:
10.18129/B9.bioc.EnhancedVolcano
BLUM, M., GAUNT, S. J., CHO, K. W. Y., STEINBEISSER, H., BLUMBERG, B., BITTNER, D. & DE
ROBERTIS, E. M. 1992. Gastrulation in the mouse: The role of the homeobox gene
goosecoid. Cell, 69, 1097-1106. doi:10.1016/0092-8674(92)90632-M
BOND, S. R., LAU, A., PENUELA, S., SAMPAIO, A. V., UNDERHILL, T. M., LAIRD, D. W. & NAUS, C.
C. 2011. Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature
growth plate chondrocytes. Journal of Bone and Mineral Research, 26, 2911-2922. doi:
10.1002/jbmr.509
CALDWELL, K. L. & WANG, J. 2015. Cell-based articular cartilage repair: the link between
development and regeneration. Osteoarthritis and Cartilage, 23, 351-362.
doi:10.1016/j.joca.2014.11.004
CAMERON, D. A. 1963. The fine structure of bone and calcified cartilage. A critical review of
the contribution of electron microscopy to the understading of osteogenesis. Clinical
orthopaedics and related research, 26, 199-228.
CHEN, C. G., THUILLIER, D., CHIN, E. N. & ALLISTON, T. 2012. Chondrocyte-intrinsic Smad3
represses Runx2-inducible matrix metalloproteinase 13 expression to maintain
articular cartilage and prevent osteoarthritis. Arthritis & Rheumatism, 64, 3278-3289.
doi:10.1002/art.34566
CHEN, Y. & GRIDLEY, T. 2013. Compensatory regulation of the Snai1 and Snai2 genes during
chondrogenesis. Journal of Bone and Mineral Research, 28, 1412-1421.
doi:10.1002/jbmr.1871
CHURCH, V., YAMAGUCHI, K., TSANG, P., AKITA, K., LOGAN, C. & FRANCIS-WEST, P. 2005.
185

Expression and function of Bapx1 during chick limb development. Anatomy and
embryology, 209, 461-469. doi: 10.1007/s00429-005-0464-z
COSDEN-DECKER, R. S., BICKETT, M. M., LATTERMANN, C. & MACLEOD, J. N. 2012. Structural
and functional analysis of intra-articular interzone tissue in axolotl salamanders.
Osteoarthritis and Cartilage, 20, 1347-1356. doi:10.1016/j.joca.2012.07.002
COSDEN, R. S., LATTERMANN, C., ROMINE, S., GAO, J., VOSS, S. R. & MACLEOD, J. N. 2011.
Intrinsic repair of full-thickness articular cartilage defects in the axolotl salamander.
Osteoarthritis and Cartilage, 19, 200-205. doi:10.1016/j.joca.2010.11.005
DECKER, R. S., KOYAMA, E. & PACIFICI, M. 2014. Genesis and morphogenesis of limb synovial
joints
and
articular
cartilage.
Matrix
Biology,
39,
5-10.
doi:10.1016/j.matbio.2014.08.006
DOBACZEWSKI, M., CHEN, W. & FRANGOGIANNIS, N. G. 2011. Transforming growth factor
(TGF)-&#x3b2; signaling in cardiac remodeling. Journal of Molecular and Cellular
Cardiology, 51, 600-606. doi:10.1016/j.yjmcc.2010.10.033
ESER, P., DEMEL, C., MAIER, K. C., SCHWALB, B., PIRKL, N., MARTIN, D. E., CRAMER, P. & TRESCH,
A. 2014. Periodic mRNA synthesis and degradation co-operate during cell cycle gene
expression. Molecular Systems Biology, 10, 717. doi:10.1002/msb.134886
FEBRES-ALDANA, C. A. & ALEXIS, J. 2020. Normal expression of SRY-related HMG-BOX gene 10
(SOX-10) in recent and old cutaneous scars is a potential mimicker of desmoplastic
malignant melanoma. Applied Immunohistochemistry & Molecular Morphology, 28,
197-204. doi:10.1097/PAI.0000000000000729
FISHER, M., ACKLEY, T., RICHARD, K., OEI, B. & DEALY, C. N. 2019. Osteoarthritis at the cellular
level: mechanisms, clinical perspectives, and insights from development. In: NARAYAN,
R. (ed.) Encyclopedia of Biomedical Engineering. Oxford: Elsevier.
FLUIDIGM CORPORATION, F. 2018. Real-Time PCR Analysis, PN 68000088 N1 User Guide.
South San Francisco, CA, USA.
FRANCO, D. L., MAINEZ, J., VEGA, S., SANCHO, P., MURILLO, M. M., DE FRUTOS, C. A., DEL
CASTILLO, G., LÓPEZ-BLAU, C., FABREGAT, I. & NIETO, M. A. 2010. Snail1 suppresses
TGF-β-induced apoptosis and is sufficient to trigger EMT in hepatocytes. Journal of
Cell Science, 123, 3467-3477. doi:10.1242/jcs.068692
GAUNT, S. J., BLUM, M. & DE ROBERTIS, E. M. 1993. Expression of the mouse goosecoid gene
during mid-embryogenesis may mark mesenchymal cell lineages in the developing
head, limbs and body wall. Development, 117, 769-778.
GOLDSMITH, A. M., BENTLEY, J. K., ZHOU, L., JIA, Y., BITAR, K. N., FINGAR, D. C. & HERSHENSON,
M. B. 2006. Transforming growth factor-beta induces airway smooth muscle
hypertrophy. American Journal of Respiratory Cell and Molecular Biology, 34, 247-54.
doi:10.1165/rcmb.2005-0166OC
GOLUB, E. E. & BOESZE-BATTAGLIA, K. 2007. The role of alkaline phosphatase in mineralization.
Current Opinion in Orthopaedics, 18, 444-448. doi: 10.1097/BCO.0b013e3282630851
GROS, J. & TABIN, C. J. 2014. Vertebrate limb bud formation is initiated by localized epithelialto-mesenchymal transition. Science, 343, 1253-1256. doi:10.1126/science.1248228
HAM, A. W. 1952. Some histophysiological problems peculiar to calcified tissues. Journal of
Bone and Joint Surgery, 24 a, 701-28.
HASHIMOTO, Y., ISHIDA, J., YAMAMOTO, R., FUJIWARA, K., ASADA, S., KASUYA, Y., MOCHIZUKI,
N. & FUKAMIZU, A. 2005. G protein-coupled APJ receptor signaling induces focal
186

adhesion formation and cell motility. International journal of molecular medicine, 16,
787-792.
HEANUE, T. A., JOHNSON, R. L., IZPISUA-BELMONTE, J.-C., STERN, C. D., DE ROBERTIS, E. M. &
TABIN, C. J. 1997. Goosecoid misexpression alters the morphology and Hox gene
expression of the developing chick limb bud. Mechanisms of Development, 69, 31-37.
doi:https://doi.org/10.1016/S0925-4773(97)00149-4
HEILIG, J., ZAUCKE, F. & NIEHOFF, A. 2018. The role of collagen IX in the ossification of the
murine
femoral
head.
Osteoarthritis
and
Cartilage,
26,
S98.
doi:10.1016/j.joca.2018.02.211
HESTAND, M. S., KALBFLEISCH, T. S., COLEMAN, S. J., ZENG, Z., LIU, J., ORLANDO, L. & MACLEOD,
J. N. 2015. Annotation of the protein coding regions of the equine genome. PLOS ONE,
10, e0124375. doi:10.1371/journal.pone.0124375
HISSNAUER, T. N., BARANOWSKY, A., PESTKA, J. M., STREICHERT, T., WIEGANDT, K., GOEPFERT,
C., BEIL, F. T., ALBERS, J., SCHULZE, J., UEBLACKER, P., PETERSEN, J. P., SCHINKE, T.,
MEENEN, N. M., PÖRTNER, R. & AMLING, M. 2010. Identification of molecular markers
for articular cartilage. Osteoarthritis and Cartilage, 18, 1630-1638. doi:
10.1016/j.joca.2010.10.002
HODGKINSON, C. P., NAIDOO, V., PATTI, K. G., GOMEZ, J. A., SCHMECKPEPER, J., ZHANG, Z.,
DAVIS, B., PRATT, R. E., MIROTSOU, M. & DZAU, V. J. 2013. Abi3bp is a multifunctional
autocrine/paracrine factor that regulates mesenchymal stem cell biology. Stem cells,
31, 1669-1682. doi:10.1002/stem.1416
HUANG, D. W., SHERMAN, B. T. & LEMPICKI, R. A. 2009. Systematic and integrative analysis of
large gene lists using DAVID bioinformatics resources. Nature Protocols, 4, 44-57.
doi:10.1038/nprot.2008.211
HYDE, G., DOVER, S., ASZODI, A., WALLIS, G. A. & BOOT-HANDFORD, R. P. 2007. Lineage tracing
using matrilin-1 gene expression reveals that articular chondrocytes exist as the joint
interzone
forms.
Developmental
biology,
304,
825-833.
doi:10.1016/j.ydbio.2007.01.026
IWATA, J. I., HACIA, J. G., SUZUKI, A., SANCHEZ-LARA, P. A., URATA, M. & CHAI, Y. 2012.
Modulation of noncanonical TGF-β signaling prevents cleft palate in Tgfbr2 mutant
mice. The Journal of Clinical Investigation, 122, 873-885. doi:10.1172/JCI61498
KALBFLEISCH, T. S., RICE, E. S., DEPRIEST, M. S., WALENZ, B. P., HESTAND, M. S., VERMEESCH,
J. R., O′CONNELL, B. L., FIDDES, I. T., VERSHININA, A. O., SAREMI, N. F., PETERSEN, J. L.,
FINNO, C. J., BELLONE, R. R., MCCUE, M. E., BROOKS, S. A., BAILEY, E., ORLANDO, L.,
GREEN, R. E., MILLER, D. C., ANTCZAK, D. F. & MACLEOD, J. N. 2018. Improved
reference genome for the domestic horse increases assembly contiguity and
composition. Communications Biology, 1, 197. doi:10.1038/s42003-018-0199-z
KARAMBOULAS, K., DRANSE, H. J. & UNDERHILL, T. M. 2010. Regulation of BMP-dependent
chondrogenesis in early limb mesenchyme by TGFβ signals. Journal of Cell Science, 123,
2068-2076. doi:10.1242/jcs.062901
KARSENTY, G. & WAGNER, E. F. 2002. Reaching a genetic and molecular understanding of
skeletal development. Developmental cell, 2, 389-406. doi:10.1016/s15345807(02)00157-0
KAWASAKI, Y., KUGIMIYA, F., CHIKUDA, H., KAMEKURA, S., IKEDA, T., KAWAMURA, N., SAITO,
T., SHINODA, Y., HIGASHIKAWA, A., YANO, F., OGASAWARA, T., OGATA, N., HOSHI, K.,
187

HOFMANN, F., WOODGETT, J. R., NAKAMURA, K., CHUNG, U.-I. & KAWAGUCHI, H.
2008. Phosphorylation of GSK-3β by cGMP-dependent protein kinase II promotes
hypertrophic differentiation of murine chondrocytes. The Journal of Clinical
Investigation, 118, 2506-2515. doi:10.1172/JCI35243
KOYAMA, E., SHIBUKAWA, Y., NAGAYAMA, M., SUGITO, H., YOUNG, B., YUASA, T., OKABE, T.,
OCHIAI, T., KAMIYA, N., ROUNTREE, R. B., KINGSLEY, D. M., IWAMOTO, M., ENOMOTOIWAMOTO, M. & PACIFICI, M. 2008. A distinct cohort of progenitor cells participates
in synovial joint and articular cartilage formation during mouse limb skeletogenesis.
Developmental Biology, 316, 62-73. doi:https://doi.org/10.1016/j.ydbio.2008.01.012
KOYAMA, N., MIURA, M., NAKAO, K., KONDO, E., FUJII, T., TAURA, D., KANAMOTO, N., SONE,
M., YASODA, A., ARAI, H., BESSHO, K. & NAKAO, K. 2013. Human induced pluripotent
stem cells differentiated into chondrogenic lineage via generation of mesenchymal
progenitor cells. Stem Cells Dev, 22, 102-13. doi:10.1089/scd.2012.0127
KREJCI, P., KRAKOW, D., MEKIKIAN, P. B. & WILCOX, W. R. 2007. Fibroblast growth factors 1, 2,
17, and 19 are the predominant FGF ligands expressed in human fetal growth plate
cartilage. Pediatric Research, 61, 267-272. doi:10.1203/pdr.0b013e318030d157
LAMBRECHT, S., ALMQVIST, F., VERDONK, P., VERBRUGGEN, G., DEFORCE, D. & ELEWAUT, D.
2010. The small heat-shock protein HSP27 shows decreased expression in OAchondrocytes and mediates IL-6 secretion in human articular chondrocytes.
Osteoarthritis and Cartilage, 18, S107. doi:10.1016/S1063-4584(10)60258-0
LANE, J. M. & WEISS, C. 1975. Review of articular cartilage collagen research. Arthritis &
Rheumatism, 18, 553-562. doi:10.1002/art.1780180605
LEONARD, C. M., FULD, H. M., FRENZ, D. A., DOWNIE, S. A., MASSAGUE, J. & NEWMAN, S. A.
1991. Role of transforming growth factor-β in chondrogenic pattern formation in the
embryonic limb: Stimulation of mesenchymal condensation and fibronectin gene
expression by exogenenous TGF-β and evidence for endogenous TGF-β-like activity.
Developmental
Biology,
145,
99-109.
doi:https://doi.org/10.1016/00121606(91)90216-P
LETH, J. M., LETH-ESPENSEN, K. Z., KRISTENSEN, K. K., KUMARI, A., LUND WINTHER, A.-M.,
YOUNG, S. G. & PLOUG, M. 2019. Evolution and Medical Significance of LU DomainContaining Proteins. International journal of molecular sciences, 20, 2760.
doi:10.3390/ijms20112760
LIU, C. F. & LEFEBVRE, V. 2015. The transcription factors SOX9 and SOX5/SOX6 cooperate
genome-wide through super-enhancers to drive chondrogenesis. Nucleic acids
research, 43, 8183-8203. doi:10.1093/nar/gkv688
LIU, Y., BEYER, A. & AEBERSOLD, R. 2016. On the dependency of cellular protein levels on
mRNA abundance. Cell, 165, 535-550. doi:10.1016/j.cell.2016.03.014
LONG, F. & ORNITZ, D. M. 2013. Development of the endochondral skeleton. Cold Spring
Harbor Perspectives in Biology, 5, a008334. doi:10.1101/cshperspect.a008334
LUO, G., DUCY, P., MCKEE, M. D., PINERO, G. J., LOYER, E., BEHRINGER, R. R. & KARSENTY, G.
1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA
protein. Nature, 386, 78-81. doi:10.1038/386078a0
MANKOO, B. S., SKUNTZ, S., HARRIGAN, I., GRIGORIEVA, E., CANDIA, A., WRIGHT, C. V. E.,
ARNHEITER, H. & PACHNIS, V. 2003. The concerted action of Meox homeobox genes
is required upstream of genetic pathways essential for the formation, patterning and
188

differentiation of somites. Development, 130, 4655-4664. doi:10.1242/dev.00687
MCCARTHY, H. E., BARA, J. J., BRAKSPEAR, K., SINGHRAO, S. K. & ARCHER, C. W. 2012. The
comparison of equine articular cartilage progenitor cells and bone marrow-derived
stromal cells as potential cell sources for cartilage repair in the horse. The Veterinary
Journal, 192, 345-351. doi:10.1016/j.tvjl.2011.08.036
MELAS, I. N., CHAIRAKAKI, A. D., CHATZOPOULOU, E. I., MESSINIS, D. E., KATOPODI, T., PLIAKA,
V., SAMARA, S., MITSOS, A., DAILIANA, Z., KOLLIA, P. & ALEXOPOULOS, L. G. 2014.
Modeling of signaling pathways in chondrocytes based on phosphoproteomic and
cytokine release data. Osteoarthritis and Cartilage, 22, 509-518.
doi:10.1016/j.joca.2014.01.001
MERZ, D., LIU, R., JOHNSON, K. & TERKELTAUB, R. 2003. IL-8/CXCL8 and Growth-related
oncogene α/CXCL1 induce chondrocyte hypertrophic differentiation. The Journal of
Immunology, 171, 4406. doi:10.4049/jimmunol.171.8.4406
MEVEL, R., DRAPER, J. E., LIE-A-LING, M., KOUSKOFF, V. & LACAUD, G. 2019. RUNX
transcription factors: orchestrators of development. Development, 146, dev148296.
doi:10.1242/dev.148296
MOHANTY-HEJMADI, P., DUTTA, S. K. & MAHAPATRA, P. 1992. Limbs generated at site of tail
amputation in marbled balloon frog after vitamin A treatment. Nature, 355, 352-353.
doi:10.1038/355352a0
MOSKALEWSKI, S., HYC, A., JANKOWSKA-STEIFER, E. & OSIECKA-IWAN, A. 2013. Formation of
synovial joints and articular cartilage. Folia Morphologica, 72, 181-7.
doi:10.5603/fm.2013.0031
MUSARÒ, A., MCCULLAGH, K. J., NAYA, F. J., OLSON, E. N. & ROSENTHAL, N. 1999. IGF-1
induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2
and NF-ATc1. Nature, 400, 581-585. doi:10.1038/23060
NEJADNIK, H., DIECKE, S., LENKOV, O. D., CHAPELIN, F., DONIG, J., TONG, X., DERUGIN, N.,
CHAN, R. C. F., GAUR, A., YANG, F., WU, J. C. & DALDRUP-LINK, H. E. 2015. Improved
approach for chondrogenic differentiation of human induced pluripotent stem cells.
Stem Cell Reviews and Reports, 11, 242-253. doi:10.1007/s12015-014-9581-5
NELSON, C. E., MORGAN, B. A., BURKE, A. C., LAUFER, E., DIMAMBRO, E., MURTAUGH, L. C.,
GONZALES, E., TESSAROLLO, L., PARADA, L. F. & TABIN, C. 1996. Analysis of Hox gene
expression in the chick limb bud. Development, 122, 1449-1466.
NG, L. J., WHEATLEY, S., MUSCAT, G. E. O., CONWAY-CAMPBELL, J., BOWLES, J., WRIGHT, E.,
BELL, D. M., TAM, P. P. L., CHEAH, K. S. E. & KOOPMAN, P. 1997. SOX9 binds DNA,
activates transcription, and coexpresses with type II collagen during chondrogenesis
in
the
mouse.
Developmental
Biology,
183,
108-121.
doi:https://doi.org/10.1006/dbio.1996.8487
NINOMIYA, K., MIYAMOTO, T., IMAI, J.-I., FUJITA, N., SUZUKI, T., IWASAKI, R., YAGI, M.,
WATANABE, S., TOYAMA, Y. & SUDA, T. 2007. Osteoclastic activity induces
osteomodulin expression in osteoblasts. Biochemical and Biophysical Research
Communications, 362, 460-466. doi:10.1016/j.bbrc.2007.07.193
NISHIDA, T., KUBOTA, S., AOYAMA, E. & TAKIGAWA, M. 2013. Impaired glycolytic metabolism
causes chondrocyte hypertrophy-like changes via promotion of phospho-Smad1/5/8
translocation into nucleus. Osteoarthritis and Cartilage, 21, 700-709.
doi:https://doi.org/10.1016/j.joca.2013.01.013
189

NISHIMURA, R., WAKABAYASHI, M., HATA, K., MATSUBARA, T., HONMA, S., WAKISAKA, S.,
KIYONARI, H., SHIHO, G., YAMAGUCHI, A., TSUMAKI, N., AKIYAMA, H. & YONEDA, T.
2012. Osterix regulates calcification and degradation of chondrogenic matrices
through matrix metalloproteinase (MMP13) expression in association with
transcription factor Runx2 during endochondral ossification. Journal of Biological
Chemistry. 287, 33179-33190. doi:10.1074/jbc.M111.337063
OGLE, M. E., OLINGY, C. E., AWOJOODU, A. O., DAS, A., ORTIZ, R. A., CHEUNG, H. Y. &
BOTCHWEY, E. A. 2017. Sphingosine-1-Phosphate Receptor-3 supports hematopoietic
stem and progenitor cell residence within the bone marrow niche. Stem cells, 35,
1040-1052. doi:10.1002/stem.2556
OH, S. K., SHIN, J. O., BAEK, J. I., LEE, J., BAE, J. W., ANKAMERDDY, H., KIM, M. J., HUH, T. L.,
RYOO, Z. Y., KIM, U. K., BOK, J. & LEE, K. Y. 2015. Pannexin 3 is required for normal
progression of skeletal development in vertebrates. The FASEB Journal, 29, 4473-4484.
doi:10.1096/fj.15-273722
ONDRÉSIK M., OLIVEIRA J. M. & REIS R.L. 2017. Knee articular cartilage. In: Oliveira J., Reis R.
(eds) Regenerative Strategies for the Treatment of Knee Joint Disabilities. Studies in
Mechanobiology, Tissue Engineering and Biomaterials, vol 21. Springer International
Publishing, Cham, Switzerland. doi:10.1007/978-3-319-44785-8
PACIFICI, M., KOYAMA, E. & IWAMOTO, M. 2005. Mechanisms of synovial joint and articular
cartilage formation: recent advances, but many lingering mysteries. Birth Defects
Research Part C: Embryo Today: Reviews, 75, 237-248. doi:10.1002/bdrc.20050
PEACOCK, J. D., HUK, D. J., EDIRIWEERA, H. N. & LINCOLN, J. 2011. Sox9 transcriptionally
represses Spp1 to prevent matrix mineralization in maturing heart valves and
chondrocytes. PloS one, 6. doi:10.1371/journal.pone.0026769
PFEIFER, A., ASZÓDI, A., SEIDLER, U., RUTH, P., HOFMANN, F. & FÄSSLER, R. 1996. Intestinal
secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II.
Science, 274, 2082-6. doi:10.1126/science.274.5295.2082
PHINNEY, D. G., GRAY, A. J., HILL, K. & PANDEY, A. 2005. Murine mesenchymal and embryonic
stem cells express a similar Hox gene profile. Biochemical and Biophysical Research
Communications, 338, 1759-1765. doi:10.1016/j.bbrc.2005.10.140
PINEAULT, K. M. & WELLIK, D. M. 2014. Hox Genes and Limb Musculoskeletal Development.
Current Osteoporosis Reports, 12, 420-427. doi:10.1007/s11914-014-0241-0
PITSILLIDES, A. A. & ASHHURST, D. E. 2008. A critical evaluation of specific aspects of joint
development. Developmental Dynamics, 237, 2284-2294. doi:10.1002/dvdy.21654
RAKIC, R., BOURDON, B., DEMOOR, M., MADDENS, S., SAULNIER, N. & GALÉRA, P. 2018.
Differences in the intrinsic chondrogenic potential of equine umbilical cord matrix and
cord blood mesenchymal stromal/stem cells for cartilage regeneration. Scientific
Reports, 8, 13799. doi:10.1038/s41598-018-28164-9
RANGANATHAN, P., AGRAWAL, A., BHUSHAN, R., CHAVALMANE, A. K., KALATHUR, R. K. R.,
TAKAHASHI, T. & KONDAIAH, P. 2007. Expression profiling of genes regulated by TGFbeta: Differential regulation in normal and tumour cells. BMC Genomics, 8, 98.
doi:10.1186/1471-2164-8-98
ROBERTSON, I. B., HORIGUCHI, M., ZILBERBERG, L., DABOVIC, B., HADJIOLOVA, K. & RIFKIN, D.
B. 2015. Latent TGF-β-binding proteins. Matrix Biology, 47, 44-53.
doi:10.1016/j.matbio.2015.05.005
190

ROKUTANDA, S., FUJITA, T., KANATANI, N., YOSHIDA, C. A., KOMORI, H., LIU, W., MIZUNO, A. &
KOMORI, T. 2009. Akt regulates skeletal development through GSK3, mTOR, and FoxOs.
Developmental biology, 328, 78-93. doi:10.1016/j.ydbio.2009.01.009
RUDINI, N., FELICI, A., GIAMPIETRO, C., LAMPUGNANI, M., CORADA, M., SWIRSDING, K.,
GARRÈ, M., LIEBNER, S., LETARTE, M., TEN DIJKE, P. & DEJANA, E. 2008. VE-cadherin is
a critical endothelial regulator of TGF-beta signalling. The EMBO journal, 27, 993-1004.
doi:10.1038/emboj.2008.46
SAITO, T., IKEDA, T., NAKAMURA, K., CHUNG, U. I. & KAWAGUCHI, H. 2007. S100A1 and S100B,
transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes.
EMBO reports, 8, 504-509. doi:10.1038/sj.embor.7400934
SCHEIJEN, B., BRONK, M., VAN DER MEER, T. & BERNARDS, R. 2003. Constitutive E2F1
overexpression delays endochondral bone formation by inhibiting chondrocyte
differentiation.
Molecular
and
Cellular
Biology,
23,
3656-3668.
doi:10.1128/mcb.23.10.3656-3668.2003
SCOTT, I. C., MASRI, B., D'AMICO, L. A., JIN, S.-W., JUNGBLUT, B., WEHMAN, A. M., BAIER, H.,
AUDIGIER, Y. & STAINIER, D. Y. R. 2007. The G protein-coupled receptor AGTRL1B
regulates early development of myocardial progenitors. Developmental Cell, 12, 403413. doi:10.1016/j.devcel.2007.01.012
SEKINE, K., OHUCHI, H., FUJIWARA, M., YAMASAKI, M., YOSHIZAWA, T., SATO, T., YAGISHITA,
N., MATSUI, D., KOGA, Y., ITOH, N. & KATO, S. 1999. Fgf10 is essential for limb and lung
formation. Nature Genetics, 21, 138-141. doi:10.1038/5096
SETTLE, S. H., ROUNTREE, R. B., SINHA, A., THACKER, A., HIGGINS, K. & KINGSLEY, D. M. 2003.
Multiple joint and skeletal patterning defects caused by single and double mutations
in the mouse Gdf6 and Gdf5 genes. Developmental Biology, 254, 116-130.
doi:10.1016/s0012-1606(02)00022-2
SHAM, M. H., LUI, V. C. H., FU, M., CHEN, B. & TAM, P. K. H. 2001. SOX10 is abnormally
expressed in aganglionic bowel of Hirschsprung's disease infants. Gut, 49, 220-226.
doi:10.1136/gut.49.2.220
SHI, Y. & MASSAGUÉ, J. 2003. Mechanisms of TGF-β signaling from cell membrane to the
nucleus. Cell, 113, 685-700. doi:10.1016/S0092-8674(03)00432-X
SHIMIZU, H., YOKOYAMA, S. & ASAHARA, H. 2007. Growth and differentiation of the
developing limb bud from the perspective of chondrogenesis. Development, Growth
& Differentiation, 49, 449-454. doi:10.1111/j.1440-169X.2007.00945.x
SHWARTZ, Y., VIUKOV, S., KRIEF, S. & ZELZER, E. 2016. Joint development involves a continuous
influx
of
Gdf5-positive
cells.
Cell
Reports,
15,
2577-2587.
doi:https://doi.org/10.1016/j.celrep.2016.05.055
SINGH, J. & PADGETT, R. A. 2009. Rates of in situ transcription and splicing in large human
genes. Nature Structural & Molecular Biology, 16, 1128-1133. doi:10.1038/nsmb.1666
SMITS, P., DY, P., MITRA, S. & LEFEBVRE, V. 2004. Sox5 and Sox6 are needed to develop and
maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth
plate. The Journal of cell biology, 164, 747-758. doi:10.1083/jcb.200312045
SOPHIA FOX, A. J., BEDI, A., & RODEO, S. A. 2009. The basic science of articular cartilage:
structure, composition, and function. Sports Health, 1, 461-468.
doi:10.1177/1941738109350438
STUART, T., BUTLER, A., HOFFMAN, P., HAFEMEISTER, C., PAPALEXI, E., MAUCK, W. M., III, HAO,
191

Y., STOECKIUS, M., SMIBERT, P. & SATIJA, R. 2019. Comprehensive integration of singlecell data. Cell, 177, 1888-1902.e21. doi:10.1016/j.cell.2019.05.031
SUN, M. M. G. & BEIER, F. 2014. Chondrocyte hypertrophy in skeletal development, growth,
and disease. Birth Defects Research Part C: Embryo Today: Reviews, 102, 74-82.
doi:10.1002/bdrc.21062
TAN, L. & YAMMANI, R. R. 2019. Nupr1 regulates palmitate-induced apoptosis in human
articular chondrocytes. Bioscience reports, 39. doi:10.1042/BSR20181473
TANG, F., BARBACIORU, C., WANG, Y., NORDMAN, E., LEE, C., XU, N., WANG, X., BODEAU, J.,
TUCH, B. B., SIDDIQUI, A., LAO, K. & SURANI, M. A. 2009. mRNA-Seq wholetranscriptome analysis of a single cell. Nature Methods, 6, 377-382.
doi:10.1038/nmeth.1315
TIAN, H., BIEHS, B., CHIU, C., SIEBEL, C. W., WU, Y., COSTA, M., DE SAUVAGE, FREDERIC J. &
KLEIN, OPHIR D. 2015. Opposing activities of Notch and Wnt signaling regulate
intestinal stem cells and gut homeostasis. Cell Reports, 11, 33-42.
doi:10.1016/j.celrep.2015.03.007
TRAPNELL, C., ROBERTS, A., GOFF, L., PERTEA, G., KIM, D., KELLEY, D. R., PIMENTEL, H.,
SALZBERG, S. L., RINN, J. L. & PACHTER, L. 2012. Differential gene and transcript
expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature
Protocols, 7, 562-578. doi:10.1038/nprot.2012.016
USDA 2017. Equine 2015, Equine Management and Select Equine Health Conditions in the
United States. United States Department of Agriculture, Animal and Plant Health
Inspection Service Veterinary Services, National Animal Health Monitoring System
Report 3.
WALTER, W., SÁNCHEZ-CABO, F. & RICOTE, M. 2015. GOplot: an R package for visually
combining expression data with functional analysis. Bioinformatics, 31, 2912-2914.
doi:10.1093/bioinformatics/btv300
WANG, W., RIGUEUR, D. & LYONS, K. M. 2014. TGFβ signaling in cartilage development and
maintenance. Birth Defects Research Part C: Embryo Today: Reviews, 102, 37-51.
doi:10.1002/bdrc.21058
WARNES, G. R., BOLKER, B., BONEBAKKER, L., GENTLEMAN, R., LIAW, W. H. A., LUMLEY, T.,
MAECHLER, M., MAGNUSSON, A., MOELLER, S. & SCHWARTZ, M. 2015. gplots: Various
R programming tools for plotting data.
WATANABE, H., DE CAESTECKER, M. P. & YAMADA, Y. 2001. Transcriptional cross-talk between
Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates
transforming growth factor-β-induced aggrecan gene expression in chondrogenic
ATDC5 cells. Journal of Biological Chemistry, 276, 14466-14473.
doi:10.1074/jbc.M005724200
WU, L., LEIJTEN, J., VAN BLITTERSWIJK, C. A. & KARPERIEN, M. 2013. Fibroblast growth factor1 is a mesenchymal stromal cell-secreted factor stimulating proliferation of
osteoarthritic chondrocytes in co-culture. Stem Cells and Development, 22, 2356-67.
doi:10.1089/scd.2013.0118
YAMAMOTO, K. R. & ALBERTS, B. M. 1976. Steroid receptors: elements for modulation of
eukaryotic transcription. Annual Review of Biochemistry, 45, 721-46.
doi:10.1146/annurev.bi.45.070176.003445
YAMAZAKI, S., NAKANO, N., HONJO, A., HARA, M., MAEDA, K., NISHIYAMA, C., KITAURA, J.,
192

OHTSUKA, Y., OKUMURA, K., OGAWA, H. & SHIMIZU, T. 2015. The transcription factor
Ehf is involved in TGF-β induced suppression of FcεRI and c-Kit expression and FcεRImediated activation in mast cells. The Journal of Immunology, 195, 3427-3435.
doi:10.4049/jimmunol.1402856
YOKOTA, J., CHOSA, N., SAWADA, S., OKUBO, N., TAKAHASHI, N., HASEGAWA, T., KONDO, H. &
ISHISAKI, A. 2014. PDGF-induced PI3K-mediated signaling enhances the TGF-βinduced osteogenic differentiation of human mesenchymal stem cells in a TGF-βactivated MEK-dependent manner. International Journal of Molecular Medicine, 33,
534-42. doi:10.3892/ijmm.2013.1606
ZENG, X. X. I., WILM, T. P., SEPICH, D. S. & SOLNICA-KREZEL, L. 2007. Apelin and its receptor
control heart field formation during zebrafish gastrulation. Developmental Cell, 12,
391-402. doi:10.1016/j.devcel.2007.01.011
ZHOU, Y., CHEN, M., RICUPERO, C. L., HE, L., WU, J., CHEN, K., FRIEDMAN, R. A., GUARNIERI,
P., WANG, Z., ZHOU, X. & MAO, J. J. 2018. Profiling of stem/progenitor cell regulatory
genes of the synovial joint by genome-wide RNA-seq analysis. BioMed Research
International, 2018, 9327487-9327487. doi:10.1155/2018/9327487
ZHU, H. & BENDALL, A. J. 2009. Dlx5 is a cell autonomous regulator of chondrocyte
hypertrophy in mice and functionally substitutes for Dlx6 during endochondral
ossification. PLOS ONE, 4, e8097. doi:10.1371/journal.pone.0008097

193

Vita

ChanHee Mok
EDUCATION
University of Kentucky, 2015 – 2020
Lexington, KY
Doctor of Philosophy in Veterinary Science
- Research subject: Equine Orthopedics, Cell Biology
Mok, C. H. 2020. Comparative chondrogenesis of interzone and anlagen cells in equine
skeletal development. University of Kentucky. Doctoral Dissertation
University of Kentucky, 2013 – 2015
Lexington, KY
Master of Science in Animal Science
- Research subject: Equine Nutrition
Mok, C. H. 2015. Using the indicator amino acid oxidation technique to study threonine
requirements in horses. University of Kentucky. Master’s Thesis
Konkuk University, 2007 – 2012
Seoul, South Korea
Bachelor of Science in Animal Science & Environment
- Research subject: Swine Nutrition
Mok, C. H. 2011. A comparison of an oven-drying method and a freeze-drying method for
measuring energy concentration in pig urine. Konkuk University. Bachelor's Thesis

AWARDS and ASSISTANTSHIPS
- Research Assistantship
Geoffrey C. Hughes Foundation, Fall 2015 – 2020
- Three-Minute Thesis (3-MT) competition for Graduate students, 1st place
College of Agriculture, Food and Environment, University of Kentucky, Spring 2019
- Three-Minute Thesis (3-MT) competition for PhD candidates, 2nd place
Department of Veterinary Science, University of Kentucky, Spring 2019
- Three-Minute Thesis (3-MT) competition for PhD candidates, 1st place
Department of Veterinary Science, University of Kentucky, Spring 2018
- Research Assistantship
Department of Animal and Food Sciences, University of Kentucky, Fall 2014 – Spring
2015
- Kentucky Opportunity Fellowship
University of Kentucky, Fall 2013 – Spring 2014
- Research Assistantship
Department of Animal Bioscience, Konkuk University, South Korea, 2011 – 2012
- Undergraduate Fellowship
Department of Animal Bioscience, Konkuk University, South Korea, 2007 – 2010

194

PUBLICATIONS
Mok, C. H. and K. L. Urschel. 2020. Amino acid requirements in horses – A review. AsianAustralas. J. Anim. Sci. 33:679–695.
Mok, C. H., C. L. Levesque, and K. L. Urschel. 2019. Precision nutrition for monogastric animals.
Monogastric Feed Research Institute, Konkuk University, Seoul, South Korea. p81 – 94. ISBN:
979-11-965289-1-1.
Mok, C. H., C. L. Levesque, and K. L. Urschel. 2018. Using the indicator amino acid oxidation
technique to study threonine requirements in horses receiving a predominantly forage diet.
J. Anim. Physiol. Anim. Nutr. 102:1366–1381.
Mok, C. H., C. Kong, and B. G. Kim. 2015. Combination of phytase and β-mannanase
supplementation on energy and nutrient digestibility in pig diets containing palm kernel
expellers. Anim. Feed. Sci. Technol. 205:116–121.
Mok, C. H., J. H. Lee, and B. G. Kim. 2013. Effects of exogenous phytase and β-mannanase on
ileal and total tract digestibility of energy and nutrient in palm kernel expeller-containing diets
fed to growing pigs. Anim. Feed. Sci. Technol. 186:209–213.
Mok, C. H., S. Y. Shin, and B. G. Kim. 2013. Aflatoxin, deoxynivalenol, and zearalenone in swine
diets: Predictions on growth performance. Rev. Colomb. Cienc. Pecu. 26:243–254.

195

